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Osteoarthritis (OA) is one of the most common forms of arthritis and chronic disease of 
the hip and knee joints [1]. It is affecting millions of people worldwide and is projected to 
increase even more due to ageing of the global population. When conservative treatment 
fails, end-stage OA of the hip and knee joint is commonly treated with arthroplasty 
surgery. These surgeries have proven to achieve long-lasting improvement of disability 
and pain symptoms with restoring patients’ quality of life [2]. Over the past decades, 
these arthroplasty procedures are increasingly performed and are expected to increase 
even more in the upcoming years. Estimations in the United States projected a raise of 
primary hip arthroplasty up to 174%, and a growth of primary knee arthroplasty with 
673% by 2030 [3]. Making these operations one of the most performed and successful 
surgeries worldwide within orthopaedic care. 
Clinical pathways
Over the past decade, hip and knee arthroplasty surgeries evolved rapidly. Minimal 
invasive techniques were developed, for example patient-specific instruments were 
introduced, and thereby outcomes after surgery improved [4]. Besides these technical 
solutions, the optimisation of the ‘patient journey’ towards this result is becoming more 
important. Traditionally, patients undergoing hip and/or knee arthroplasty are treated in 
so-called joint arthroplasty pathways. These pathways are defined as a combination of 
evidence-based clinical features included in the pre-, peri-, and postoperative protocols, 
with its aim to streamline the arthroplasty procedure from admission to discharge. The 
main goals are to reduce mortality, morbidity and to improve (medical and functional) 
outcome during and after surgery. Ideally, the usage of these pathways results in a 
decreased length of hospital stay (LOS) and improved patient satisfaction regarding 
the complete surgical process [5]. 
From a historical point of view, patients were in the hospital for several weeks after 
arthroplasty surgery with obligated bed rest for the first days up to several weeks. Patients 
were then mobilised with restricted weight-bearing during their hospital stay. This 
resulted in a high level of comorbidities and (serious) adverse events ((S)AEs) regarding 
arthroplasty surgery (e.g. risk of thrombosis, high percentage of perioperative blood 
transfusions and extensive use of (opioid) pain medication resulting in postoperative 
nausea and vomiting (PONV)). 
In the late 90’s, arthroplasty pathways were optimised. Several introductions were 
made to prevent for blood transfusions (e.g. autologous transfusion of drain content, 
preoperative erythropoietin usage), reduce pain experience (e.g. patient controlled 
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analgesia (PCA)), shorten LOS (e.g. introduction of discharge criteria) and improved 
patient satisfaction (e.g. involvement of a coach, patient centred care) [6,7]. A less 
stringent postoperative policy was then introduced, making it able for patients to be 
mobilised the first day after surgery. These optimisations tremendously changed the 
in-hospital treatment of arthroplasty patients in terms of postoperative outcomes (e.g. 
reduction of transfusion rate and thrombo-embolic events, and improvement of pain 
scores and patient reported outcomes measures (PROMs)) and reduced LOS [8]. The 
introduction of evidence-based pathways was thereby established as an indispensable 
factor in the treatment of hip and knee arthroplasty patients. 
Fast-track surgery and surgical stress response
As a further development of the previously described pathways, fast-track surgery 
pathways were introduced in the 21st century [9]. The fast-track philosophy is based 
on the reduction of the surgical stress response [10]. This response is characterized 
by activation and changes of several systems. After surgical tissue injury, the nervous 
system activates the stress response leading to an endocrine response, as well as 
induction of changes in the immunological and haematological systems with a systemic 
inflammatory response [11]. 
To manage and even reduce this response, optimised perioperative protocols are 
needed to guide the patient through the operative process with minimized effects of 
surgical stress.
The surgical stress tops within the first days after surgery. Therefore, the first days 
(even first hours) after surgery are of crucial importance to prevent for (S)AEs. Several 
crucial optimisations are the basis of an optimised pathway and the reduction of surgical 
stress, starting preoperatively until the end of the rehabilitation. For example, with the 
introduction of a multimodal pain protocol, which included a time-based schedule 
of several non-opioid medications, the consumption and need for opioid medication 
could be significantly reduced [12]. One of these factors is the usage of local infiltration 
analgesia (LIA) in knee arthroplasty [13]. Furthermore, systemic glucocorticoids were 
introduced to prevent for PONV [14]. With a positive side effect on pain reduction, 
systemic glucocorticoid holds an important role in early discharge. Low-dose spinal 
anaesthesia or low dose opioid general anaesthesia provided the basics for patients 
to be mobilised early during the direct postoperative phase. Combined with LIA, 
patients are able to mobilise safe within several hours after surgery. Which allows to 
rapidly achieve discharge criteria (e.g. safe mobilisation, walking stairs with crutches if 




1Traditions were thereby ceased; patients were no longer obligated to be in hospital for 
more than 2 days, based on their medical conditions. To facilitate early mobilisation 
(and thereby early achievement of these discharge criteria), urinary catheters and 
closed-suction drainage were no more used on a regular basis but only in case of 
an adverse course or in patients with pre-existing comorbidities. One of the most 
remarkable optimisations can be seen in the usage of tranexamic acid (TXA) 
perioperatively [15,16]. It reduced allogenic blood transfusion dramatically and ruled 
out the arguments to use autologous blood (re)transfusion via closed-suction drains. 
Fast-track surgery pathways are characterised by the multidisciplinary approach 
to patient care with use of evidence-based protocols [5]. The multidisciplinary 
team consist of surgeons, anaesthesiologists, hospital pharmacist, nursing staff and 
physiotherapists on the medical basis, coordinated by a professional project leader 
and person of contact, such as a physician assistant. Other specialities are involved 
as well on the more practical side of the process (e.g. managers, planners, secretaries, 
communication office). Success depends on the collaboration of these different 
entities as a total process. 
Outpatient joint arthroplasty
With the ongoing improvement of the perioperative process and the further reduction 
in LOS of fast-track surgery programs, outpatient joint arthroplasty (OJA) becomes 
feasible. Substantiated with an increasing amount of evidence, these OJA pathways 
are extended to daily practice [17,18,19,20,21]. The introduction of OJA pathways 
was done on the basics of two major principles. Firstly, due to the growing trends in 
amounts of arthroplasties performed globally. As the global population ages, demand 
for hip and knee arthroplasty will rise. To cope with this demand, hospitals need to 
be equipped to treat high volumes of patients in the upcoming years. By reducing the 
LOS, the volume of arthroplasty procedures can be increased, substantiated with an 
optimisation of the complete arthroplasty process in the hospital (e.g. operation-room 
planning, improvement of surgery duration). Secondly, patient’s preferences should 
be taken into account. Although no precise evidence is available, it is assumed that 
patients prefer to recover in their own environment. OJA pathways encounter these 
preferences. Despite the growing trend and evidence of OJA, these pathways are at 
the beginning of their development [22]. Evidence-based guidelines on the selection 
of ‘appropriate’ patients should be investigated further [17,23]. With an aim to first 
improve the arthroplasty pathway, a safe and efficient reduction of LOS towards OJA 




AIM of this thesis
The studies of the present thesis were performed to analyse several aspects of the 
implementation of clinical pathway features, to improve outcome after hip and knee 
arthroplasty (part 1). Additional aims for this thesis were to examine the safety and efficacy 
of the implementation of outpatient joint arthroplasty pathways into daily practice in a 
teaching hospital (part 2). Resulting in the following research questions:
Part 1: Clinical pathway optimisation
1. Preoperative patient education: Are patients satisfied with the offered preoperative 
information? 
2. Blood management: Does tranexamic acid reduce, in a safe manner, perioperative 
allogenic blood transfusions? 
3. Pain management: Is local infiltration analgesia with ropivacaine alone at least equal 
effective compared to ropivacaine with adrenaline in the mixture? 
4. Urinary management: Can we omit standard usage of urinary catheters in primary hip 
and knee arthroplasty without causing increased postoperative urinary retention? 
Part 2: Outpatient joint arthroplasty
5. Outpatient unicompartimental knee arthroplasty: Is outpatient joint arthroplasty 
feasible for unicompartmental knee arthroplasty in a selected group of patients? 
6. Evidence based practice and the literature: Are outpatient joint arthroplasty pathways 
safe and effective? 
7. Patient selection: Which patients are eligible for outpatient joint arthroplasty? 
8. Physical activity: How physically active are patients after outpatient surgery in their 
own environment compared to inpatient knee arthroplasty? 
9. Quality of life: Does outpatient joint arthroplasty, compared to the standard inpatient 
joint arthroplasty, effect the improvement of patient reported quality of life after 
surgery?
Outline of the thesis 
The presented studies in this thesis are divided into two parts; firstly the pre- and 
perioperative clinical optimisations and secondly the implementation of outpatient joint 
arthroplasty. 
Part one starts with a qualitative study regarding patients experiences on preoperative 
patient information and thus patients’ expectations. Management of these expectations 
after surgery directly influence postoperative outcomes and is therefore of major 
importance. Chapter 2 outlines the patients’ experiences on the usage of an information 
brochure handed out to knee arthroplasty patients.
General introduction
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1The following chapters focusses on three major issues in primary hip and knee 
arthroplasty; firstly, the introduction of TXA (chapter 3), to reduce blood loss and 
prevent for allogenic blood transfusions after hip and knee surgery, was examined. 
Secondly, LIA in total knee arthroplasty (TKA), administered via an intra-operative 
single shot analgesic mixture with or without adrenaline was studied (chapter 4). And 
finally, examination of a management protocol for prevention of urinary retention after 
hip and knee arthroplasty was performed (chapter 5). 
Part two continues the journey on implementing an OJA pathway. Chapter 6 presents 
the first results of a selective group of patients undergoing unicompartmental knee 
arthroplasty (UKA) in an outpatient setting. These patients were compared to a match 
cohort of patients receiving the standard of care (inpatient). 
A systematic review with meta-analysis was performed to review the current literature 
regarding OJA pathways compared to the standard of care (chapter 7). Chapter 8 shows 
an evidence based statement regarding patient selection criteria for OJA pathways. To 
prevent for (S)AEs in the (early) postoperative phase and to successfully discharge 
patients on the day of surgery, adequate patient selection is paramount. In chapter 9 
patients’ physical activity after TKA was assessed in the patients’ home-environment. 
Patients’ activity level undergoing TKA on an outpatient base were compared to patients 
undergoing surgery in an inpatient (fast-track) pathway. 
Finally, a comparison between outpatient and inpatient arthroplasty patients in the 
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PATIENTS’ EXPERIENCES OF AN
INFORMATION BROCHURE IN
KNEE ARTHROPLASTY. A BRIEF
QUALITATIVE STUDY.
CHAPTER 2
Yoeri FL Bemelmans, Bob Heijkens, Emil H van Haaren, 
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Introduction Patient information holds an important role in knee arthroplasty surgery 
regarding patients’ expectations and therefore outcome after surgery. The purpose of 
the present study was to explore the experiences and opinions of patients undergoing 
knee arthroplasty (KA) surgery on a preoperatively provided information brochure.
Methods A qualitative case study in 8 patients, with use of individual semi-structured 
interviews, was conducted to evaluate patients’ opinion on an information brochure in 
KA surgery. 
Results Patients rated the brochure as good and recommended its use. Unsatisfying 
information regarding wound healing, pain expectations, postoperative exercises 
and usage of walking aids was reported. Patients stated that the table of content was 
insufficient and the size of the brochure (A4-format) too large. Patients reported to have 
no need for additional digital sources (e.g. applications, websites). 
Conclusion These opinions support the use of an information brochure and improved 
the content and formal requirements. The reported opinions were used to improve the 
brochure. Future research should focus on the improvement of information sources by 
involving patients (and other users) in de development process, in which the information 
is tailored towards the patient demands. 
Keywords Knee Arthroplasty; Patient Information; Preoperative Education




Patient information holds an important role in knee arthroplasty (KA) surgery. 
Traditionally, patients receive verbal and written information by the surgeon on the 
preoperative preparations, hospital admission, surgical procedure, postoperative care 
and expectations after surgery. Walker [21] reviewed the literature on the effects of 
information on general patient satisfaction. Despite the fact that this study concluded 
that there is contradicting evidence, good-quality preoperative information seems 
to facilitate patients to get actively involved in their care. In the information process, 
patient expectation management holds an indispensable role and good preoperative 
information can prevent unfulfilled expectations [18]. Patient information is ideally 
provided as written content, since the retention of verbal information by patients is low 
[8,13]. To increase reproducibility, patient information should be repeatedly available 
for patients. 
The purpose of the present study was to explore the experiences and opinions of 
patients undergoing KA surgery on a preoperatively provided information brochure.
Methods
This study included patients undergoing primary elective unicompartmental or total 
KA. A qualitative and exploratory case study, with use of individual semi-structured 
face-to-face interviews, was conducted.
Preoperative patient information
After consultation of the orthopaedic surgeon, patients undergoing KA surgery received 
a brochure on the day that the patient was added to the waiting list. The orthopaedic 
operation room (OR) planner handed out the brochure and explained its use. On 
average, patients received the brochure 6-8 weeks prior to surgery. The brochure (A4 
format) contains information on the patient pathway, divided in several sections (table 
1). It was developed in collaboration with all stakeholders forming the multidisciplinary 
team (consisting of nurses, physiotherapists, physician assistants, anaesthesiologists, 
hospital pharmacist orthopaedic surgeons, managers, planners and communications 
department). Content of the brochure was based on the information supplied by the 
Dutch Orthopaedic Society [15] and adjusted to incorporate in our clinical pathway. 
Continues improvements were made after several patients gave solicited and unsolicited 
advice on the content of the brochure. 
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Furthermore, patients underwent a physical education session by the hospital 
physiotherapists and were trained to walk with crutches and climbing stairs. A 
preoperative consultation by the anaesthesiologist was performed to prepare and 
discuss type anaesthesia during surgery, and consultation by a nurse to help patients 
preparing their environment prior to surgery. 




● Information on the illness and arthroplasty procedure
● Expectations after surgery regarding functional improvements and 
possible adverse events
● Home preparations
● Relative or coach selection for postoperative aiding
● Screening by anaesthesiologist and nurse
● Physical physiotherapy education class
Hospital admission ● Timetable of admission
● Procedures and transfers within the hospital
● Preoperative medication protocol
● General preparations for surgery
Postoperative treatment ● Expectations after surgery regarding anaesthesia, pain and length of 
hospital stay 
● Exercise instructions and physiotherapy sessions
● Self-administration of thrombosis prophylaxis
● Postoperative medication protocol
● Wound care
● Discharge criteria
Follow-up after surgery ● Information in case of any adverse events or questions after discharge
● Postoperative outpatient visits 
Procedure 
Patients were invited to participate on their six weeks postoperative visit. It was 
assumed that within this timeframe, patients would still remember their experiences 
after surgery, and they had enough opportunities to actually apply the information of 
the brochure. Participants who received primary elective KA surgery and who are able 
to read and understand the Dutch language were eligible candidates. Patients who were 
not able to read the brochure (e.g. because of cognitive disorders) and/or experienced 
severe complications (e.g. requiring re-admission or re-operation) after surgery, were 
excluded. Eligible participants received an information letter and gave written informed 
consent. The interview took place at the patient’s home. 




Semi-structured interviews were conducted by two researchers, one functioning as 
conversation partner and the other as subscribe. The interviews were audio recorded. 
A semi-structured topic list was used (table 2). Patients had the opportunity to give and 
explain their opinion on each topic. Summarization was used during the interviews to 
determine accuracy and correctly interpreted data. Subsequently, idea’s on and need 
for other information sources were evaluated. 
Table 2. Semi-structured interview topic list. 
Topic Subtopic
Explanation of the interview ● Purpose of the interview
● Practical considerations
Design of brochure ● First impression
● Size
● Formal requirements (font size, style)
● Titles
● Colour
● Figures / pictures / tables
Structure of the brochure ● Table of contents
● Chapter structure
● Order of subjects
● Clarity
Content of the brochure ● Importance of information
● Description of the content
● Completeness of the information
● Depth of the topics
● Adequacy
Usage of the brochure ● Frequency
● Other users
Need for usage of other information sources ● Video material
● Website
● Applications
● Additional figures / pictures
Other ● Patients’ input
● Questions
Data-analysis
Demographic data of the participants were collected. All interviews were transcribed 
verbatim. Data analysis was performed with use of inductive content analysis. The 
answers were collected and coded according to the topics. To state the codes, the 
most extensive interviews were coded first. If no new information emerges during the 
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interviews, code saturation was expected to be reached. Investigator triangulation was 
achieved by interviewing the patients and analysing the data with two researchers 
separately. Any discrepancies between researcher’s interpretations were discussed 
until agreement was reached
Ethics
This study was performed in compliance with the Helsinki Declaration of 1975, as revised 
in 2013 and was studied and approved by the IRB and conducted in accordance with the 
guidelines for Good Clinical Practice.
Results
A total of 8 participants were included. The demographic data of the participants are 
presented in table 3. Patients’ experiences and opinions are outlined according to the 
topic list (table 2). 
Table 3. Patient characteristics and demographics. 
ID Gender Age (years) Education level Profession Type of arthroplasty
1 Male 72 Bachelor’s degree Commercial manager UKA
2 Male 53 Associate degree Grocer UKA
3 Female 58 Associate degree Cabdriver UKA
4 Male 71 Bachelor’s degree Architect UKA
5 Male 60 Associate degree Assembly operator UKA
6 Female 64 Associate degree Fitness instructor TKA
7 Male 76 Associate degree Justice TKA
8 Female 71 High school Saleswoman TKA
UKA, unicompartmental knee arthroplasty; TKA, total knee arthroplasty
Design of the brochure
Patients reported that the brochure is written with a clear letter size, letter type, line spacing 
and sizing of the paragraphs. The current size of the brochure is too large and had a deterrent 
effect on the participants and they prefer a smaller size (A5 instead of A4 format). 
P1: “I actually thought it was a big brochure. I thought, hey, what am I getting here?” 
Structure of the brochure
Patients reported that the table of content was not clear enough, which made it hard for 
them to find certain information on specific subjects. 
Patient information in knee arthroplasty
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P2: “[…] and then you just have to browse [...] the index is not really clear.” 
Not all pictures regarding exercises clarified the plain text enough and could be 
presented in a higher resolution. 
Content of the brochure
The content was overall clear and written in an understandable language. Patients 
stated that the information as reliable. Several adjustments were proposed, such as 
description on other walking aids, besides canes/crutches, is missing. 
P7: “Well I found out; it just tells you about crutches. That you have to bring them in 
advance, but I have found that it is much easier to walk with a walker instead.”
There should be more information on self-exercising and intensity build-up of 
exercises during rehabilitation. One patient stated to describe more accurate 
expectations on pain experiences. 
P1: “[...] there, you highlight what you are not allowed to do. But maybe the process of 
what you feel after the surgery, where you say the first step is wound pain [...] so that 
you are at least reassured.” 
Patients advised to describe more accurate information on spinal anaesthesia and in 
particular how long the anaesthetic would last. Furthermore, patients were interested 
in information about the surgeons (e.g. background information, specialties). It was 
advised by several patients to delete the 3-month outpatient visit, since this was 
omitted from the follow-up after surgery.
Usage of the brochure
All patients stated that they used the brochure and recommend its use. Patients 
indicated that the brochure was necessary to provide all the information regarding 
their KA surgery. Caregivers also used the brochure. 
P3: “Yes, my daughter and son used it very extensive. They liked it.” 
Need for usage of other information sources
Patients stated that medical care apps were not an option for them, although they 
could imagine the usage of it by next generations. 
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P1: “Of course, you could have a video, or you could download a mobile app. But maybe 
that’s for a few years later. Because now I saw almost all older people who, like me, 
don’t really like apps. You wouldn’t fulfill their needs, I guess.” 
Discussion
The most important finding of this study is that the overall experiences on the provided 
patient information were positive. Patients were satisfied with the given information 
regarding their KA surgery. 
Patient expectation management holds an important role in KA surgery, unmet 
expectations after surgery can result in dissatisfaction [5,10,14]. To prepare patients 
before surgery, information regarding the procedure and expectations after surgery 
can be done by providing oral and written content, with a possible addition of face-
to-face contacts (e.g. physical therapy sessions, preoperative information classes, so-
called ‘joint-schools’). Besides providing written content, patients had several face-to-
face contacts in the current study; the orthopaedic surgeon provided oral information, 
patients received information from the OR planner regarding practical considerations 
(e.g. date of surgery), had a preoperative consultation by the anaesthesiologist/nurse 
and underwent a physical education session by the physiotherapist. The combination 
of preoperative educational programs with written information has been examined 
before [11,16,2]. These papers concluded that this strategy did not (positively) affect 
postoperative outcomes in terms of safety (e.g. complication rates, length of hospital 
stay). When analysing other outcomes, a multimodal educational approach (verbal 
and written information) on opioid consumption and pain resulted in reduced usage of 
opioids after surgery [16]. The authors stated further that information solely on patients’ 
expectations after surgery did not reduce pain scores, indicating that a multimodal 
educational approach is desirable. This is in line with another study reporting no effect 
of preoperative education alone on postoperative pain scores [3]. 
Another proposed advantage of patient education is reduced preoperative anxiety. 
As anxiety is strongly related to poorer postoperative outcomes (in terms of patients 
satisfaction after KA), it is of major importance to address this anxiety prior to surgery 
[1]. Aydin et al. [2] reported a reduction of preoperative anxiety after implementation 
of preoperative patient education. In addition, Tong et al. [19] reported psychological 
interventions prior to surgery to be beneficial in the reduction of anxiety and mental 
components of quality of life on the long term. This addresses the need for patient 
specific and targeted preoperative patient information. 
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Several studies [12,17] examined the patients’ needs regarding perioperative information. 
They concluded that patients need information on the healthcare specialists, 
postoperative care, recovery and medication. Especially information on medication 
(e.g. expected levels of pain, medication use, side-effects) was found to be of major 
importance, which is in line with the presented opinions and recommendations by the 
patients in the current study. 
The points for improvement to increase readability (e.g. table of content, figure/image 
resolution), are also in line with other studies. As stated by other authors, these aspects 
regarding design are of major importance (e.g. letter type, letter size, paragraph usage) 
[6,7,9,20]. 
With the introduction of applications and websites, the availability of information 
increased. Despite great advantages of this freely available information, concerns 
regarding the reliability and variability are present [4]. Although patients reported less 
need for additional applications or websites, patients reported the size of the brochure 
as a limitation, in which an application could be more tailored towards the patient’s 
wishes regarding size. Another major advantage would be the ease to change and 
manage information. For example, patients reported that the given information was 
outdated on the postoperative visits in the hospital. 
This study has several limitations. The sample might be biased because all participants 
stated that they were satisfied with their overall treatment process. To extract more 
insight in adverse experiences, the cohort should ideally include dissatisfied patients 
as well. Furthermore, it is to be expected to gain more data saturation in a larger cohort 
of patients. 
The next step should be to improve information brochures (or other material) by 
involving the patients (and other users) in the development process (co-creation).
Conclusion
In conclusion, patients rated the information brochure on KA surgery as good and 
recommended its use. The reported opinions on content (e.g. wound healing, pain 
experiences, exercise intensity build-up, usage of walking aids) and formal requirement 
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Purpose The purpose of this study was to retrospectively evaluate the efficacy of a 
tranexamic acid (TXA) perioperative protocol for primary hip- and knee arthroplasty, 
in terms of allogenic blood transfusion rates. 
Methods A retrospective cohort study was conducted and included all primary hip 
and knee arthroplasty procedures in the period of 2014-2019. Patients who underwent 
surgery due to trauma or revision were excluded. A total amount of 5205 patients 
were eligible for inclusion. Two equal and weight depending doses of TXA were given, 
preoperative as an oral dose and intravenously at wound closure. The primary outcome 
was blood transfusion rate. Further analysis on patient characteristics (e.g. age, gender), 
blood loss, perioperative haemoglobin (Hb) levels and complication/readmission rate 
was performed. 
Results A total of 49 (0.9%) patients received perioperative allogenic blood 
transfusions. Mean age, distribution of gender, body-mass index, American Society 
of Anaesthesiologists score, duration of surgery, type of arthroplasty, estimated blood 
loss, perioperative Hb levels and length of stay were statistically significant different 
between transfused and not-transfused patients. The incidence of thromboembolic 
adverse events (e.g. deep vein thrombosis/lung embolism) was 0.5%. 
Conclusion Low blood transfusion rate was found after implementation of a standardized 
perioperative TXA protocol for primary hip and knee arthroplasty. 
Keywords Tranexamic Acid, Fast-Track Surgery, Knee Arthroplasty, Hip Arthroplasty, 
Unicompartmental Knee Arthroplasty




Since the introduction of tranexamic acid (TXA) usage in primary hip- and knee 
arthroplasty procedures, perioperative blood loss is reduced with a decreased 
incidence of allogenic blood transfusions [1,7,15,27,30]. TXA is a synthetic analogue of 
the amino acid lysine that reduces blood loss by inhibiting the degradation of fibrin and 
disintegration of blood clots. Perioperative allogenic blood transfusions are strongly 
related to increased risk of surgical site infection and deep venous thrombosis [14,17]. 
Therefore, it is of paramount importance to prevent blood transfusions. Standardized 
perioperative protocols are used without an increased risk of perioperative thrombo-
embolic events (e.g. deep venous thrombosis/pulmonary embolism) [8,9,10,19]. Given 
these benefits, a perioperative TXA protocol is increasingly implemented and used 
in primary hip and knee arthroplasty. Different perioperative protocols exist on type 
of administration, frequency of administration, dosage and timing of administration. 
TXA can be administered orally, intravenously or topical, with equal safety and 
efficacy in terms of postoperative blood transfusions and (low) adverse events (AE) 
rates [2,3,8,10,11,19,21,28,29]. To maximise the effect of TXA and minimise AE rates, 
perioperative protocols are needed with substantial clinical evidence. The aim of this 
study was to evaluate the incidence of perioperative allogenic blood transfusions after 
the implementation of a combined low-dose oral and intravenous TXA protocol for 
elective hip and knee arthroplasty.
Patients and methods
This retrospective cohort study evaluates the incidence of allogenic blood transfusions in 
patients who have been operated on primary total hip (THA), unicompartimental (UKA) 
- and total knee arthroplasty (TKA). All data was obtained from the hospital transfusion 
and surgery registration. To evaluate possible inclusion in this study, the complete 
database of surgeries performed between June 2014 and June 2019 were screened. All 
primary unilateral THA, UKA and TKA patients were included. Arthroplasty surgeries 
related to complications, revision or trauma were excluded from analysis. Selection of 
patients is presented in figure 1.
Pre-, peri, and postoperative protocols
All patients were operated with the use of standardized perioperative protocols regarding 
fast-track or outpatient surgery (e.g. multimodal pain management, mobilisation <24hrs 
after surgery, no drain/urinary catheter) [22]. In UKA procedures, tourniquet was used. 
Only in knee arthroplasty patients, local infiltration analgesia was used. Patients were 
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either operated in the inpatient pathway, with an average length of hospital stay of 2 days, 
or as an outpatient with discharge from the hospital on the day of surgery [18]. Blood typing 
and cross matching was performed preoperatively in all patients. Patients were screened 
for preoperative anaemia and if deemed necessary, further analysed preoperatively in our 
hospital. Operations were performed under general or spinal anesthesia (with or without 
sedation). All patients received antibiotic prophylaxis (intravenous (IV) administration 
of 2000mg (<100 kg); 3000mg (>100 kg) Cefazolin) in three doses; 15-60min before 
incision, 8 and 24hrs postoperative. In case of a known allergy for Cefazolin, Vancomycin 
(IV administration of 1000mg (<100 kg); 1500mg (>100 kg), preoperative dose and 12hrs 
postoperative second dose) was given. For patients following the outpatient pathway, the 
last dose was not given due to practical consideration.




















Arthroplasty related surgeries, n= 6394 
Excluded patients, n= 1189 
 Trauma related, n= 627 (e.g. hemi- hip 
arthroplasty, periprosthetic fractures) 
 Revision surgery, n= 328 (e.g. 
stem/cup revision, bearing change) 
 Complication related, n= 234 (e.g. 
persistent wound leakage, infection, 
luxation, arthrofibrosis, puncture) 
Included, n= 5205 
 UKA, n= 412 
 TKA, n= 2546 
 THA, n= 2247 
Patients received blood 
transfusion within the total 
cohort*, n= 49 
 TKA, n=16 
 THA, n=33 
TXA was given in two doses. First dose was given orally (Cyclokapron®, Mylan, Hatfield, 
United Kingdom) 2hrs before incision by the nurse on the orthopaedic ward. Second 
dose was given IV (Cyclokapron®, Pfizer, New York City, United States) at the end of the 
surgery when the wound was closed, administered by the anaesthesiology assistant. 
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The dosage, orally and intravenously, depended on the weight of the patient; <100kg: 
1000mg, >100kg: 1500mg. In case of a known hypersensitivity for TXA, severe renal 
function disorders (<50 mL/min creatinine clearance or dialysis depending) or recent 
history (<6 months) of a vascular event (e.g. cerebrovascular/myocardial infarction or 
deep venous thrombosis/pulmonary embolism), TXA was not given. Postoperatively, all 
patients received thrombosis prophylaxis with the use of low molecular weight heparin 
(LMWH), except for patients who were on vitamin K antagonists (VKA) or non-VKA oral 
anticoagulants (NOAC) prior to surgery. LMWH thrombosis prophylaxis (subcutaneous 
injection of 5000IE (Dalteparin®, Pfizer, New York City, United States) once daily started 
on the day of surgery and was continued up to six weeks after the arthroplasty. After 
surgery patients were monitored at the Post Anaesthesia Cure Unit (PACU) for several 
hours, before being transferred to the orthopaedic ward. Postoperatively, haemoglobin 
(Hb) levels were determined the first postoperative day. Except for patients undergoing 
UKA surgery via the outpatient pathway, Hb levels were not routinely measured. In case 
of general unwell-being, Hb levels were determined. Depending on Hb levels and clinical 
evaluation of the patient by the orthopaedic ward physician, allogenic blood transfusion 
was considered according to the recent national guidelines [20]. 
Data collection
Data collection was performed via the in-hospital registration system of blood 
transfusions and the patient’s digital medical records. 
Outcome measures
The primary endpoint of this study was the incidence of blood transfusions in elective hip- 
and knee arthroplasty. As secondary outcomes, patients in the transfusion group were 
compared to patient in the non-transfusion group on the following variables: gender, side 
of surgery, age, body-mass index (BMI), American Society of Anaesthesiologists (ASA) 
classification, type of anaesthesia (spinal or general), duration of surgery (minutes), 
type of arthroplasty (THA, UKA or TKA), patient specific instruments (PSI) usage in 
TKA, cementation in THA, estimated blood loss, pre- and postoperative Hb levels and 
length of hospital stay (LoS). In addition, the incidence of postoperative thrombo-
embolic events (e.g. deep venous thrombosis/pulmonary embolism, cerebrovascular, 
myocardial) up to 3 months postoperatively was assessed in both groups.
Ethics
This study was performed in compliance with the Helsinki Declaration of 1975, as revised 
in 2013 and was studied and approved by the IRB (METC Z, Heerlen, the Netherlands, 





All statistical analyses were performed with the use of Statistical Package for the Social 
Sciences version 26.0 for windows (SPSS., Inc., Chicago, IL). Descriptive statistics are 
used to summarize data. Student’s t-tests were performed on significant interactions 
between both groups. Chi-square test was used for categorical variables. A threshold for 
all statistical comparisons of p-value ≤ 0.05 was considered to be statistically significant. 
Data are presented as means with standard deviations, 95% confidence level (CI), 
frequencies (%) or medians with ranges.
Results
A total group of 5205 patients were analysed. The incidence of perioperative blood 
transfusion was 0.94% (n=49). One patient (TKA) received blood transfusion during the 
operation, as the other patients received blood transfusion after surgery on the clinical 
ward. Study patients were divided into two groups, transfused- (BT) and non-transfused 
(non-BT) patients. Differences for patient demographics and perioperative outcome 
measures between BT and non-BT patients are presented in table 1. 
Patients in the BT group had significant (P ≤0.05) higher ASA score (≥III), age, prolonged 
LoS, and lower BMI scores. No significant differences were found for type of anesthesia 
and side of surgery. Only in THA patients, the BT group had a longer duration of 
surgery, higher estimated blood loss and consisted of significantly more uncemented 
arthroplasties. 
Pre- and postoperative Hb levels in THA and TKA patients were statistically significant 
different between BT and non-BT patients. Since there were no transfusions in the UKA 
group; estimated blood loss, duration of surgery and perioperative Hb levels could not 
be sub-analysed. AE’s and readmission rates are presented in table 2 for both groups 
with an incidence of 0.46% for thromboembolic AE’s (e.g. deep vein thrombosis/lung 
embolism/cerebrovascular- or myocardial event).
Tranexamic acid in hip and knee arthroplasty
37
3
Table 1. Demographic data for non-transfused and transfused patients are presented as mean (SD) with 
95% confidence interval [CI] or frequencies (%). A p-value of ≤0.05 was considered to be statistically 
significant different.
Non-transfused (n=5.156) Transfused (n=49) p-value
Patient demographics
Gender, female 3140 (60.9) 39 (79.6) 0.008
Side of surgery, right 2779 (53.9) 24 (49.0) 0.492
Agea 69.0 (9.3) [68.8-69.3] 76.3 (10.2) [73.4-79.2] 0.000
BMIb 28.9 (5.0) [28.7-29.0] 26.1 (4.8) [24.7-27.5] 0.000
ASA classification, I/II/III/IV 788/3918/444/6 0/38/10/1 0.000
Anesthesia, spinal/general 3743/1413 36/13 0.891
THA/TKA/UKA 2206/2523/412 33/16/0 0.001
Duration of surgeryc, THA 0:59 (0:16) [0:58-0:59] 1:02 (0:19) [0:56-1:09] 0.028
Duration of surgeryc, TKA 1:04 (0:16) [1:03-1:05] 1:10 (0:25) [0:56-1:24] 0.133




Blood lossd, THA 362.3 (171.7) [354.4-370.2] 421.7 (263.2) [307.9-535.6] 0.024
Blood lossd, TKA 261.5 (119.1) [256.1-266.8] 323.1 (123.5) [248.4-397.7] 0.262
Pre-OR Hb levele, THA 8.7 (0.8) [8.6-8.7] 7.2 (1.1) [6.8-7.6] 0.000
Post-OR Hb levele, THA 7.3 (0.9) [7.2-7.3] 5.7 (0.7) [5.4-6.0] 0.000
Pre-OR Hb levele, TKA 8.7 (0.8) [8.7-8.8] 7.3 (1.2) [6.6-7.9] 0.000
Post-OR Hb levele, TKA 7.4 (0.8) [7.4-7.5] 5.5 (0.7) [5.1-5.8] 0.000
Delta Hb levele, THA 1.4 (0.6) [1.3-1.4] 1.5 (0.8) [1.3-1.8] 0.873
Delta Hb levele, TKA 1.3 (0.6) [1.2-1.3] 1.8 (1.2)  [1.2-2.4] 0.000
Length of stayf 2.5 (2.0) [2.5-2.6] 5.4 (4.1) [4.3-6.6] 0.000
THA, total hip arthroplasty; TKA, total knee arthroplasty; UKA, unicompartimental knee arthroplasty; 
ASA, American Society of Anaesthesiologists; PSI, Patient Specific Instruments; a presented in years; b 
BMI: body-mass index is presented in kg/m2; c presented in minutes; d presented in mL; e Hb, hemoglobin 
levels were presented in mmol/L; f presented in days
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Table 2. Adverse event and readmission rates for the total cohort presented as frequencies (%). 
Total
Embolism (VTE/LE) 15 (0.29)
Neurologic (e.g. CVA, TIA) 7 (0.13)
Infection (e.g. surgical site infection) 23 (0.44)
Wound related (e.g. persistent drainage, dehiscence, haematoma) 79 (1.5)
Prosthesis related (e.g. dislocation, periprosthetic fracture) 74 (1.4)
Cardiac (e.g. acute myocardial infarction, acute heart failure, rhythm disorder) 16 (0.3)
Urologic (e.g. postoperative urinary tract infection, urinary retention) 191 (3.6)
Other (e.g. organ infection/dysfunction, nerve lesion) 77 (1.5)
Readmissions <3mnd post OR 262 (5.0)
VTE, venous thrombo embolism; LE, lung embolism; CVA, cerebrovascular accident; TIA, transient 
ischemic attack
Discussion
The most important finding of the present study is that the use of TXA in primary hip- and 
knee arthroplasty results in low allogenic blood transfusion rates. Before implementation 
of TXA in hip- and knee arthroplasty, allogenic blood transfusion rates rose to more than 
half of the patients [9]. These transfusion rates decreased significantly by implementing 
a perioperative TXA protocol without increasing perioperative complications (e.g. 
thromboembolic, cardiovascular events) [10,19,11]. Different protocols are examined and 
proven to be effective and safe [3,8,10,11,19,21,29]. Nevertheless, none of these regimens 
regarding type of administration (e.g. topical, IV and oral), dosage and timing is superior 
[10]. In previous high-quality studies (e.g. meta-analysis) different types of administration 
resulted in similar decreased transfusion risks for TKA and THA patients [11,27,30]. Only 
in TKA patients, slight superiority is found for pre-incisional administration of IV TXA 
[11]. In terms of safety, multiple doses induce a prothrombotic state but do not provoke 
thrombosis in TKA and THA patients and would therefore be safe to use [28]. But, as 
known from the recent literature, a second or extended dose seems not to be more 
effective than single dosage in knee or hip arthroplasty [11]. No differences were found 
between low (<20mg/kg) and high (>20mg/kg) dose intravenous TXA in hip and knee 
arthroplasty [11]. As well as for timing of administration, no regimen is superior [2,11]. 
The protocol in this study was set-up to be firstly evidence based, but secondly 
manageable without any nuisance for the patient. Due to the current fast-track 
protocols, which include 2hrs preoperative oral administration of pain medication, the 
implementation of preoperative oral TXA was done at that same administration time. 
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When looking closely to the pharmacokinetics and pharmacodynamics of TXA, oral 
uptake is rapid, which makes oral TXA eligible. Bioavailability of TXA is approximately 
45% in a healthy population, therefore a preoperative high dose of oral TXA can be 
considered to maximise the intraoperative blood sparing effect. T-max of TXA was 
estimated to be around 3 hours, in which the oral dose would almost be maximum at time 
of incision. Equal timeframe is stated for the elimination half-life of TXA. Therefore, the 
IV administration at the end of the surgery provides coverage for the first postoperative 
hours. These first 4 hours postoperative were stated by Jung et al. [16] to be most crucial 
in postoperative blood loss after knee arthroplasty. 
A topical dose was not considered due to the use of local infiltration analgesia in TKA 
patients. Thereby, an addition of TXA would result in a high fluid volume which would 
be infiltrated in the surrounding knee tissue. 
Various IV doses are used, with similar blood transfusion results [21,27,29,30]. Doses 
above 20mg/kg are considered to be a ‘high dose’. Thus, in the presented study, a low 
dose oral and IV TXA was used which led to low blood transfusion rates. These results 
are in line with previous studies and would support a low dose TXA usage to prevent 
for drug side effects [11]. 
The BT group consisted of significant more females. Other studies report female gender 
to be a risk factor for perioperative blood transfusion [12,25]. The exact mechanism 
remains unclear, but several hypotheses (e.g. lower preoperative haematocrit level and 
smaller body habitus) exists [23]. BT patients were significantly older and had a higher 
ASA classification, in line with previous findings [12,23]. This could be explained by the 
fact that in this group, blood transfusion was considered more often due to comorbidity 
status. On the other hand, the decision for blood transfusion was not only based on 
ASA classification, but also strongly dependent on postoperative Hb levels and the 
clinical well-being of the patient. Since different thresholds for Hb levels were used, 
the transfusion rate could be biased. Nevertheless, BT patients had significant lower 
Hb levels preoperatively which can be seen as a risk factor for transfusion. Basora et 
al.[4] reported similar results regarding preoperative Hb level (7.7 mmol/L) and ASA 
classification (III-IV) in transfused TKA patients. A cut-off value for preoperative 
optimisation was not given, but based on these and our results, preoperative Hb 
level seems to play a role in postoperative blood transfusion and should therefore be 
monitored preoperatively which was also found by other studies [4,25]. Unsurprisingly 
the BT group consisted of more THA patients, since blood loss in THA is higher and 
therefore significant higher risk for blood transfusion [23,24]. 
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In uncemented procedures more blood transfusions were given. In contrast to our 
results, Trice et al. [26] found no differences between a small cohort of uncemented 
and cemented/hybrid THA patients. Possible explanation for our results could be the 
opening of the intra-medullar canal, which is directly covered after cementation of the 
prosthesis in cemented THA. In the current cohort, uncemented THA was the preferred 
operation technique, even for patients with a higher age and thus relatively higher 
comorbidity status, which could have biased the results. To our knowledge, no clear 
evidence exists on the underlying mechanism. 
No difference in anaesthesia method was found between BT and non-BT patients. In 
contrast to previous results, which have shown that spinal anaesthesia protects against 
allogenic blood transfusions [13,23]. Spinal anaesthesia decreases blood loss based on 
a reduction in sympathetic tone and blood flow to the operative extremity [23]. But 
these results were found in studies before implementation of TXA which makes it less 
comparable to the presented study. In most of the high-quality TXA studies, no data is 
provided. 
There is of course a relation between duration of surgery and amount of blood loss 
with a self-evident increased transfusion risk [12]. Duration of surgery was previously 
described by Song et al. [25] as an independent risk factor for blood transfusion in THA 
patients. These results were obtained from arthroplasty surgeries with duration longer 
than 2 hours and only in THA patients [25]. For TKA patients, no significant difference 
was found. This is in line with our results. Although we found a significant longer 
duration of surgery in blood transfused THA patients, mean time between both groups 
was merely three minutes. The clinical relevance of three minutes is doubtful in our 
opinion. 
Carling et al. [6] found low BMI to be associated with an increased risk of excessive 
blood loss and thereby increased risk for blood transfusion. In line with these results, 
our study found that BMI was significant lower in the BT group. Contrarily, other studies 
reported no difference or even significant more blood loss in obese patients [5]. The 
current evidence is divided on the role of BMI in blood transfusion risk after arthroplasty 
surgery. In this study we can’t give more clarification on this topic and further studies 
are thus needed. 
There are some potential limitations. Due to the retrospective nature of the study, 
presented perioperative complications (in particular vascular/hematologic) could 
possibly be underestimated. Data in this study depends on the registration of 
complications in our hospital system. On the other hand, similar (low) rates of thrombo-
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embolic events were found after the implementation of high-dose TXA in other studies 
[8,9,19,28]. In advantage of these results, the current protocol consists of a low-dose 
TXA protocol and should therefore be safe to implement in daily practice. Another 
possible limitation of the study is the lack of correction for anti-coagulant usage. This 
could potentially bias the blood transfusion rates due to the negative influence on 
perioperative blood loss. 
Conclusions
Substantiated among with high-quality trials, TXA use in primary hip and knee 
arthroplasty holds an indispensable role in the perioperative process. As presented in 
this retrospective cohort study, an oral and IV administration protocol of TXA was found 
to be effective and safe for primary hip and knee arthroplasty procedures.
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Purpose Local infiltration analgesia (LIA) is widely applied in patients undergoing total 
knee arthroplasty (TKA). In daily practice, adrenaline is added to the LIA mixture to 
achieve vasoconstriction. However, adrenaline has some possible negative side effects 
(e.g. tissue necro-sis). This trial investigated whether ropivacaine alone is at least as 
effective for postoperative pain relief after LIA. 
Methods Fifty patients scheduled for primary TKA were included in this prospective 
randomized, double-blind, controlled pilot study receiving high-volume (150 mL) 
single-shot intra-capsular LIA with ropivacaine (2 %) with (Ropi+) or without (Ropi−) 
adrenaline (0.01 %). All patients received the same pre-, peri- and postoperative care 
with multimodal oral pain protocol. Postoperative pain was assessed before and after the 
first mobilization and during the first 48 h postoperative using the visual analogue scale 
(VAS). Secondary outcomes were rescue medication use, early mobilization, length of 
hospital stay, adverse events (AE’s) and readmission rates. Patient reported outcomes 
measures (PROMS); Oxford Knee Score and WOMAC, were obtained preoperative and 
3 months postoperative. 
Results VAS scores were not significantly different before (n.s.) and after the first 
mobilization (n.s.), neither over the first 48 h postoperative (n.s.). Patients who needed 
rescue medication (n.s.), who mobilized <6 h postoperative (n.s.), who were discharged 
before postoperative day 3 (n.s.), AE’s and readmission rate (n.s.) were comparable 
between both groups. At 3-month follow-up, PROMS significantly improved within both 
groups.
Conclusion To prevent possible negative side effects (e.g. tissue necrosis), adrenaline 
should be omitted from the LIA mixture. Single-shot LIA with ropivacaine alone results 
in clinical acceptable adequate pain control and can be used in daily TKA practice.
Keywords Adrenaline; Epinephrine; Local infiltration analgesia; Pain management; Total 
knee arthroplasty; Early mobilization; Early discharge; Fast track




Early mobilization after TKA can be delayed due to severe high intense pain 3 to 6 h 
postoperative [6, 11]. Recent literature supports the use of LIA to challenge with direct 
postoperative pain after TKA [17]. LIA with ropivacaine in joint replacement surgery 
was first described in 2003 after which the technique was further developed [4, 19, 31]. 
The literature shows progressive results in terms of pain control, early mobilization and 
discharge from hospital and reduced opiate use [1, 3, 11, 30, 31]. Several results are attribut-
able to different analgesic infusion techniques after TKA, all with positive and negative 
side effects [11, 30]. This technique involves intra-operative infiltration of an analge-sic 
mixture. The combination of ropivacaine with adrena-line is most common used and 
described in the literature to deal with postoperative pain [17]. During surgery, the use 
of locally administered adrenaline reduces potentially toxic blood concentrations of 
ropivacaine [4, 6, 17, 22, 24], decreases the clearance and distribution processes into the 
blood flow [29], and it may also reduce the risk of bleeding into the knee [7]. However, 
there are also some potential local and systemic adverse effects such as tissue necrosis 
and increased risk of infections [12, 21, 22, 29, 30]. The data are limited to support the role 
of adrenaline during intra-operative single-shot LIA in combination with ropiv-acaine in 
patients undergoing TKA [17, 18, 23, 27, 28, 30, 34]. The theoretical advantage of adrenaline 
is the vaso-constrictive effect. On the other hand, ropivacaine itself is a long-acting 
analgesic with vasoconstrictive properties to reduce local absorption [4, 5, 22, 24]. There 
are no data to support the effect of ropivacaine alone for single-shot LIA on postoperative 
pain relief after TKA compared with LIA, consisting a ropivacaine and adrenaline mixture.
This study hypothesized that LIA with only ropivacaine is at least as effective in short 
terms as the widely used current method, LIA procedure with mixture of ropivacaine 
and adrenaline. This prospective, randomized, double-blind controlled trial examines 
the effect of adrenaline in the LIA mixture in patients undergoing TKA.
Materials and methods
Fifty patients with a painful and disabled knee joint result-ing from osteoarthritis, a 
high need to obtain pain relief and improve function, able and willing to follow instruc-
tions were included after informed consent. Patients with a general or an active knee 
infection, failure of previous joint replacement of the knee to be operated on, pregnancy, 
con-traindication for ropivacaine and/or adrenaline, and patients who were not able 
to understand and complete the proce-dure due to cognitive dysfunction or language 
barrier were not included in this pilot study.
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Multidisciplinary enhanced clinical pathway
The following pathway applies to both groups. A personal coach was involved as much 
as possible to inspire, correct and support the patient while in hospital and directly after 
discharge. In addition, the coach also indirectly reduces the workload on the nursery in 
terms of helping with all-day activities. All patients received preoperative education and 
exercise training, to become familiar with walking (stairs) with crutches and transfers 
from bed to a chair and vice versa, information about the in- and outpatient pro-cess 
and home-based rehabilitation. The first mobilization was attempted <6 h postoperative 
including transfer from a bed to a chair and vice versa following walking with a walker 
if possible under supervision of a physiotherapist and nurse. All patients were familiar 
with the overall dis-charge criteria: mobilize and transfer into and out of bed individual 
and safe, able to get into and up from a chair, walk independently with crutches and if 
necessary walk-ing stairs with crutches. After discharge, physiotherapy in their home 
environment was started 14 days postoperative. All patients were seen at the outpatient 
clinic at 2, 6 and 12 weeks postoperative.
Table 1. Multimodal opioid sparing pain protocol was provided. 
Preoperative Postoperative
2h 4h 8h First day Day 2-14
Arcoxia (mg) 90 90 90
Paracetamol (g) 1 1 1 1* 1*
Gabapentin (mg) 600 300 300
Omeprazol (mg) 40 40 40
*Paracetamol (1g) was given four times daily on fixed intervals throughout the day.
Randomization and blinding
To make sure LIA medication was blinded to the patients, orthopaedic surgeon, 
investigator and other persons direct and indirect involved in the study, randomization 
and prep-aration of the syringes for both ropivacaine with (Ropi+) and without 
adrenaline (Ropi−), were performed by the hospital pharmacist (HK). Randomization 
was performed using computer, web-based generated randomized num-bers (www.
random.org). Three syringes (50 ml each) were numbered from one to three, whereas 
syringe one and two contained ropivacaine (2 %) with or without adrenaline (0.01 %) 
and the third syringe was always without adrena-line. Randomization was unblinded 
after study completion or in case of a suspected unexpected serious adverse reac-tion 
(SUSAR).
Local infiltration analgesia in knee arthroplasty
49
4
Operative and analgesia treatment
According to a standardized pain protocol (Table 1), patients received premedication 
2 h before operation. Patients were operated under spinal or general anaes-thetic 
treatment by a single experienced knee arthroplasty surgeon (NK) with the use of 
patient-specific positioning instruments (Signature™, Biomet, Warsaw IN) for TKA. 
All patients received a cemented Vanguard™ Complete Knee System. (Biomet, Inc, 
Warsaw, IN) A pneumatic tourniquet was positioned on the thigh before surgery 
and inflated to 350 mmHg during cementing. Single-shot LIA was injected by the 
orthopaedic surgeon (NK), intra-oper-atively according to Kerr and Kohan [19]. 
Mean operation time (incision to closure in minutes) and mean blood loss (total 
volume of blood in the suction device prior to rins-ing the knee with pulse lavage 
system in millilitres) were recorded in the patients’ operative records. Patients did 
not receive an intra-articular catheter, nor postoperative injec-tions with analgesia 
nor a drain or urinary catheter. Urinary retention was tested with the use of a 
bladder scan (Vera-thon®, BVI 9400). Pre- and postoperative patients received a 
multimodal opioid sparing pain protocol (Table 1). Daily thromboprophylaxis 
(Fondaparinux) was administered sub-cutaneously once each evening for 35 days, 
starting on the day of surgery. Compression bandage was removed <24 h. On day one 
postoperative patients received analgesics in the morning (Table 1) and daily four 
times paracetamol (1 g). If analgesics were ineffective on the day of surgery or the 
first or second day postoperative, rescue analgesia (Tramadol, 100 mg) once daily 
was provided on demand. From day two till day 14 postoperative, patients received 
analgesics according to a multimodal opioid sparing pain protocol (Table 1).
Study endpoints
Experienced pain was measured with a visual analogue scale (VAS; 0 to 100, 100 being 
‘worst pain’). Pain was measured before and after the first mobilization and dur-ing 
the first 48 h postoperative on fixed time points (direct postoperative, and daily 8:00, 
16:00 and on 22:00 h). Res-cue medication use was evaluated, the amount of patients 
who used postoperative Tramadol were registered. Early mobilization (minutes) 
was recorded as time between the start of anaesthesia until the first mobilization. 
Length of hospital stay (days) was evaluated as time between hospi-tal admission 
and discharge. Adverse events (AE’s) were classified as patient related [e.g. 
postoperative nausea and vomiting (PONV)], thromboembolic events and wound 
dis-orders (e.g. persistent wound leakage), surgical related (e.g. infection) and/or 
prosthesis related (e.g. loosening). Pain, PONV and discharge criteria were evaluated 
daily on fixed time points (8:00, 16:00 and on 22:00 h). Besides the dif-ference of 
the LIA mixture, pre-, peri- and postoperative procedures and pain protocol were 
identical in both groups as well as the completed operative and clinical case report 
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forms. PROMS were obtained preoperative and 3 months postoperative including 
the Oxford Knee Score (OKS; 12 to 60, 12 being the best outcome) [13] and Western 
Ontario and McMaster Universities Arthritis Index (WOMAC; 0 to 100, 100 being the 
best outcome) [25].
This prospective, randomized, double-blind pilot study was performed in compliance 
with the Helsinki Dec-laration of 1975, as revised in 2000 and was studied and approved 
by the IRB (METC Atrium-Orbis Zuyd, Heerlen, the Netherlands, IRB Nr. 13T112) and 
registered online at the European Clinical Trials Database (EudraCT, Nr. NL 20140403), 
the Dutch Trial Register (www.trialregister. nl, Nr. NTR4769) and conducted in 
accordance with the guidelines for Good Clinical Practice (GCP).
Statistical analysis
Sample size and power calculations were made based on our expectations. We assumed 
that both LIA with (Ropi+) or without (Ropi−) adrenaline significantly improves the 
mean VAS pain score by 20 mm postoperative with a stand-ard deviation of 15 mm on 
a VAS pain score of 100 mm. With an alpha of 0.05 and 1-beta error of 0.8, we needed 21 
patients: 25 taking into account 10 % lost of follow-up. This study included 50 consecutive 
patients, 25 in each arm. The Shapiro–Wilk test showed that the data were not normal 
distributed. Statistically significant differences between both groups were analysed with 
nonparametric Mann–Whitney U test (e.g. VAS pain score, early mobili-zation, early 
discharge and PROMS), and Chi-square tests were used for categorical variables (e.g. 
rescue medication use and AE’s). P value was considered to be statistically significant at 
P ≤ 0.05 for all analysis. All statistical analyses were performed with use of SPSS version 
17.0 for win-dows (Inc., Chicago, IL). Results are presented as either with frequencies 
(%), mean (SD), or median (range).
Results
Fifty randomized patients completed this study. None of the patients were lost to follow-
up. Randomization was unblinded after study completion no SUSAR’s occurred. Baseline 
demographics and OR data were not significant different (Table 2). 
One patient in both groups used rescue medication on day two. Early mobilization 
was comparable between both groups (n.s.). Twenty-two patients (88 %) in the Ropi+ 
group could mobilize within a mean of 336 min (76.0) compared to 21 patients (84 %) 
who mobilized within a mean of 350 min (68.0) after anaesthesia in the Ropi− group. 
Length of hospital stay was comparable between both groups (n.s.). Twenty patients 
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(80 %) in the Ropi+ group compared to 15 patients (60 %) in the Ropi− group were 
discharged before postoperative day 3 (n.s.). AE’s are summarized in Table 3. There 
were no thromboembolic or prosthesis related AE’s although one patient in the Ropi+ 
group underwent electric cardioversion due to atrial fibrillation and was discharged on 
postoperative day 3. At 3-month follow-up, the mean WOMAC and OKS significantly 
(P < 0.00) improved within each group with a mean of 30.7 (22.6) and 15.5 (10.9) in the 
Ropi+ group and 23.5 (25.3) and 12.5 (10.8) in the Ropi− group. There were no significant 
differences between both groups for both PROMS. 
Table 2. Baseline demographics and OR data presented as mean (SD) or absolute number between 
the groups.
Variables Ropi + Ropi-
Age (years) at index surgery 62.8 (6.1) 66.3 (9.8)
Gender M/F 14/11 10/15
BMI kg/m2 27.6 (5.7) 29.6 (3.8)
ASA classification I/II/III 7/17/1 6/19/0
Operative data
General/ Spinal 2/23 6/19
Blood loss ml 251.1 (97.7) 235.4 (96.1)
OR time min 62.4 (12.1) 63.0 (15.1)
VAS pain scores were not significantly different (Fig. 1). Thirteen patients (52 %) in the Ropi− group 
used rescue medication on postoperative day one compared to 7 patients (28 %) in the Ropi+ group 
(n.s.). 
Table 3. The amount of AE’s between both groups were not significant different. All adverse events 
occurred during initial admission except for the readmissions (*)
AE’s Ropi + Ropi- Remarks
Patient related 10 6 PONV, vasovagal syncope, electric cardioversion, delirium
Wound disorders 3 0 Major wound leakage
Surgical related 3 1 Loss of sensibility due to delayed recovery from anesthesia, 
limited knee flexion*, superficial wound infection*
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Figure 1. Mean experienced pain (vertical axis) before and after the first mobilization, during the first 
48h, measured direct postoperative (post OR), and daily 8:00, 16:00 and on 22:00 h (horizontal axis) 
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Discussion
The most important findings of the present study was that the ropivacaine and 
adrenaline LIA mixture was not clearly superior to LIA consisting only ropivacaine with 
respect to experienced pain before and after the first mobilization and during the first 
48 h postoperative. In this study, both groups gave improved and comparable pain relief 
after TKA.
These comparable results on pain relief could be explained by the fact that ropivacaine 
itself is a long-acting analgesic with vasoconstrictive properties to reduce local absorption 
[4, 5, 22, 24]. Poorly managed postoperative pain after TKA negatively influences early 
postoperative recovery [14] and discharge [8, 16, 17]. In this trial none of the patients 
had a delayed mobilization due to high pain intensity. Most of the delayed mobilization 
occurred in patients infiltrated with adrenaline including vasovagal syn-copes, major 
wound leakages and one patient did not had any sensibility in both legs due to delayed 
recovery from spinal anaesthesia. These patients had a delayed discharge, which was 
in line with the results of Husted et al. [15, 16] who found a relation between length of 
hospital stay and early mobilization. In this trial serious side effects were observed in 
both groups, which resulted in prolonged hos-pital stay and hospital readmissions.
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Many studies have shown the effects of postoperative LIA [3, 8, 34]. Most of these 
studies focus on analgesic consumption, early mobilization, pain relief and early dis-
charge from hospital [17]. The postoperative pain relief presented in this trial may be 
comparable to the results from other studies [4, 8, 9, 14]. However, not all results are 
based on single-shot injections [4]. Many techniques are described in literature, but 
there is no gold standard in the treatment of pain control after TKA. Most of the studies 
included single-, continuous [32, 34], intra- or extra-artic-ular infiltrations [3, 7, 26, 30] 
and with frequent postop-erative injections through an intra- [19, 20] or extra-artic-ular 
catheter [10] Recent published series consist positive results on the LIA technique with 
ropivacaine and adrena-line infiltrated intra-operatively with single-shot injections [8, 
33]. This trial found comparable results in the literature if it becomes to pain, PONV, early 
mobilization and dis-charge after single-shot injections of ropivacaine with or without 
adrenaline. However, also high postoperative pain scores were seen after single-shot 
injection LIA [34].
One of the limitations in this study, circulating blood levels of ropivacaine were not 
measured to check for pos-sible considerable chondrotoxicity. Adrenaline reduces 
potentially toxic blood concentrations of ropivacaine and can extend the effects of the 
local anaesthetics by keep-ing it localized to the area of injection, but with possible side 
effects such as tissue necrosis and increased risk of infections, which was found in one 
patient per group in our series [12, 21, 22, 29, 30]. Both patients were success-fully treated 
with antibiotics. Other than Andersen et al. [2] reported, a possible risk of considerable 
chondrotoxic-ity is clinical relevant in case of performing a TKA without resurfacing 
the patella.
Secondly, it can be argued that the absent effect of adren-aline may be explained by a 
continuous effect of the used optimised pain protocol although both groups received 
the same pre- peri- and postoperative treatment including the same opioid sparing 
multimodal oral pain protocol. In contrast to other published trials, ketorolac was not 
added to the LIA mixture. Etoricoxib was part of the multimodal oral pain protocol, 
administered 2 h pre- and daily up to postoperative day 14.
Thirdly, a comparison with a placebo-controlled group that received LIA with only saline 
was not made. Given the fact that single-shot LIA is an added value after TKA to cope 
with postoperative pain relief, LIA should belong to the daily practice during TKA [33]. 
However, it is unclear which LIA mixture has the most favourable outcome with minimal 
side effects. Recently, Xu et al. [33] published their meta-analysis of RCT’s on single-shot 
LIA in TKA patients. They concluded that single-shot LIA is effective for postoperative 
pain management in TKA patients with satisfactory short-term safety without any 
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consensus on the widespread used analgesia. This study found limited evi-dence to 
support the role of adrenaline during intra-oper-ative single-shot LIA in combination 
with ropivacaine in patients undergoing TKA. Further larger RCT’s exploring the effect 
of adrenaline are of interest [10, 17, 27, 28, 30, 33].
Finally, we recommend that LIA with only ropivacaine should be part of daily practice in 
TKA including a well-established multimodal pain protocol to cope with postop-erative 
pain, without the possible negative side effects of adrenaline.
Conclusion
This randomized, double-blind, prospective clinical trial could not confirm the added 
value of adrenaline into the ropivacaine solution for LIA, since both groups showed 
comparable experienced pain during the first 48 h postoperative.
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Purpose Postoperative urinary retention (POUR), defined as the inability to empty 
the bladder voluntary after surgery, is a commonly reported complication. This study 
reports the incidence and possible risk factors for POUR after elective fast-track hip or 
knee arthroplasty when using a nurse-led bladder scan protocol. 
Methods This retrospective cohort study included data from 803 patients who underwent 
unilateral hip or knee arthroplasty. Patients’ digital clinical records were reviewed for 
eligibility. Patients with incomplete data registration, preoperative bladder volume 
>250 ml, preexisting bladder catheterization, and/or patients following the outpatient 
pathway were excluded. Bladder volumes were assessed at different moments pre- and 
postoperatively. The outcome was the incidence of POUR, defined as the inability to void 
spontaneously with a bladder volume >600 ml, treated with indwelling catheterization. 
Further analysis between POUR and non-POUR patients was performed to detect 
possible risk factors for POUR.
Results Six hundred and thirty-eight patients operated on primary unilateral hip or knee 
arthroplasty were analyzed. The incidence of POUR was 12.9% (n = 82, 95% CI 9.4–15.5). 
Gender, age, BMI, ASA classification, preoperative bladder volume, type of anesthesia, 
type of arthroplasty, and perioperative fluid administration were not significant different 
between POUR and non-POUR patients. Patients with a bladder volume of >200 ml at 
the recovery room were at higher risk (OR 5.049, 95% CI 2.815–9.054) for POUR.
Conclusions When using a nurse-led bladder scan protocol in fast-track hip and knee 
arthroplasty, the incidence of POUR was 12.9%, with a bladder volume of >200 ml at the 
recovery room as a risk factor for POUR. 
Keywords Postoperative urinary retention; POUR; Bladder scan; Hip arthroplasty; Knee 
arthroplasty




Since the introduction of fast-track surgery pathways in orthopedic departments, peri- 
and postoperative indwelling bladder catheterization is no longer routinely performed 
[19,22,27]. Postoperative urinary retention (POUR), defined as the inability to empty 
the bladder voluntary after anesthesia and surgery, is a commonly reported adverse 
event after elective total hip- (THA) and knee arthroplasty (TKA) [1,2,4,5]. The reported 
incidence of POUR after TKA and THA following a fast-track or conventional pathway 
ranges widely between 0-75% [1,4-6,16,17,27]. Many factors contribute to the risk of 
POUR, such as type of anesthesia, male gender, comorbidities and perioperative fluid 
management [2,3,4-6,13,21]. An ultrasound bladder scan is introduced as a diagnostic 
tool to monitor bladder volume in the prevention of POUR [8,9,18]. General consensus 
on definition of POUR, cut-off values, time of measurement with a bladder scan and 
treatment strategies (intermittent vs. indwelling catheterization) is lacking [4,14,29]. 
Most studies reported POUR as the inability to void spontaneously after surgery with 
a high bladder volume, ranging between 400-800ml [2,5,6]. As other studies defined 
POUR as the need for postoperative urologic consultation [26] or the postoperative 
inability to void spontaneously without monitoring bladder volume [21,27]. Based 
on physiological knowledge, exceeding 600ml of bladder volume is considered 
to be pathophysiological [29]. The potential risk of POUR is overdistension of the 
bladder, which can cause urologic adverse events [3]. Indications for postoperative 
catheterization after THA and TKA in fast-track surgery are based on the bladder 
volume and is widely diverse in literature [1-3,5,6] ranging from 400-800ml. Early 
detection and treatment of POUR is paramount in prevention of bladder overdistension 
and thereby urologic adverse events [23]. Treatment of POUR consists of intermittent 
or indwelling catheterization, which both is often associated with an increased risk 
of urinary tract infection, morbidity and prolonged hospital stay [7,25,29]. With the 
use of an ultrasound-guided bladder scan protocol, elective bladder catheterization 
is unnecessary in patients undergoing THA and TKA [2]. However, there is limited 
evidence regarding a standardized pre-, peri- and postoperative bladder scan protocol 
with general applicable cut-off values and strategies regarding the treatment of high 
bladder volumes to prevent for POUR [2,5,14,18]. This study reports the incidence and 
the potential risk factors for POUR, after elective fast-track hip- and knee arthroplasty, 




This retrospective analysis included all patients who underwent elective unilateral 
primary total hip (THA), total knee (TKA), or unicompartmental knee (UKA) arthroplasty 
in a fast-track pathway between June 2014 and May 2015 in the Zuyderland Medical 
Center (Sittard-Geleen, the Netherlands). Patients were excluded from analysis in case 
of incomplete data registration, preoperative bladder volume >250 ml, and therefore 
placement of an indwelling catheter prior to surgery, preexisting usage of bladder 
catheterization, and/or patients who underwent arthroplasty surgery in an outpatient 
pathway. A total of 638 patients were analysed after application of the exclusion criteria 
(Fig. 1). A urinary bladder management protocol was used for the prevention of POUR by 
using an ultrasound bladder scanner (BladderScan® BVI 9400; Verathon Medical Europe 
BV, the Netherlands), based on the available literature [2, 3, 14, 18, 28] and the expert 
opinion of the hospital urologists (Fig. 2).
Figure 1. Selection of patients.
 Total primary joint arthroplasty 
n=803  
-Hip arthroplasty; n=381 (47%) 
-Knee arthroplasty; n=422 (53%) 
 
 Excluded n=165 (21%) 
-Outpatient surgery; n=66 (8%) 
-Preoperative bladder volume >250ml; n=31 
(4%) 
-Incomplete data; n=68 (9%) 
Analysed n=638 (79%) 
-THA; n=322 (40%) 
-TKA; n=302 (37%) 
-UKA; n=14 (2%) 
 
Pre-, peri-, and postoperative treatment
Bladder volumes were monitored preoperatively after voiding to detect a possible urinary 
retention >250 ml, which has been found as a risk factor for POUR [3]. In case of >250 ml of 
urinary retention preoperative after spontaneous voiding, indwelling catheter was placed 
prior to surgery [27]. When indwelling catheter was used, it was removed the next day.
All nurses were trained in using the bladder scanner and were familiar with the 
online available bladder scan protocol (Fig. 2). All surgeries were performed by 
seven experienced arthroplasty surgeons. Patients were operated under spinal or 
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general anesthesia with intravenous fluid restriction (max. 1000 ml). Local infiltration 
analgesia (LIA) was used intraoperative in knee arthroplasty [24]. In order to prevent 
PONV, intravenous dexamethasone (single shot, 8 mg) was administrated during the 
surgery. Oral tranexamic acid (1 g if weight <100 kg, 1.5 g if weight >100 kg) was provided 
preoperatively. At wound closure, the same doses were given intravenous for prevention 
of blood loss. No wound drains were used. An opioid-sparing pain protocol was provided 
(Table 1). In case of inadequate pain control, tramadol was used with a maximum of two 
times 50 mg per day, and occasional oxycodone was used when the patient experienced 
side effects from tramadol. After surgery, patients were observed in the recovery room 
until their cardiorespiratory status was stable and pain control was adequate before 
transferring them to the orthopedic ward.
Directly postoperative at the recovery room and every 3 h at the orthopedic ward, 
bladder volume was monitored until spontaneous voiding (Fig. 2). If the bladder volume 
exceeded more than 600 ml, with the inability to void spontaneously, catheterization 
was performed with an indwelling catheter to cope with a possible overdistension of the 
bladder [23]. In case of catheterization, the catheter was removed the next day. If the 
patient was able to void spontaneously, with a bladder volume <100 ml, monitoring was 
discontinued. Within 6 h postoperative, the patient was mobilized under supervision of 
a physiotherapist after recovery from anesthesia. After the first mobilization, patients 
were transferred to the restroom under guidance of a nurse in case of urge to void. 
Patients were discharged from the hospital if they met the discharge criteria: overall 
general well-being, spontaneous voiding with bladder volume <100 ml, a dry wound, 
adequate pain control, individual and safe mobilization with transfer into and out of 
bed and chair, walk independently with a walking aid, and if necessary walking stairs 
with crutches.
Outcome
The primary outcome of this study was the incidence of POUR defined as the inability 
to void spontaneously with a bladder volume >600 ml, detected with a bladder scan, 
requiring indwelling catheterization. Secondary, to detect potential risk factors: gender, 
age, body mass index (BMI), ASA classification, preoperative bladder volume, type 
of anesthesia, type of arthroplasty, perioperative fluid administration, and bladder 
volume at the recovery room were analysed between POUR and non-POUR patients. All 
outcomes were recorded in the patients’ digital clinical record. This study was performed 
in compliance with the Declaration of Helsinki 1975, as revised in 2000, and the study 
was approved by the IRB (METC Zuyderland, Heerlen, the Netherlands, IRB Nr. 15-N-
136) and conducted in accordance with the guidelines for Good Clinical Practice (GCP).
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Figure 2. Pre- and postoperative bladder scan (BS) protocol for the prevention of POUR used by the 
nursing staff.
 




All data collected for this study was entered into an Excel database (Microsoft Office 
2003) and analyzed using the SPSS 17.0 (SPSS Inc. Chicago, IL) statistical program. A 
descriptive analysis of the sample was done using rates for categorical variables and 
the mean (SD) for continuous variables. The collected data were tested for normality 
with use of the Shapiro–Wilk test. Since data were not normally distributed, differences 
between the POUR and non- POUR group were tested with the use of Mann–Whitney 
U test. A p value ≤ 0.05 was considered to be statistically significant. If there was a 
significant difference for one of the secondary outcomes measures, the odds ratio (OR) 
with 95% confidence interval (CI) was calculated to determine possible risk factors for 
POUR. To create a cutoff point, median values of the total group were used. Results are 
presented as either frequencies (%) or mean (SD). 
Table 1. Pain protocol. 
Preoperative Postoperative
2hrs 4hrs 8hrs First day Day 2-14
Meloxicam (mg) 15 15 15
Paracetamol (g) 1 1 1 1 1
Gabapentine (mg) 600 300 300
Pantoprazol (mg) 40 40 40
Results
The incidence of POUR was 12.9% (n = 82; 95% CI 9.4–15.5%). There were no significant 
differences for patient demographics and pre- and perioperative outcome measures 
between POUR and non-POUR patients (Table 2). 
Table 2. Baseline demographics are presented as frequencies (%) or mean (SD) with p-value.
Pour (n=82) Non-Pour (n=556) p-value
Patient demographics
Male/female, (%) 29/53 (35/65) 200/365 (36/64) 0.915
Age in years, (SD) 68.64 (11.04) 69.42 (8.72) 0.827
BMI in kg/m2, (SD) 28.63 (4.39) 28.94 (5.97) 0.742
ASA classification, I/II/III 7/43/5 35/332/20 0.312
Spinal/general anesthesia, (%) 59/23 (72/28) 398/158 (72/28) 1.000
THA/TKA, (%) 51/31 (62/38) 272/284 (49/51) 0.059
Fluid administration in ml, mean (SD) 941.89 (367.80) 881.49 (343.33) 0.231
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None of the patients underwent re-catheterization after treatment of POUR. Median 
bladder volume at the recovery room for the total group was 200 ml. When using this 
as a cutoff value, bladder volume of >200 ml at the recovery room was a risk factor for 
POUR (OR 5.049, 95% CI 2.815–9.054) (Table 3).
Table 3. Pre- and postoperative bladder volume outcomes are presented as mean (SD) with p-value.
Pour (n=82) Non-Pour (n=556) P-value
Preoperative
Preoperative bladder volume in ml, (SD) 47.78 (61.69) 37.99 (53.68) 0.131
Postoperative
Bladder volume at recovery room in ml, mean (SD) 468.21 (257.67) 215.47 (139.59) 0.000
Discussion
The most important finding of the present study was that with the use of a nurse-led 
bladder scan protocol combined with pre-, peri-, and postoperative optimisations (e.g., 
fluid restriction, opioid-sparing pain protocol), the incidence of POUR after arthroplasty 
patients following a fast-track pathway was 12.9%, with >200 ml of bladder volume 
at the recovery room as a risk factor for POUR. The first large-scale and multicenter 
prospective study on POUR after arthroplasty showed an incidence of approximately 
40% [5]. Later series found an incidence of 13–32% depending on the used cutoff 
value for bladder volume, respectively, 800 and 500 ml [6]. Balderi et al. [2] reported 
an incidence of 25% in arthroplasty patients and concluded that the use of a bladder 
scan algorithm can reduce the incidence of POUR. An even lower incidence of POUR 
after hip and knee arthroplasty was found by Tischler et al. [27]. They performed only 
bladder scans on patients with symptomatic bladder distention and could therefore 
underrate the incidence of POUR. Compared to these studies, the presented incidence 
of POUR in this study was low. A possible explanation for the low incidence of POUR 
could be the selection prior to surgery. Since it is known that a preoperative bladder 
volume of >270 ml is a risk factor for POUR [3], the present study created a safe cutoff 
value for preoperative urinary retention (>250 ml) and excluded these patients from 
analysis. In case of preoperative urinary retention, patients were treated with indwelling 
catheterization prior to surgery [29]. Another explanation could be the wide range of 
bladder volume as cutoff values (400–800 ml) in the literature [2, 5, 6, 29]. These cutoff 
values can affect a valid comparison between the study results. Frequent monitoring 
with the use of a bladder scan decreases the incidence of POUR [8, 9, 18] and should 
be performed 6–8 h after the start of anesthesia [15]. In the current study, monitoring 
continued directly postoperative at the recovery room and was repeated every 3 h at 
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the orthopaedic ward until spontaneous voiding. As far as we know, this is the first study 
showing that >200 ml of bladder volume on the recovery room is a risk factor (OR 5.049) 
for POUR after hip or knee arthroplasty. Previously, Keita et al. [20] found >270 ml at 
the post anesthesia care unit as a predictive factor for POUR (OR 4.8), but these results 
were found after surgeries of different specialties (e.g., orthopedic, abdominal, urologic). 
Bladder volume monitoring should be performed directly postoperative to detect an 
early development of POUR [14]. For patients who exceed >200 ml of bladder volume 
at the recovery room, a more stringent follow-up, in terms of frequent bladder scan 
monitoring at the orthopaedic ward, should be considered. Treatment strategies in case 
of POUR (intermittent vs. indwelling catheterization) and duration of catheterization 
remain controversial [3]. Zhang et al. [29] found that indwelling catheterization was 
superior to intermittent catheterization in the prevention of POUR after the routine 
use of indwelling catheterization for all patients undergoing THA or TKA. They found 
comparable risk of urinary tract infection. The superior treatment of POUR, without the 
routine use of preoperative indwelling catheterization, remains questionable. In case 
of POUR and treatment with indwelling catheterization in the postoperative phase, the 
present study found no recurrent POUR as seen after intermittent catheterization [5, 
6, 12]. Literature on anesthesia technique as a risk factor for POUR is divided. Several 
studies found that the use of spinal anesthesia increased the risk of POUR [5, 6, 15, 22], 
as other studies concluded that type of anesthesia did not influence the incidence of 
POUR [1, 21, 26]. Based on the negative influence on detrusor activity, which can lead 
to a subsequent atonic bladder, postoperative epidural anesthetics can increase POUR 
[2, 21]. Patient-controlled analgesia [15] and intrathecal morphine use [10, 11, 27, 28] 
were also found to be risk factors and should be avoided in the pain management to 
prevent for POUR. Higher amounts of perioperative fluid administration are related 
to increased risk of POUR [3, 13]. Unfortunately, a precise cutoff value is unknown. 
When using a restrictive protocol (max. 1000 ml), perioperative fluid administration 
did not increase the risk of POUR in the present study. Several studies reported male 
gender as a risk factor for POUR [1–3, 11, 13, 15, 21, 26]. Bjerregaard et al. [5] did not find 
gender to be a risk factor, but an increased International Prostate Symptom Score (IPSS) 
was related to POUR. In a retrospective analysis on 376 male THA patients, Hollman 
et al. [15] could not confirm these results since they found no relation between POUR 
and prostate pathology. Nevertheless, a high incidence (39.9%) of POUR after THA in 
men was reported [15]. This study has several limitations. Firstly, the presented study 
examined a general applicable protocol for hip and knee arthroplasty patients following 
a fast-track pathway, without consideration of the patients’ specific comorbidity (e.g., 
IPSS, urologic or renal comorbidities), which could have led to confounding results. 
Secondly, there is no consensus on cutoff value’s for bladder volume. Therefore, the 
presented incidence of POUR, when using a cutoff value of more than 600 ml, could be 
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underrated. Randomized controlled trials on the bladder scan protocol are needed to 
confirm the presented results and should focus on cutoff value’s at different steps in the 
bladder scan protocol. Furthermore, selection criteria are needed to detect high-risk 
patients. To ensure patient’s safety, these patients should be treated with indwelling 
catheterization prior to surgery. When using a nurse-led bladder scan protocol, this 
study showed a low incidence of POUR after fast-track hip and knee arthroplasty in 
comparison with recent literature.
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Purpose There has been increasing interest in accelerated programs for knee 
arthroplasty. We examined the efficacy and safety of an outpatient surgery (OS) pathway 
in patients undergoing unicompartmental knee arthroplasty (UKA).
Methods This case-controlled study evaluates patients operated for UKA in an OS 
pathway (n=20) compared to Rapid Recovery (RR), the current standard (n=20). We 
investigated whether patients could be discharged on the day of surgery, resulting 
in comparable or better outcome by means of adverse events (AE’s) in terms of pain 
(Numerical Rating Scale, NRS), incidences of postoperative nausea and vomiting 
(PONV) and opiate use (<48hrs postoperative), complication and readmission rates 
(<3mth postoperative). Patient reported outcomes measures (PROMS) were obtained 
pre- and 3mth postoperative. 
Results  Postoperative pain (NRS >5) was the most common reason for prolonged 
hospital stay in the OS pathway. Eighty-five percent of the patients were discharged on 
the day of surgery, whereas 95% of the patients were discharged on postoperative day 
3 in the RR pathway. Overall, median pain scores in both pathways did not exceed a NRS 
score of 5, without significant differences (RR vs. OS) in the number of patients with 
PONV (4 vs. 2) and opiate use (11 vs. 9) <48hrs postoperative. At 3mth postoperative, 
no significant differences were found for AE’s and PROMS between both pathways.
Conclusions The results of this study illustrates that an OS pathway for UKA is effective 
and safe with acceptable clinical outcome. Well-established and adequate standardized 
protocols, in- and exclusion criteria and a change in mindset for both the patient and 
the multidisciplinary team are the key factors for the implementation of an OS pathway.
Keywords Outpatient surgery; Short-stay; Unicompartmental knee arthroplasty; Partial 
knee arthroplasty; Pain management




Care pathways in orthopedic surgery are designed to prepare and optimise patients 
before, during, and after surgery. These pathways improve the quality of the patient’s 
care ensuring reduction of surgical stress, PONV and pain, [16-19, 21] with increased 
patient satisfaction whilst reducing the length of stay [17]. Slowly but surely, orthopedic 
surgeons are convinced of revolutionary changes on evidence-based interventions 
within the elective knee arthroplasty [16-19, 21]. Success requires the implementation 
of a clear pathway applying a selected number of scientifically supported procedures, 
used together and implemented in a multimodal care pathway [15, 19, 20, 33]. Outpatient 
surgery (OS) pathways are designed for patients initiated for elective surgery on the day 
of admission into the hospital with a planned discharge, without an overnight stay in a 
hospital bed [32]. OS is commonly used for small elective surgical procedures, but may 
be used for more complex and challenging cases. For example, knee arthroplasty, which 
is more common in the United States of America (USA) than in Europe [31]. 
Due to the ageing of the population and the implantation of prosthesis in younger 
patients, the number of knee joint replacement surgeries in Western countries are 
increasing strongly [26]. The number of joint arthroplasties in the USA in 2006 was 
estimated at 600.000 operations [9]. This number of operations will even increase with 
134% in 9 years [23]. Due to the advancement of multidisciplinary pathways, outpatient 
UKA is allowing more surgical procedures to be performed; a cost reduction should be 
possible [3, 30].On the other hand, health care organizations create strategies to decline 
the use of resources, with the preservation of the quality of care [27].
In 2011 optimisation of the conventional pathway [28] resulted into an enhanced recovery 
pathway for knee arthroplasty. After years of experience, this optimisation resulted in an 
OS pathway for UKA. OS is accomplished by a patient specific approach, an optimised 
process in which the individual proactive patient is essential. Recent literature supports 
early discharge on the day of operation [4,8,10,13,22]. Published results on outpatient 
knee arthroplasty are rare and only consist papers from the USA. Europe is more 
conservative to change care pathways and/or healthcare systems. At the moment 
optimised enhanced recovery programs still needs to be implemented in most of the 
orthopedic departments around Europe, since the literature on enhanced recovery for 
knee arthroplasty mostly included literature from the scandinavian countries.
Further research needs to be done to emphasize the effectiveness and safety of 




A case-controlled pilot study was performed over the first 20 consecutive cases 
operated in an OS pathway, these results were compared with a control group operated 
in a convential enhanced recovery pathway (RR). We investigated whether patients 
could be discharged on the day of surgery as scheduled, resulting in comparable or 
better outcome by means of adverse events (AE’s) and patient reported outcome 
measurements (PROMS).
Materials and Methods 
All patients were informed and consented to providing data for anonymous use. Between 
December 2013 and June 2014, 34 patients with indication for primary UKA [29] were 
potential candidates to participate in the OS pathway. Patients with severe cardiologic, 
pulmonary and/or internal diseases were excluded. These patients required an overnight 
stay for additional treatment pre-, peri- and postoperative for adjustment of medication 
(e.g. diabetes mellitus (DM), bridging anticoagulation). Patients who were not able to 
understand and complete the procedure due to cognitive dysfunction, fear to follow the 
outpatient procedure, or those who could not be discharged to their home environment 
were also excluded (Figure 1). Twenty patients were eligible candidates to participate in 
the OS pathway. If patients were excluded from the OS pathway, they were treated in the 
RR pathway as the standard pathway in our department for hip- and knee arthroplasty.
Figure 1. Flowchart of potential and included patients for the OS pathway. 
Initiated for UKA
n=34




• Home environment (n=1)
• Severe cardiologic diseases (n=1)
• Severe internal diseases (n=4)
• Participated in another trial (n=6)
Pathways 
Within OS, a personal coach (a relative) indirectly reduces the workload on the ward, 
by involvement as much as possible, to inspire, correct, and support the patient during 
inpatient and outpatient for the first 48 hours (hrs) postoperative. 
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Patients received preoperative education and exercise training, to become familiar 
with walking (stairs) with crutches and transfers from bed to a chair and vice versa, 
information about the in- and outpatient process and home-based rehabilitation. 
All surgeries were performed with the use of patients specific pin guides (Signature, 
Biomet, Warsaw INC) and tourniquets by a single experienced knee arthroplasty 
surgeon (NK). Patients received the (un-) cemented Oxford phase III UKA (Biomet, 
Bridgend, UK). Prophylactic antibiotics (2g Cefazoline) were administered 30 minutes 
(min) before incision. A second dose (1g Cefazoline) was administered before discharge. 
The third dose (300mg Cedax) was taken orally the first postoperative morning at 
home. Patients were operated under general or spinal anesthesia. Local infiltration 
analgesia (LIA) was used intraoperative according to Kerr and Kohan [21]. In order to 
prevent PONV, dexamethasone was used intraoperative (8mg i.v.). Tranexamic acid 
(dose: 1g if weight <100kg, 1,5g if weight >100kg) was provided intravenously at wound 
closure. No drains or urinary catheters were used. Urinary retention was tested with 
the use of a bladder scan (Verathon®, BVI 9400). A compression bandage was used 
to reduce knee swelling [7] and to increase the effect of the LIA [1] during the first 
8hrs postoperative and was removed before discharge. Cooling by ice packs, to cope 
with knee swelling, was advised within the first 24hrs postoperative. An optimised 
and opioid sparing-pain protocol was provided (Table 1). As rescue pain medication, 
Tramadol 50mg was administered (max. 2 times daily). If the patient still suffered from 
high pain intensity while still in hospital after Tramadol, 15mg of dipidolor was injected 
intramuscular (max. 6 times daily). 
Table 1. Optimised pain protocol. 
Preoperative Postoperative
2hrs 4hrs 8hrs First day Day 2-14
Arcoxia (mg) 90 90 90
Paracetamol (g) 1 1 1 1* 1*
Gabapentine (mg) 600 300 300
Omeprazol (mg) 40 40 40
*One Paracetamol (1g) was given four times daily on fixed intervals throughout the day.
The first mobilization was attempted within 4-6hrs postoperative, including transfer 
from the bed to a chair, standing and walking with a walker if possible. If necessary in 
their home-environment, walking stairs with crutches was practiced before discharge. 
Patients received instructions for self-administering subcutaneous syringes for 
thrombosis prophylaxis (Fondaprinux 2.5 mg, Arixtra®, GlaxoSmithKline) administered 
once each evening for 35 days, starting at 22:00pm directly postoperative. After 
Chapter 6
80
discharge, physiotherapy in their home environment was started 14 days postoperative. 
All patients were seen at the outpatient clinic on day 4 and 14, and at the 6 weeks (wks) 
and 3 months (mth) postoperative. 
Patients were briefed on the overall discharge criteria (dry wound, general well-being, 
independent mobilization with crutches and if necessary walking stairs with crutches). 
The ward physician examined the discharge criteria. If there was any deterioration or a 
lack of progress in the function, the operating surgeon was consulted. All patients were 
contacted by telephone the first day after discharge by the ward physician.
Twenty patients without severe cardiologic, pulmonary, internal diseases, and/
or cognitive dysfunction, who had been operated on by the same surgeon between 
December 2011 and November 2012 for UKA following the RR pathway, were randomly 
selected from this cohort (n=79). Beside the differences between both pathways as 
summarized in Table 2, pre-, peri- and postoperative procedures and pain protocol were 
identical in both groups as well as the completed operative and clinical reports.
Table 2. Differences between both pathways extracted for pre-, peri- and postoperative care and 
discharge criteria. 
RR pathway OS pathway
Preoperative
Admission Night before/day of operation Day of operation
Planned discharge <3 days postoperative Day of admission
Perioperative
Dexamethason No Yes, perioperative
Tranexamic acid No Yes, perioperative 
Antibiotics prophylactic I.v. I.v. and oral 
Postoperative
First mobilization <6hrs <4hrs
Compression bandages 24hrs postoperative 8hrs postoperative, first 4 days 
postoperative elastic bandage
Discharge criteria
Knee flexion of 70 degrees Not assisted as discharge criteria
Outcome
AE’s were classified as patient related (e.g. pain, PONV), thrombo-embolic events (e.g. 
deep venous thrombosis; DVT) and wound disorders, surgical related (e.g. infection) 
and/or prosthesis related (e.g. loosening). Experienced pain, measured by a Numerical 
Rating Scale (NRS, 0 to 10, 10 being ‘worst pain’), and incidences of PONV were evaluated 
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during the first 48hrs postoperative. If pain or PONV was reason for delayed first 
mobilization and/or prolonged hospital stay, it was recorded in the patient’s clinical 
report. All patients filled in a diary on if they were affected with (extreme) pain and/
or PONV. All AE’s and re-admissions to the hospital were recorded throughout the 
entire study period of 3mth postoperative. Length of hospital stay was evaluated as 
time between hospital admission and discharge in days. Early mobilization (hrs) was 
recorded as time between the start of anesthesia until the first mobilization. PROMS 
were obtained pre- and 3mth postoperative including the Dutch validated Oxford knee 
score (OKS; 12 to 60, 12 being the best outcome) [14] and EuroQol-5D (EQ-5D; 0 to 1, 1 
indicates the best health state) [6]. 
This case-controlled study was performed in compliance with the Helsinki Declaration 
of 1975, as revised in 2000, and was studied and approved by the local Institutional 
Review Board (IRB: Atrium-Orbis Zuyd, Heerlen, The Netherlands, IRB Nr. 14-N-52) and 
registered online at the Dutch Trial Register (www.trialregister.nl, Nr. NTR4579).
Statistical analysis
The primary outcome of this case-control pilot study was to investigate whether UKA 
patients can go home as scheduled on the day of surgery. Sample size calculations 
were performed based on the results with two different pathways we used before 
implementation of the OS pathway; Joint Care [28] and RR (see materials and methods). 
Ten random selected patients (Joint Care) undergoing elective UKA had a mean (SD) 
hospitalization of 3.7 (1.17) days. The mean (SD) hospitalization of 10 other random 
selected patients, who followed the RR pathway, was 2.6 (0.97) days. With an alpha of 
0.05 and 1- beta error of 0.8, an expected reduction of 1.6 days in the OS group, we would 
need 18 patients; 20 taking into account if assumed that both groups have the largest SD 
(1.17). This study included 40 patients, 20 in each arm. Statistically significant differences 
between both groups were analyzed with non-parametric Mann-Whitney-U test, since 
data were not normally distributed as tested with the Shapiro-Wilk test. Chi-square tests 
was used for categorical variables. P-values were considered to be statistically significant 
at P≤0.05 for all analysis. All statistical analysis were done with use of SPSS version 17.0 
for windows (Inc., Chicago, IL). Results are presented as either with frequencies (%), 




Forty patients were recruited for this study, 20 patients in each group. No patients were 
lost to follow-up. Baseline demographics and operative data are summarized in Table 3. 
Table 3. Baseline demographics were not significant different between the groups. 
Baseline RR pathway OS pathway p-value
Age, years, at index surgery 61.2 (5.15) 60.5 (5.65) n.s.
BMI, kg/m2 27.7 (3.27) 29.1 (3.85) n.s.
Gender, male 11 (55) 13 (65) n.s.
ASA classification I/II/III 6/13 /1 10 /10/0 n.s.
Operative data
General/ Spinal/ Spinal +Sedation 4/12/4 1/19/0 n.s.
OR time, min 48.0 (8.5) 57 (15.3) n.s.
Secondary disorders and concomitant diseases
Cardial (heart failure, hypertension) 1 3 n.s.
Pulmonal (bronchitis, COPD) 2 3 n.s.
Other* 6 3 n.s.
*Autoimmune diseases, renal function disorders, diabetes mellitus type 2, sleep apnea.
All patients were discharged to their home environment, accompanied by a personal coach 
or relative. Seventeen patients (85%) in the OS pathway were discharged on the day of 
surgery as scheduled whereas in the RR pathway 95% of the patients were discharged <3 
days postoperative. Prolonged hospital stay was not significantly different. Three patients 
in the OS pathway had a prolonged hospital stay; 2 patients suffered from high pain 
intensity (NRS >5) and both were discharged on postoperative day 2, as 1 other patient 
had a fear to go home and was discharged on postoperative day 1. In the RR pathway, 1 
patient was suspicious for a DVT and therefore discharge was delayed (discharged on 
postoperative day 3). However, DVT was not diagnosed with echo duplex. 
Early mobilization was comparable between the RR and OS pathway (n.s.). In both pathways, 
1 patient was not able to mobilize due to high pain intensity <6hrs and <4hrs respectively. 
Delayed first mobilization occurred in 1 patient (RR) because of PONV, as another patient 
in the RR pathway had to cope with vasovagal syncope. Time between hospital admission 
and discharge was significantly different (p<0.00) between both pathways: 2.6 days (1.2 – 
4.1) in the RR pathway compared to 0.5 day (0.4 – 2.2) in the OS pathway. NRS pain scores 
were not significantly different preoperatively and <48hrs postoperative, measured on 
fixed time points throughout the day. Overall, median postoperative pain scores did not 
exceed a NRS score of 5 during the first 48hrs (Figure 2). 
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Figure 2. Distribution of median, 1st and 3rd percentile and range for NRS pain scores (Y-axis) for both 
pathways (RR: Rapid Recovery, OS: Outpatient Surgery) measured preoperative (Pre OR), before-
(BFM) and after (AFM) the first mobilization, at 16:00hrs and 22:00hrs and on day 1 and 2 at 8:00hrs, 
16:00hrs and 22:00hrs (X-axis). Minimum and maximum are displayed with the whiskers.
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There were no significant differences (RR vs. OS) in the number of patients with PONV 
(4 vs. 2) and opiate use (11 vs. 9) <48hrs postoperative. AE’s occurred only in one patient 
in the OS pathway. This patient was readmitted <3mth postoperative. The patient did not 
follow instructions for home based physiotherapy during the first 6 weeks postoperative 
and suffered from knee stiffness resulting in a limited knee flexion of 30 degrees. This 
required manipulation under anesthesia after which the patient recovered completely. 
At 3mth follow up, the mean (SD) OKS and EQ-5D significantly (p<0.05) improved within 
each pathway, from 35.2 (8.1) to 22.7 (6.5) and 0.77 (0.1) to 0.85 (0.1) for the RR pathway 
and 32.0 (7.5) to 24.4 (7.6) and 0.75 (0.1) to 0.85 (0.1) in the OS pathway. There were no 




The most important findings of the present study was that outpatient unicompartimental 
knee arthroplasty is effective and safe with good short term clinical results in selected 
patients, with comparable outcomes as patients operated in a conventional pathway. 
Only six papers studied the feasibility of an outpatient pathway for knee arthroplasty of 
which the methodological evidence was poor (Table 4). These papers have considerable 
limitations including poorly presented details of their cohorts [4,13,10,22]. For example, 
only four studies provided data on in- and exclusion criteria and only the study of Kolisek 
et al. [22] included a control group. However, they all reported comparable outcome 
without significant worsened results, in terms of AE’s, readmission rates and prolonged 
hospital stay. This paper presents the preliminary results on elective UKA in an OS 
setting in The Netherlands.
There are some contradictions about the definition of OS. Kolisek et al. [22] aimed to 
discharge patients <23hrs after surgery. As presented by the WHO [32], OS is defined as 
admission and discharge on the day of surgery, without an overnight stay in the hospital. 
Berger et al. [4, 5] operated patients in an outpatient pathway as the first surgeries of the 
day [5] or before noon [4]. Their pain protocol allows sufficient time for postoperative 
pain control. Therefore, these organisational aspects should be taken into account in 
order to prevent a prolonged hospital stay. 
Our results show that it is effective and safe to operate selected patients in an outpatient 
UKA pathway, as 85% of all the UKA patients were discharged on the day of surgery as 
scheduled, without increased AE’s and readmission rate as compared to our conventional 
pathway. This was in line with our expectations and with previously published results by 
others, who also studied the feasibility and safety of outpatient knee arthroplasty (Table. 
4). Cross et al. [8] reported that 100% of the patients operated for UKA (n=105) were 
directly discharged home on the day of surgery. Slightly less (93%) were discharged on 
the day of surgery with total knee arthroplasty (TKA) compared to 96% of the patients 
operated for UKA [4]. Recently, Gondusky et al. [13] published their prospective study 
comparing UKA patients in a pathway with a planned overnight stay (n=47) and one 
with a planned discharge on the day of surgery (n=160). They found that 100% of the 
patients were able to return home the evening of the day of surgery. 
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In our series, high pain intensity was the main factor for an overnight stay in our hospital. 
Berger et al. [4] found that 3.6% of the TKA patients could not be discharged on the day 
of surgery due to inadequate pain control. Pain management is one of the key factors for 
acceptable outcomes of multidisciplinary outpatient pathways [4]. This includes a well-
established multimodal protocol, consisting peri-operative LIA [3,12] and an optimised 
pain protocol for pre-, peri- and postoperative analgesia.
The optimised pain protocol also intended to prevent side effects of medication, which 
enables patients to mobilize <4hrs postoperative. Only one patient (RR) could not 
mobilize due to PONV. As we know, these preventions are crucial for early mobilization 
[11] and length of hospital stay [25]. Our discharge results could be influenced by the 
use of tranexamic acid and dexamethasone in the OS pathway, since there is extensive 
literature on the advantages of using these medications during arthroplasty procedures 
in the prevention of blood loss [34] and PONV [2]. This could be seen as a confounder 
in our series, although none of the patients in the OS and RR pathway needed blood 
transfusion or had a prolonged hospital stay due to wound leakage. Even though the 
amount of patients with PONV was lower in the OS pathway without a significant 
difference. Another possible reason for prolonged hospital stay is fear to go home, as 
found by Berger et al. [4]. Therefore, fear to go home must be included as exclusion 
criteria for the OS pathway, which was seen in one patient in the OS pathway, resulting 
in prolonged hospital stay with discharge the first day postoperative. Other causes that 
can delay discharge are administrative failures [3, 30] but were not seen in our series. 
AE’s and readmission rates were not significantly different between both groups. This 
was in line with the results published by others (Table. 4). More complications <1 week 
postoperative were seen after TKA rather than UKA during the outpatient procedure [4]. 
Previous series published by Berger et al. [5], showed fewer complications for outpatient 
TKA, in which they used more stringent inclusion criteria. Recently, Lovald et al. [24] 
concluded that pre-existing co morbidities and particularly heart failure are major risk 
factors for AE’s after outpatient and short stay TKA. Furthermore, evidence to in- or 
exclude patients in an outpatient setting is limited. Beside the pre-selected patients in 
our series, based on general criteria, we suggest that there is a need for proper in- and 
exclusion criteria for outpatient knee arthroplasty. 
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Table 4. Literature overview on outpatient knee arthroplasty pathways.
Author(s) N Arthroplasty Study design In-/exclusion criteria Discharge Prolonged hospital stay Complications/readmission
Berger et al. 2005 [5] 50 TKA Case series Primary TKA without history 
of prior open knee surgery, 
between 50-80 years of age / 
history <1year of myocardial 
infarction, pulmonary embolism 
or anticoagulation therapy
96%, day of 
surgery
N=1, not willing to go home
N=1, PONV and orthostatic 
hypotension
N=1, GI bleeding 8 days postoperative
N=1, delayed wound healing necessitating 
superficial irrigation and debridement
N=1, manipulation under anaesthesia 
9weeks postoperative
Berger et al. 2009 [4] 111 UKA and TKA Case series None 94%, day of 
surgery
N=4 difficulty with pain control
N=1 chest pain, workup for 
myocardial infarction, which was 
negative
N=1 fear to go home
N=1 PONV
<1week




>1week and <3 mth
N=2, wound complications necessitating 
superficial irrigation and debridement
N=1, manupilation under anesthesia
N=1, GI bleeding
Cross and Berger 2014 [8] 105 UKA Case series None 100%, day of 
surgery
None N=1, infection/>1 week and <12 weeks
Dervin et al. 2012 [10] 24 UKA Case series ASA I&II, caregiver the first 
3-4 days, understanding post 
operative analgesia regimen 
/ major systemic illness, 
ASA>II, chronic pain or opioid 
consumption, contraindications 
to FNB and residence outside 




NA N=1 patient had prolonged wound 
drainage that required daily dressing 
changes and, ultimately, repeat arthrotomy 
for definitive wound closure. N=1 had a 
dislocation of a lateral mobile-bearing 
insert at 9 mth, which was successfully 
revised to a fixed bearing.
Gondusky et al. 2014 [13] 160 UKA Case series Cardiac clearance, ASA I-III, 
social situation and home 
environment needed to be 
deemed safe with adequate 
aid of a caregiver available / 
cognitive issues and not capable 
of complying with the peri-
operative protocol
100%, day of 
surgery
None N=2 reoperation (dislocation mobile 
bearing and revision to TKA due to 
progression of lateral sided arthritis).
N=1 haematoma day 6 post operative,
/ N=1 wound healing disorders<24hrs, n=1 
internal multifactorial etiology at day 9 
post operative
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Author(s) N Arthroplasty Study design In-/exclusion criteria Discharge Prolonged hospital stay Complications/readmission
Kolisek et al. 2009 [22] 64 TKA Case 
controlled
lived <1hrs from the office, who 
had an adult to help them at 
home / any history of diabetes, 
myocardial infarction, stroke, 
congestive heart failure, venous 
thrombo-embolism, cardiac 
arrhythmia, respiratory failure, 
or chronic pain requiring
regulair opioid medications.
100%, <23hrs None N=1, developed a foot drop and a heel 
ulcer secondary
to peroneal nerve dysfunction. 
N=1, revisions for a genu recurvatum 
deformity <10
N=1, tibial plateau fracture >1 YPO
N=2, manipulation under
anaesthesia to treat knee stiffness >3 
and>6 MPO
Current study 40 UKA Case 
controlled
severe cardiologic, pulmonary 
and/or internal diseases, 
not able to understand and 
complete the procedure due to 
cognitive dysfunction, fear to 
follow the outpatient procedure, 
not be discharged to their home 
environment.
85%, <11hrs N=2, high pain intensity
N=1, fear to go home
N=1, manipulation under
anaesthesia to treat knee stiffness >6 WPO
This single surgeon, case-controlled pilot study, with a limited number of patients, could 
raise questions about the general applicability. We agree with Berger et al. [4], based 
on the experience with the use of clinical pathways, a stepwise implementation of an 
enhanced pathway, with the aim to discharge patients on the day of surgery, will be 
more effective and safe. Once these changes have been put in place, it will often be 
necessary to re-evaluate the new structures, to explore and extend the roles of the 
multidisciplinary team, to ensure optimal pre-, peri- and postoperative care. On the other 
hand, expansion of a day care surgery pathway involves an extensive change in mindset, 
both for patients and dedicated multidisciplinary team. Health care organizations and 
hospital management needs to be convinced of the possibilities of optimised clinical 
pathways. With the use of simplified protocols and standards, wich are applicable in 
every hospital, each hospital is able to reduce waiting periods and length of hospital stay 
[28]. This could result in lower costs, with comparable or improved patient satisfaction. 
Obviously, there are some methodological limitations in order to say something about 
the AE’s beceause of the small number of patients included in this study. These results 
might be inappropriate to use to conclude that the amount of AE’s are comparable 
between both pathways. Further studies on AE’s as an outcome with sufficient power 
and sample size are needed to assess whether these outcome measures differs between 
both pathways.




Author(s) N Arthroplasty Study design In-/exclusion criteria Discharge Prolonged hospital stay Complications/readmission
Kolisek et al. 2009 [22] 64 TKA Case 
controlled
lived <1hrs from the office, who 
had an adult to help them at 
home / any history of diabetes, 
myocardial infarction, stroke, 
congestive heart failure, venous 
thrombo-embolism, cardiac 
arrhythmia, respiratory failure, 
or chronic pain requiring
regulair opioid medications.
100%, <23hrs None N=1, developed a foot drop and a heel 
ulcer secondary
to peroneal nerve dysfunction. 
N=1, revisions for a genu recurvatum 
deformity <10
N=1, tibial plateau fracture >1 YPO
N=2, manipulation under
anaesthesia to treat knee stiffness >3 
and>6 MPO
Current study 40 UKA Case 
controlled
severe cardiologic, pulmonary 
and/or internal diseases, 
not able to understand and 
complete the procedure due to 
cognitive dysfunction, fear to 
follow the outpatient procedure, 
not be discharged to their home 
environment.
85%, <11hrs N=2, high pain intensity
N=1, fear to go home
N=1, manipulation under
anaesthesia to treat knee stiffness >6 WPO
This single surgeon, case-controlled pilot study, with a limited number of patients, could 
raise questions about the general applicability. We agree with Berger et al. [4], based 
on the experience with the use of clinical pathways, a stepwise implementation of an 
enhanced pathway, with the aim to discharge patients on the day of surgery, will be 
more effective and safe. Once these changes have been put in place, it will often be 
necessary to re-evaluate the new structures, to explore and extend the roles of the 
multidisciplinary team, to ensure optimal pre-, peri- and postoperative care. On the other 
hand, expansion of a day care surgery pathway involves an extensive change in mindset, 
both for patients and dedicated multidisciplinary team. Health care organizations and 
hospital management needs to be convinced of the possibilities of optimised clinical 
pathways. With the use of simplified protocols and standards, wich are applicable in 
every hospital, each hospital is able to reduce waiting periods and length of hospital stay 
[28]. This could result in lower costs, with comparable or improved patient satisfaction. 
Obviously, there are some methodological limitations in order to say something about 
the AE’s beceause of the small number of patients included in this study. These results 
might be inappropriate to use to conclude that the amount of AE’s are comparable 
between both pathways. Further studies on AE’s as an outcome with sufficient power 
and sample size are needed to assess whether these outcome measures differs between 
both pathways.
Finally, we recommend that further well designed randomized controlled trials with 
larger patient series will be needed to confirm our preliminary results. After this, health 
care organizations and hospital management will probally be convinced of the need of 
optimised clinical pathways.
Conclusion
Well-established and adequate protocols, standardized general applicable in- and 
exclusion criteria and a change in mindset for both the patient and the multidisciplinary 
team are the key factors for the successful implementation of an outpatient surgical 
pathway for unicompartimental knee arthroplasty. 
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Introduction This systematic review aimed to assess the safety and efficacy of outpatient 
joint arthroplasty (OJA) pathways compared to inpatient pathways.
Materials and methods An electronic literature search was conducted to identify eligible 
studies. Studies comparing OJA with inpatient pathways—following hip and/or (partial) 
knee arthroplasty—were included. Included studies were assigned—based on OJA 
definition—to one of the following two groups: (1) outpatient surgery (OS); outpatient 
defined as discharge on the same day as surgery; and (2) semi-outpatient surgery (SOS); 
outpatient defined as discharge within 24 h after surgery with or without an overnight 
stay. Methodological quality was assessed. Outcomes included (serious) adverse 
events ((S)AEs), readmissions, successful same-day discharge rates, patient-reported 
outcome measures (PROMs) and costs. Meta-analyses and subgroup analyses by type 
of arthroplasty were performed when deemed appropriate.
Results A total of 41 studies (OS = 26, SOS = 15) met the inclusion criteria. One RCT 
and 40 observational studies were included, with an overall risk-of-bias of moderate 
to high. Forty studies were included in the meta-analysis. Outpatients (both OS and 
SOS) were younger and had a lower BMI and ASA class compared to inpatients. 
Overall, no significant differences between outpatients and inpatients were found for 
overall complications and readmission rates, and improvement in PROMs. By type of 
arthroplasty, only THAs in OS pathways were associated with fewer AEs [OR = 0.55 
(0.41–0.74)] compared to inpatient pathways. 92% of OS patients were discharged on 
the day of surgery. OJA resulted in an average cost reduction of $6.797,02.
Conclusion OJA pathways are as safe and effective as inpatient pathways in selected 
populations, with a potential reduction of costs. Considerable risk of bias in the majority 
of studies emphasizes the need for further research.
Keywords Outpatient joint arthroplasty; Knee arthroplasty; Hip arthroplasty; Clinical 
pathway




As a result of successful fast-track surgery pathways and its continuous optimisation, 
hip and knee arthroplasty are increasingly performed on an outpatient basis. These 
day-care surgery pathways are being designed to discharge patients home without 
an overnight stay in the hospital [1]. This might benefit patients in terms of possible 
reduced risk for hospital-acquired infections, starting early rehabilitation in their 
own home environment, and the possibility of enhanced patient participation and 
improved satisfaction. Besides, there is potential to reduce the economic burden 
on the healthcare systems, as the demand for hip and knee arthroplasties is 
increasing internationally [2,3,4,5,6]. When implementing a new treatment (e.g. an 
outpatient joint arthroplasty (OJA) pathway following hip and knee arthroplasty), 
it is paramount to ensure the quality of the provided care and safety of patients. 
Acceptable clinical outcomes, in terms of complications and readmission rates, were 
found for both hip and (partial) knee arthroplasty in previous systematic reviews 
[7,8,9,10]. These systematic reviews mainly consisted of observational case series, 
which included a selected group of patients. Patients selected for OJA are generally 
expected to be healthier compared with the average population undergoing hip or 
knee arthroplasty. However, even in an unselected group of patients, similar results 
were found [11, 12].
When comparing outcomes on OJA, variation in used definitions in the literature has to 
be accounted for. Some authors defined outpatient as a length of stay (LOS) less than 
24 h, whereas others defined outpatient as hospital discharge on the day of surgery. 
Also large national registry databases (e.g. the NSQIP) which are frequently used in 
OJA research, use a controversial outpatient definition. A study by Bovonratwet et al. 
reported that only 11–12% of patients who were registered as outpatients were actually 
discharged on the day of surgery, because regulations in the USA allow these patients 
to stay more than 1 night in hospital under observation status. Off all studies reporting 
on the NSQIP data, different variables are used to indicatie OJA: (1) the “outpatient 
status variable”; and (2) the “LOS (= 0) variable” (which appears to be more accurate). 
To ensure clarity and uniformity, we agree with Vehmeyer et al. [13] to reserve the term 
“outpatient joint arthroplasty” solely for patients who are discharged to their own home 
on the day of surgery and who do not have an overnight stay at either the hospital or 
another non-home facility.
The purpose of this systematic review was to study the safety and efficacy of outpatient 
pathways compared with standard inpatient recovery pathways following hip and 
(partial) knee arthroplasty, accounting for the abovementioned definitional differences 
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in OJA. We primarily aimed to assess whether there were significant differences in (1) the 
number of (serious) adverse events ((S)AEs) and readmission rates; (2) postoperative 
improvement in patient-reported outcome measures (PROMs) and (3) total hospital 
costs.
Materials and methods
A review protocol was developed according to the Preferred Items for Reporting 
Systematic Reviews and Meta-Analysis (PRISMA-P) statement [14] and registered 
in PROSPERO (under review: no 161688), the International Prospective Register of 
Systematic Reviews.
Search strategy
A comprehensive electronic literature search was conducted to identify eligible 
studies on outpatient pathways following primary hip and (partial) knee arthroplasty. 
Five databases (Embase, PubMed, Wiley/Cochrane Library, Clarivate Analytics/Web 
of Science and EBSCO/CINAHL) and three trial registers (World Health Organization 
portal, ClinicalTrials.gov, and PROSPERO) were searched in December 2019 for 
published and ongoing trials. Reference lists of included studies were also searched by 
two independent reviewers to identify eligible studies that were missed by the search. 
The full search strategies are presented in the supplementary data.
Eligibility of studies
Both randomized controlled trials (RCTs) and (prospective or retrospective) 
observational studies were included in this systematic review. Only studies that 
compared safety and/or efficacy outcomes (e.g. (S)AEs, readmission rates, PROMs, 
costs) between OJA pathways and standard inpatient pathways—following hip and/
or (partial) knee arthroplasty—were included. Results needed to be published as a full 
report and there were no restrictions on the date of study publication. Only studies 
published in English were selected. Studies were excluded if they reported on patients 
undergoing revision surgery, bilateral arthroplasty or arthroplasty due to traumatic 
conditions. Strictly descriptive studies (e.g. historical and/or editorial studies) were 
also excluded.
Selection and data collection process
Two reviewers independently extracted the search results of the different databases 
with the RefWorks tool (ProQuest LLC ©, 2020). The aforementioned two reviewers 
independently screened titles and abstracts of all studies retrieved by the literature 
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search. Then the full texts of all potentially eligible studies were retrieved and 
independently reviewed. The decision regarding study selection was based on the 
inclusion criteria. Discrepancies between reviewers were discussed and, if necessary, 
an agreement was reached by the adjudication of a third reviewer.
Data extraction and outcomes
Two reviewers independently extracted the data for each included study using a 
predefined standardized data extraction form. The data extraction form contained 
information on study characteristics (e.g. author, year, country, setting, study design, type 
of arthroplasty and number of selected patients), patient demographics (e.g. age, gender, 
body mass index (BMI), American Society of Anesthesiologists (ASA) classification and 
type of anesthesia) and outcomes (e.g. complication rates, readmission rates, success 
rates of same-day discharge (SDD), PROMs and/or costs).
To account for differences in “outpatient” definitions, studies were assigned to one 
of the following two categories: (1) outpatient surgery (OS); outpatient defined as 
discharge to their own home on the day of surgery; and (2) semi-outpatient surgery 
(SOS); outpatient defined as discharge within 24 h after surgery with or without an 
overnight stay. Studies that did not specifiy the “outpatient” definition were also 
included in the SOS group.
Complications were defined as adverse events (AEs), including wound dehiscence, 
wound leakage, urinary retention/infection, pneumonia, renal disorder, and blood 
transfusion; or serious adverse events (SAEs), including death, sepsis, coma, (prolonged) 
intubation, stroke, thromboembolic event (deep vein thrombosis/pulmonary embolism), 
infection of the prosthesis, myocardial infarction, cardiac arrest, arrhythmia, acute renal 
failure, perioperative fracture, failure of prothesis, hip dislocation and/or peripheral 
nerve injury, and return to the operating room (all re-operations). A minimal follow-up 
period of 30 days was required.
Patient demographics were described as means with standard deviations (SD) for 
continuous variables (age and BMI) and frequencies with percentages for categorical 
variables (gender, ASA score > II, and type of anesthesia). (S)AEs, readmission rates, 
and successful SDD rates were described as frequencies with percentages. PROMs and 
costs were reported descriptively. The two reviewers had to reach a consensus on data 
extraction. Any discrepancies between reviewers were discussed and, if necessary, an 
agreement was reached by the adjudication of a third author.
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Risk of bias in individual studies
Two reviewers independently assessed the risk of bias of each of the included studies. 
The Cochrane Risk of Bias tool [15] (version 2 of the Cochrane risk-of-bias tool for 
randomized trials) was used to assess the risk of bias in randomized trials. The risk of 
bias for non-randomized studies was assessed with use of the ROBINS-I tool [16]. Any 
discrepancies between reviewers were discussed and, if necessary, an agreement was 
reached by the adjudication of a third author.
Data synthesis
All outcome measures were analysed using RevMan 5 [17]. Continuous data were 
described as mean differences with 95% confidence intervals (CI) or standardized mean 
differences. Dichotomous data were described as odds ratios (OR). Where possible, the 
data were pooled in a meta-analysis. To quantify statistical heterogeneity, the Cochran’s 
Q test and I2 statistic (the proportion of the total variance explained by heterogeneity) 
were conducted. I2 values of > 75% were interpreted as high heterogeneity [18]. 
Subanalyses were performed for the two defined outpatient groups (experimental): 
(1) OS versus (2) SOS, compared with inpatient pathways (control) to account for 
differences in “outpatient” definitions as described above. Subanalyses were also 
performed for THA, TKA and UKA to account for fundamental differences between the 
three types of arthroplasty. In case meta-analysis was eligible, forest and funnel plots 
were presented.
Ethical considerations
This review is a non-Medical Research Involving Human Subjects Act study.
Results
This systematic electronic search identified 8.718 references. No additional records 
were identified by cross-checking reference lists. The search and selection process are 
shown in the PRISMA flow diagram (Fig. 1). After removal of duplicates, 4.538 references 
remained for screening on title and abstract. In total, 52 full texts were assessed for 
eligibility. After review, 41 studies met the inclusion criteria and were included in the 
systematic review. Twenty-six studies were allocated to the OS group [2,3,4,5,6, 12, 19,2
0,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38] and 15 to the SOS group [39,40,41
,42,43,44,45,46,47,48,49,50,51,52,53] for subanalyses. 
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Figure 1. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flow diagram 
of the literature search.
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Thirty-one studies were conducted in the United States [2,3,4,5, 19, 21,22,23,24, 26,27,28, 
30, 31, 33, 35, 38,39,40,41,42,43, 45,46,47,48,49,50,51,52,53], four in the Netherlands [25, 
29, 36, 38], three in Canada [6, 32, 34], two in France [20, 44] and one in Denmark [12] 
(Fig. 1). All studies were published between 2005 and 2019. Of the included studies, 
there was 1 RCT [24], 5 prospective observational studies [5, 6, 28, 36, 51], 1 prospective 
observational study with a matched inpatient cohort [43], 16 retrospective observational 
studies [5, 6, 29, 37, 52], 1 prospective observational study with a matched inpatient 
cohort [44], 16 retrospective observational studies [20, 21, 27, 30, 35, 36, 38,39,40,41, 43, 
44, 47, 49, 51, 53], 16 retrospective observational studies with a matched inpatient cohort 
[2,3,4, 12, 19, 22, 23, 28, 31,32,33,34, 42, 45, 46, 50], and 2 qualitative studies [25, 26]. Of 
the included studies, 18 used large national databases (e.g. national private insurance 
databases or national registry databases) [2,3,4, 19, 21, 28, 31,32,33, 39, 40, 42, 43, 46, 
48,49,50,51]. The setting of the outpatient pathways varied from ambulatory surgical 
centers [22, 26, 41, 45] or hip/knee centers [5, 38], secondary and tertiary care hospitals 
[6, 12, 20, 23,24,25, 27, 29, 30, 34, 36, 37, 44, 48, 52, 53], or a combination of settings [35]. 
Ten studies described OJA following total hip arthroplasty (THA) [5, 24, 27, 31, 34, 40, 
41, 44, 51, 53], 13 following total knee arthroplasty (TKA) [3, 6, 20, 21, 28, 30, 32, 37, 39, 
47,48,49, 52], 6 following unicompartmental knee arthroplasty (UKA) [2, 22, 25, 29, 35, 
46] and 11 studies presented results on both hip and (partial) knee arthroplasty [4, 12, 
19, 23, 26, 33, 36, 38, 42, 43, 45, 50]. In total, the complete sample of studied patients 
consisted of 40.758 outpatients (OS = 8.358; SOS = 32.400) and 1.212.370 inpatients. A 
summary of the study characteristics and patient demographics is presented in Table 1.
Risk of bias
For all observational studies, more than 75% of the studies had a moderate or high 
risk of bias (Fig. 2). The included RCT was of high-quality regarding the low risk-of-bias 
judgment (Fig. 3). Blinding of participants, to prevent performance bias, was not possible 
because of the nature of the studied objective.
Figure 2. Overall risk of bias for non-randomized trials, with use of the ROBINS-I tool.
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The methodological structure, measured outcomes, and description of data types varied 
between studies. Only studies that used comparable outcomes with a similar description 
of data were included in a meta-analysis. Data were pooled for total complication rates, 
SAEs, AEs, and readmissions.
In OS studies, demographics on the distribution of gender, BMI, and type of anesthesia 
were homogeneous, whereas data on age and ASA class were highly heterogeneous. 
All data on primary outcomes (e.g. total complication rate, (S)AEs and readmission 
rates) were homogeneous. In SOS studies, all data on total complication rate, SAEs, 
readmission rates and demographics (age, gender, BMI, ASA, and type of anesthesia) 
showed heterogeneity. Subanalysis on AEs for THA, showed homogeneity. Data on 
PROMs and costs were analysed in a qualitative method.
Demographic data
Demographics were pooled and presented in the supplementary data. Within the OS 
studies, patients were significantly younger (P = 0.009), had a lower BMI (P < 0.001), and 
had a lower ASA class (P = 0.002) compared to patients in the inpatient pathways.
Patients in the SOS studies were significantly younger (P = 0.002) and were significantly 
more likely to be female (P = 0.03) compared to patients in the inpatient pathways. The 
amount of ASA score > II patients, between the SOS pathways and inpatient pathways 
was not statistically significant different (P = 0.13).
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Table 1. Summary of included study characteristics and demographics. 
Author Year Type of
arthroplasty
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or ASC without inpatient 
hospital admission and 
absolute LOS of <24hrs
SOS 128,951 4,391 Age, gender (S)AE’s
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or ASC without inpatient 
hospital admission and 
absolute LOS of <24hrs
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transferred from the hospital 
at 23h postoperatively














Discharge the day of the 
surgical procedure
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Surgery and discharge 
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Patients with a LOS of 0 days 
and discharged on the same 
day of surgery
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and discharged home on the 
same day of surgery without 
overnight stay in the hospital
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Not specified in methods and 
materials
SOS 4,443 1,481 NA (S)AE’s, 
readmissions, 
costs





(excluded patients who were 
alone at home on the evening 
of the procedure)












Hospital definition of 
outpatient and inpatient, 
according to database
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materials
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THA, total hip arthroplasty; RHA, resurfacing hip arthroplasty; TKA, total knee arthroplasty; UKA, 
unicompartmental knee arthroplasty; USA, United States of America; FR, France; DK, Denmark; NL, 
Netherlands; CA, Canada; HS-PDPR, Humana subset PearlDiver Patient Record; ASC, ambulatory 
surgical center; ACS-NSQIP, Amercian College of Surgeons National Surgical Quality Improvement
Program; THAMCR, Truven Health Analytics Marketscan Commercial Research; LOS, length of stay; 
hr(s), hours; SOS, semi outpatient surgery; OS, outpatient surgery; BMI, body-mass index; ASA, 
american society of anesthesiologists score; NA, not applicable; (s)AE’s, (serious) adverse events; 
SDD, same day discharge.
Complications ((S)AEs)
Overall complication rates were described in 33 studies (OS = 19; SOS = 14) [2,3,4,5,6, 
19,20,21,22,23,24,25, 28, 29, 31, 32, 34, 35, 38,39,40,41,42,43,44,45,46,47,48,49,50,51,52]
. No significant differences were found for overall complication rates in OJA pathways 
(OS, P = 0.24; SOS, P = 0.71) compared to inpatient pathways (Fig. 4).
Adverse events (AEs) were described in 27 studies (OS = 17, SOS = 10) [2,3,4,5,6, 19, 21, 
22, 24, 25, 28, 29, 31, 32, 34, 35, 38,39,40,41, 44,45,46,47,48,49, 52]. For OS studies, only 
THAs showed statistically significant fewer AEs in outpatient pathways [OR = 0.55 (0.41–
0.74); I2 = 0%] compared to inpatient pathways (Fig. 5). For SOS studies, no statistically 
significant differences (by types of arthroplasty) were found for AEs between the two 
pathways.
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. No significant differences were found for overall complication rates in OJA pathways 
(OS, P = 0.24; SOS, P = 0.71) compared to inpatient pathways (Fig. 4).
Adverse events (AEs) were described in 27 studies (OS = 17, SOS = 10) [2,3,4,5,6, 19, 21, 
22, 24, 25, 28, 29, 31, 32, 34, 35, 38,39,40,41, 44,45,46,47,48,49, 52]. For OS studies, only 
THAs showed statistically significant fewer AEs in outpatient pathways [OR = 0.55 (0.41–
0.74); I2 = 0%] compared to inpatient pathways (Fig. 5). For SOS studies, no statistically 
significant differences (by types of arthroplasty) were found for AEs between the two 
pathways.
Readmission rates
No statistically significant differences (by types of arthroplasty) were found for 
readmission rates in both outpatient pathways (OS and SOS) compared to inpatient 
pathways (Fig. 7). The follow-up period ranged from 4 weeks to 1 year.
SDD success rate
Success rates of SDD following an OJA pathway was presented in 14 studies [5, 6, 20, 
22,23,24,25, 27, 29, 34,35,36,37,38]. Overall, we found that 941 of 1.077 outpatients of the 
OS studies (average success rate of 92%, ranging from 61 to 100%) were successfully 
discharged on the day of surgery. TKAs and UKAs had an average SDD success rate of 
95%, whereas 86% of THAs were successfully discharged on the day of surgery.
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Figure 4. Forest plot for overall complication rate, presented as numbers (n).
 
Experimental, outpatient joint arthroplasty pathway; control, inpatient pathway. 
 
Serious adverse events (SAEs) were described in 29 studies (OS = 17, SOS = 12) [2,3,4,5,6, 
19, 21, 22, 24, 25, 28, 29, 38,39,40,41,42, 44,45,46,47,48,49, 51, 52]. For both OS and SOS 
studies, no statistically significant differences (by types of arthroplasty) were found for 
SAEs compared to inpatients (Fig. 6).
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Figure 5. Forest plot for adverse events with subgroup analysis for total hip arthroplasty (THA), total 
knee arthroplasty (TKA) and unicompartmental knee arthroplasty (UKA), presented as numbers (n).
 





Seven studies reported a comparison of postoperative improvements in PROMs 
between outpatient and inpatient pathways [25, 26, 29, 36,37,38, 48]. Used PROMs varied 
and included the Knee Injury and Osteoarthritis Outcome Score (KOOS), Oxford Knee 
Score (OKS), Knee Society Score (KSS), Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC), EuroQol-5D (EQ-5D), Visual Analogue Scale (VAS) 
for pain, and patient satisfaction questionnaires. The postoperative improvement was 
similar between outpatient pathways and inpatient pathways for all PROMs. The follow-
up period ranged from 30 days to 1 year. High patient satisfaction was reported in three 
studies for OJA and inpatient pathways [26, 38, 48]. Two studies (one in an ambulatory 
surgical center and one in a hip/knee center) [26, 38] reported favorable outcomes on 
patient satisfaction. Patient satisfaction was either measured with a numerical scale 
[48] or with the use of a survey by telephone [26, 38].
Costs
Seven observational studies reported on costs [5, 6, 28, 35, 41, 42, 52]. Evaluation and 
description of costs varied highly across studies. Six of seven studies (86%) reporting 
on costs were conducted in the United States. Only total costs were compared between 
outpatient and inpatient pathways. A mean (SD) cost reduction of $6.797,02 ($5.394,81) 
was found in favor of outpatient pathways, but with a large range ($2.468,62-$20.573,00). 
Overall, usage of surgery (e.g. surgery facility fee, operation room supplies) and 
hospital facility (e.g. nursing, room charges, laboratory tests, medication, perioperative 
physiotherapy) contributed the most in the cost reduction.
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Figure 6. Forest plot for serious adverse events with subgroup analysis for total hip arthroplasty (THA), 
total knee arthroplasty (TKA) and unicompartmental knee arthroplasty (UKA), presented as numbers 
(n).
 




Figure 7. Forest plot for readmissions with subgroup analysis for total hip arthroplasty (THA), total 
knee arthroplasty (TKA) and unicompartmental knee arthroplasty (UKA), presented as numbers (n).
 
Experimental, outpatient joint arthroplasty pathway; control, inpatient pathway. 
 




Current literature is divided on the safety (in terms of complications and readmissions) 
of OJA pathways. Several studies reported an increased risk for (S)AEs if patients were 
discharged on the same day of surgery [32, 39, 50], while others stated that there were 
no safety issues [9, 24, 29, 34, 53]. The most important finding of this study was that the 
implementation of OJA pathways in a selective group of patients resulted in acceptable 
clinical outcomes regarding complications and readmission rates while reducing costs 
and preserving the patient-reported outcome compared to standard inpatient pathways. 
Subanalyses by type of arthroplasty (e.g. THA, TKA, UKA) found that THAs in OS 
pathways were associated with fewer AEs compared to inpatient pathways. For SAEs 
and readmissions, subanalyses found no significant differences between outpatient and 
inpatient pathways, suggesting that OJA following hip or knee arthroplasty is most likely 
safe in a selected patient population.
The current literature on OJA, however, consists of low to moderate quality with moderate 
to high risk of selection bias. Only one RCT was included in the present systematic 
review. Most included studies, however, had a retrospective and observational design, 
with high risk of selection bias [5, 6, 20, 21, 25,26,27, 29, 30, 35,36,37,38,39,40,41, 43, 44, 
47, 51,52,53].
Many studies on outpatient joint arthroplasty used large (national claims and 
administrative) databases [2,3,4, 19, 21, 28, 31,32,33, 39, 40, 42, 43, 46, 47, 49,50,51]. 
These databases provide high power to outcome measures and although results 
can provide a raw estimate of certain relationships, heterogeneity in the sample (as 
variations in practice patterns are not accounted for can lead to potential recording 
bias and/or confounding) may worsen the accuracy that comes with interpreting the 
results. Bonvonratwet et al. [4] also found that definitional differences in “outpatient” 
status were present in the American College of Surgeons (ACS) National Surgical 
Quality Improvement Program (NSQIP®) – a national (USA) database which is used 
in many studies on OJA [4]. The same study also described the possible influence 
of definitional differences on outcomes. An explanation for this could be a more 
stringent patient selection for patients discharged on the day of surgery compared 
to patients discharged within 24 h (i.e. the first postoperative day). Besides, there 
is substantial potential of confounding by selection bias in these database and 
observational studies, as OJA is often reserved for the more “active” and “healthy” 
patients. As expected, we found that patients included in the OJA pathways were 
overall younger and less infirm (in terms of ASA class), and had a lower BMI 
compared to patients in the inpatient pathways [20, 24, 28, 34, 43, 45, 48]. This should 
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be taken into account while interpreting the current results and emphasizes the need 
for large randomized controlled clinical trials comparing outpatient with inpatients 
pathways following hip and knee arthroplasty.
Another factor that might impede the interpretation of the results is a lack of consistent 
use of the same definitions for complications/adverse events [54]. Some studies 
described (S)AEs in terms of surgical versus medical complications [50], whereas others 
described minor versus major complications [32]. Scoring of complications was based 
on the authors’ interpretation or the availability of data in databases. Furthermore, the 
majority of (S)AEs occur within 4 days postoperatively [54]. Most inpatient pathways 
(consisting of fast-track recovery pathways) discharge patients within 2–3 days after 
surgery. This might explain why the current meta-analysis did not find differences 
in terms of overall complications and readmission rates, since both outpatients and 
inpatients are discharged within this time-frame. Another potential limitation could be 
the fact that the follow-up period for reporting complications and readmission rates 
varied between studies.
Patients in the outpatient pathways improved equally postoperatively in terms of 
PROMs compared to patients in the inpatient pathways. Previous research did not find 
differences in the long-term (1 year) outcomes between these pathways [36]. PROMs 
are used to transform qualitative symptoms and limitations into quantitative data 
that can be compared over time, across patients, and benchmarked against different 
populations [55]. In the literature, the utilization of PROM tools varies strongly in and 
between measured domains following hip and knee arthroplasty, making it difficult to 
compare and interpret outcomes. The possible implementation of Patient-Reported 
Outcomes Measurement Information System (PROMIS®)—a systematic measurement 
system applying a standardized metric that is based on the normative data of the general 
population—is increasingly being researched in the orthopedic [55, 56] and might allow 
for a better comparison of PROMs (also between different domains and populations) if 
adopted internationally in research.
All studies on costs (and made a comparison between outpatient and inpatient pathways) 
included in this systematic review showed a total cost reduction in favor of outpatient 
pathways. All of these studies, however, treated costs differently which led to a wide range 
of outcome and made comparison difficult. One study assessed total charges to a patient’s 
insurance carrier (including surgical facility fees, OR supplies, hospital room facility, et 
cetera) and negotiated reimbursement [35]. Another study assessed total hospital charges 
because they found it impossible to assign actual costs to items such as nursing or therapist 
care and used fixed facility costs [5]. Two studies assessed direct costs (charges to the 
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patient including costs for medical supplies, implants, nursing and medication et cetera), 
indirect costs (overhead expenses that were not directly related to patient care including 
administration, housekeeping et cetera), and total costs [6, 52]. Two studies assessed payment 
for the index hospitalization or index outpatient encounter, with a correction of payments 
for all post-acute care to 90-day follow-up [28, 42]. Almost all studies reporting on costs were 
conducted in the United States. Since healthcare systems and reimbursement models differ 
between countries, these results lack external validity. This implicates that there is a need 
for cost-efficiency analysis in different settings to assess the potential benefits of outpatient 
joint arthroplasty internationally [5, 6, 28, 35, 41, 42, 52].
Conclusions
The present systematic review and meta-analysis suggests that OJA pathways are as 
safe and effective as inpatient pathways following hip and knee arthroplasty in selected 
populations, with a potential reduction of costs. Considerable risk of bias in the majority 
of studies, however, emphasizes the need for large randomized controlled clinical trials 
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Purpose General consensus of patient selection criteria for outpatient joint arthroplasty 
is lacking, which is paramount to prevent prolonged hospital stay, adverse events and/
or readmissions. This review highlights patient selection criteria for OJA based on the 
current literature and expert opinion.
Methods A search of the English and International electronic healthcare databases 
including MEDLINE/PubMed, EMBASE, AMED and the Cochrane library was performed 
in November 2015 to include studies published during the last 10 years. Furthermore, a 
survey of physicians from different specialties was performed.
Results Fourteen studies described results regarding outpatient joint arthroplasty. Studies 
on outpatient hip and/or knee arthroplasty resulted in similar outcome in preselected 
patients. Patients who are able and willing to participate, with a low ASA classification 
(<III), undergoing primary arthroplasty, age <75 and with support at home during the 
first postoperative days are eligible candidates for outpatient joint arthroplasty. Patients 
with a high ASA classification (>II), bleeding disorders, poorly controlled and/or severe 
cardiac (e.g. heart failure, arrhythmia) or pulmonary (e.g. embolism, respiratory failure) 
comorbidities, uncontrolled DM (type I or II), a high BMI (>30 m2/kg), chronic opioid 
consumption, functional neurological impairments, dependent functional status, 
chronic/endstage renal disease and/or reduced preoperative cognitive capacity should 
be excluded from outpatient joint arthroplasty. The expert opinion-based selection 
criteria were comparable to literature with a further extension of exclusion for patients 
with practical issue’s, urologic medical history and/or severe mobility disorders.
Conclusion Based on the current literature, the presented patient selection criteria 
provide a basis for outpatient joint arthroplasty and can be useful when selecting 
patients. Together with a change in mindset, a multidisciplinary approach and literature-
based protocols, outpatient joint arthroplasty can be applied in daily orthopaedic 
practice while ensuring patients’ safety.
Keywords Outpatient surgery; Hip arthroplasty; Knee arthroplasty; Patient selection 
criteria




In recent years, care pathways in orthopaedic surgery have improved, resulting in 
high quality of patient care with increased patient satisfaction [19, 23]. Outpatient 
surgical pathways are designed for elective surgery patients, as these patients are 
admitted and discharged on the same day without an overnight stay in a hospital bed 
[9]. These pathways were first used for less complex surgeries, and there have been an 
increasing number of more complex surgeries performed on an outpatient basis. Due 
to the advancement of these multidisciplinary pathways, outpatient joint arthroplasty 
(OJA) is increasingly performed in the general practice of orthopaedic departments, 
which allows more arthroplasty procedures to be performed and may be cost effective 
while preserving the quality of care [17]. Previous studies have found that OJA is a 
safe and effective procedure without increased incidence of peri- and post-operative 
complications [2, 4–6, 10–13, 15, 16, 26, 27, 30]. These studies included preselected 
patients, whereas patients with severe comorbidities were excluded. Recently, Lovald 
et al. [28] concluded that pre-existing comorbidities and particularly heart failure are 
major risk factors for adverse events (AEs) after outpatient and short-stay total knee 
arthroplasty (TKA). The evidence for patient selection criteria for OJA is limited, and 
no generally applicable criteria exist to safely operate OJA patients. Nevertheless, it is 
paramount to develop these criteria, as they affect clinical outcomes and the incidence 
of postoperative complications [4]. This review highlights patient selection criteria for 
OJA based on current literature and expert opinion.
Materials and methods
A search of the English and International electronic healthcare databases including 
MEDLINE/PubMed, EMBASE, AMED and the Cochrane library was performed in 
November 2015 to include studies published during the last 10 years (2005–2015). The 
following keywords were used: ‘outpatient’, ‘day care surgery’, ‘hip arthroplasty’ and 
‘knee arthroplasty’ which were combined with AND/OR as follows: (outpatient surgery 
OR day care surgery) AND (hip arthroplasty OR knee arthroplasty). The lead author 
performed the search and the results were agreed on by a consensus of two other 
authors (YB, MS), who independently reviewed the list of titles and all studies concerning 
outpatient surgery and arthroplasty and, if available, the abstracts to determine their 
potential usefulness. All studies on outpatient knee and/or hip arthroplasty were 
eligible for inclusion, with exclusion of review articles. Only full-text published articles 
were used. A consensus method was used to resolve disagreements, and the third or 
fourth author (JJ, HK) was consulted. Prior to formulating general conclusions, final 
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consensus on the included studies concerning patient selection criteria for OJA was 
achieved between the authors. Quality assessment was performed on the included 
studies using the Critical Appraisal Skills Programme (CASP) tools [8]. The study flow 
chart is demonstrated in Fig. 1. Besides this extended literature search, a survey of seven 
physicians from different specialties in the hospital (cardiology, pulmonology, internal 
medicine, geriatric medicine, urology, neurology and psychiatry) was performed. All the 
experts were familiar with the OJA pathway. In daily practice, in cases of pre-existing 
comorbidities, patients were screened and treated by these experts. They were asked to 
give their expert opinion on possible inclusion and exclusion criteria, based on general 
comorbidities and comorbidities which were related to their disciplines.
Figure 1. Flow chart of database search with excluded and included studies for final analysis. 
 Database search (MEDLINE/PUBMED, EMBASE, 
AMED and the Cochrane library) 
n=619 
 
Excluded studies after screening title and abstract; 
n=600 
Eligible studies for inclusion 
n=19 
 
Excluded articles N=5 
(not available full-text article n=3, review article 
n=2) 
Included studies n=14 
 
 
Outpatient joint arthroplasty (OJA) pathway at the Zuyderland Medical Center 
Indications for hip and knee arthroplasty were osteoarthritis, pain and loss of function 
as generally accepted [32, 33, 35]. Patients could be included in the OJA pathway if they 
satisfied three criteria; (1) able and willing to participate in the OJA pathway, (2) able to 
understand the procedures and (3) a personal coach (partner or relative) needs to be 
involved as much as possible, to inspire, correct, and support the patient during the first 
48 h postoperatively. Patients with severe cardiologic, pulmonary and/or internal diseases 
(e.g. diabetes mellitus (DM), renal function disorders) that required additional pre-, peri- 
and postoperative treatment were excluded. Patients who were not able to understand 
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and complete the procedure due to cognitive dysfunction (based on medical history), fear 
of following the outpatient procedure, or those who could not be discharged to their home 
environment were also excluded. Pre-, peri- and post-operative protocols (e.g. type of 
anaesthesia, multi-modal pain protocol) were described by Kort et al. [27], which included 
patients for unicompartmental knee arthroplasty (UKA). These protocols are the same 
protocols used for total hip arthroplasty (THA) and TKA. Local infiltration analgesia was 
only used perioperative for TKA according to Kerr and Kohan [25] without adrenaline [36].
Results
The search revealed 14 clinical studies describing the results of outpatient surgery in 
109.233 arthroplasty patients, including 10 case series and 4 case–control studies. These 
studies on OJA consisted of 9 knee and 5 hip arthroplasty papers (Table 1). There were no 
prospective randomized controlled trials. The results from these studies mostly consisted 
papers from the USA [20, 25]. The first studies on outpatient knee arthroplasty [4, 5, 1, 
12, 15, 26–28, 30] concluded that the pathway was safe and effective. Low complication 
and readmission rates (0.7–8 %) were found, including a high percentage of discharge 
on the day of surgery (73.7–98.9 %) and cost reduction [30]. Studies on outpatient hip 
arthroplasty [2, 6, 10, 13, 16] resulted in similar outcome in pre-selected patients. 
Inclusion criteria
In all of these studies, an extensive diversity of inclusion criteria were used. Most of the 
inclusion criteria used were the understanding, ability and willingness to participate in 
the outpatient procedure [2, 12, 16, 27]. Only primary arthroplasty patients were included 
in all these studies; additionally, Berger et al. [5, 6] included patients without a history of 
previous hip or knee surgery. Classification of patients according to the ASA was used 
as inclusion to select patients varying from ASA I–III [12, 15, 16]. Poorer health status 
(ASA > II) and bleeding disorder was associated with higher readmission rates and AEs 
(revision, infection, mortality, deep vein thrombosis (DVT) and wound complications) 
after both hip and knee arthroplasty [7, 28]. Patients were operated if they were younger 
than 65 years of age [13] or ranging from 45 to 80 years [5, 6]. As previously found [27], 
a high age (>75 years) was a risk factor for postoperative falls, knee stiffness, pain and 
urinary retention with an increased readmission risk at 1 year postoperative. In particular, 
patients >80 years of age were at even at higher risk for falls [hazard ratio (HR) 2.06] and 
readmissions (HR 1.27), which can increase AEs [28]. Therefore, health status and age 
should be considered when selecting patients for OJA. Preoperative cardiac examination 
was performed if patients had a history of a cardiovascular disease [15]. Besides transient 
postoperative hypotension [13], which led to delayed discharge, no cardiovascular-related 
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AEs or readmissions were reported in these series without preoperative cardiac clearance. 
Nevertheless, patients with a history of heart failure were at higher risk for readmission 
[28]. On the other hand, patients with severe cardiologic comorbidities (ASA > II) were 
not included for OJA [2, 5, 6, 10, 12, 16, 26, 27].
Logistic factors such as surgery completed by noon [4] or living <1 h from the hospital 
[26] were used as inclusion criteria. In these studies, neither prolonged hospital stay nor 
readmissions were documented based on these logistic factors. Support at home (partner 
or relative) during the first days after surgery and an adopted home environment was 
frequently performed [12, 15, 16, 26, 27]. Dorr et al. [13]. reported ‘home problem’ as a reason 
for delayed discharge. However, exact insight information on these ‘home problems’ 
were not described. One of the reasons for fear of early discharge is the postoperative 
dependence on someone else [5]; this fear can cause delayed discharge [27]. Nevertheless, 
a change in the mindset of the patient, in terms of an early discharge, is a key factor 
for prevention of prolonged hospital stay [27]. Therefore, preoperative screening and 
preparation of the home environment is crucial for preventing a prolonged hospital stay 
and should be considered as an inclusion criteria for OJA. 
Exclusion criteria
As for the inclusion criteria, a wide range of criteria were reported in OJA studies. Two 
studies [4, 11] examined the feasibility of an outpatient knee arthroplasty pathway in an 
unselected group. Berger et al. [4] found higher readmission rates within the first week (3.6 
%) compared to preselected patients (0.0 %) in their previous series [5] during the same 
postoperative period. It was concluded that a more stringent screening process could 
prevent complications and subsequent readmissions [4]. This preoperative screening 
process has been studied before, in outpatient and short-stay TKA [28, 30]. Patients with 
poorer health status, older patients, inpatients, patients not receiving a femoral nerve 
block (FNB) and those with a history of heart failure were at higher risk for readmission. 
When reviewing the exclusion criteria in the OJA studies, only two AEs related to the 
cardiovascular and/or pulmonary system were reported. Overall, patients with cardiac (e.g. 
heart failure, history of myocardial infarction, arrhythmia) [5, 6, 10, 16, 26, 27], pulmonary 
(e.g. embolism, respiratory failure) [5, 6, 10, 26, 27] and poorly controlled comorbidities [2, 
6] were excluded. This might be the reason for the low incidence of AEs and readmissions. 
On the other hand, outpatient or short-stay TKA patients with a history of ischaemic heart 
disease were not at higher risk for postoperative AEs [28]. Nevertheless, postoperative 
myocardial ischaemia can prolong hospital stay [3, 21]. Kallio et al. [21] suggested that 
preoperative anaesthesia evaluation and treatment may improve postoperative outcome 
in diabetic patients. Pain, dizziness, general weakness and postoperative nausea and 
vomiting (PONV) were seen as clinical reasons for prolonged hospital stay when patients 
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were operated in an enhanced recovery pathway for joint arthroplasty [18]. Most reported 
reasons for prolonged hospital stay in outpatient literature also consisted of pain and 
PONV [4, 5, 13, 16, 27]. When using peripheral nerve blocks, no prolonged hospital stay 
or readmission due to uncontrolled pain was found after OJA [12]. Readmission rate was 
lower in patients receiving a FNB. However, the risk of pain after 1 year postoperative 
was significantly higher [28]. Protocols for OJA should focus on adequate analgesia and 
prevention for PONV [5,10, 11, 15, 27, 30]. Some papers excluded patients with DM (type 
I and II) [16, 26]. Diabetic patients were at higher risk for AEs after joint arthroplasty [21, 
28, 29, 38]. Patients with a high body mass index—BMI (>40 m2/kg) were excluded [6]. 
Although there was no correlation between prolonged hospital stay and BMI in THA [18] 
or TKA [4] patients, Ibrahim et al. [20] concluded that a high BMI (>40 m2/kg) increases 
operative time and intraoperative blood loss in THA due to technical difficulties in obese 
patients. After TKA, obese patients (≥30 m2/kg) are at higher risk for deep infection and 
revision surgery [24]. Therefore, a high BMI of >30 m2/kg should be considered as a 
general exclusion criteria for arthroplasty and not specifically for OJA.
Chronic opioid consumption prior to THA resulted in worse clinical outcome, opioid-
induced hyperalgesia and prolonged hospital stay [34]. Since these patients need a more 
stringent analgesia treatment, it seems justified to exclude these patients from OJA for 
postoperative pain control [12, 26]. Evidence on arthroplasty after stroke is rare, and 
functional impairments due to neurologic deficits (e.g. Parkinson’s disease) are preferably 
treated in an enhanced recovery pathway [37]. Nevertheless, history of a stroke was 
reported as exclusion criterion [26]. In case of unavailability for homecare service [12] 
or discharge other than home environment [27], which were also applied as exclusion 
criteria, one needs to consider whether OJA is possible. On the other hand, dependent 
functional status (partial or total independency) was found to be a risk factor for increased 
readmissions after THA [7]. Patients with difficulties with self-care tasks should be 
excluded from OJA [38]. The incidence of chronic renal disease is high (26–27 %) in 
patients undergoing joint arthroplasty [39]. A significantly higher risk for postoperative 
AEs was found in patients with moderate to severe chronic renal disease. In particular, 
there is a twofold higher risk of mortality. Preoperative screening for renal function should 
be performed and risks for complications in patients with moderate to severe chronic 
renal disease should be discussed when performing elective joint arthroplasty, since these 
comorbidities (renal impairment and major systemic illness) were reported as exclusion 
criteria [12, 27, 30]. Postoperative cognitive dysfunction is frequently (20–40 %) reported 
after joint arthroplasty [1]. Enhanced recovery programs may decrease the risk of this 
cognitive dysfunction [38]. One of the most important determinants for development of 
cognitive dysfunction is reduced preoperative cognitive capacity [31], which is used as 
exclusion criterion [15, 27]. 
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Table 1. Literature overview on patient selection criteria in OJA pathways. *Only described post-
clinical outcome. **AEs and readmission rate were not specified for outpatient TKA.
Author(s) N Arthroplasty Study design AEs Readmission (rate) Prolonged hospital stay FU CASP score
Aynardi et 
al.[2]
197 THA Case 
controlled
4 patients (3.4%) intraoperative fracture, 
atelectasis, monitoring after ECG changes
None 4 patients (3.4%) intraoperative 





50 TKA Case series GI tract bleeding (2.0%), superficial 
infection (2.0%), manipulation under 
anesthesia (2.0%)
3 patients (6.0%) e.g. GI tract 
bleeding, superficial infection, 
manipulation under anesthesia






111 UKA and TKA Case series Symptomatic anemia requiring blood 
transfusion (0.9%), GI bleeding (0.9%), 
DVT (0.9%), 
wound complications (1.8%), 
manipulation under anesthesia (0.9%), GI 
bleeding (0.9%)
4 patients (3.6%) e.g. anemia, GI 
bleeding, DVT.
7 patients (6.3%) e.g. difficulty with 
pain control,
chest pain workup for myocardial 
infarction, which was negative, fear 




150 THA Case series Stress fracture (0.7%), pneumonia (1.4%), 
dehydration (0.7%), anemia (0.7%), pain 
(0.7%), leg swelling (0.7%), urinary tract 
infection (0.7%), fall (0.7%), medication 
reaction (0.7%), hypotension (0.7%)
1 patient (0.7%) periprosthetic 
fracture
None 3 months 10
Dorr et 
al.[13]
69 THA Case series 1 revision after fracture during surgery 
(1.5%)
None 16 patients (26.3%) e.g. hypotension, 





24 UKA Case series Dislocation (4.2%), arthrotomy after 
persistent wound leakage (4.2%) 
2 patients (8.4%) e.g. 
arthrotomy, revision
NA 2.4 years 9
Chen and 
Berger [10]
87 THA Case series Infection (1.1%) 1 patient (1.1%) infection one-
stage revision





105 UKA Case series Infection (1.0%) 1 patient (1.0%) infection None 3 months 11
Gondusky 
et al.[15]
160 UKA Case series Reoperation (1.3%), hematoma (0.6%), 
wound drainage (0.6%), fatigue and 
urinary tract infection (0.6%)









128 TKA Case 
controlled
Developed drop foot (1.6%), manipulation 
under anesthesia (3.2%), iatrogenic 
ligament deficiency (1.6%), revisions 
(3.2%)
4 patients (4.6%) e.g. 
manipulation under anesthesia, 
revision
None 24 months 7
Kort et 
al.[27]
40 UKA Case 
controlled
Manipulation under anesthesia (5%) 1 patient (5%) manipulation 
under anesthesia
3 patients (15%) e.g. fear to go home 
and pain
3 months 10
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clinical outcome. **AEs and readmission rate were not specified for outpatient TKA.
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Author(s) N Arthroplasty Study design AEs Readmission (rate) Prolonged hospital stay FU CASP score
Lovald et 
al.[28]
5.401 TKA Case series NA** NA** NA* 1 year 8
Lovald et 
al.[30]
102.684 TKA Case 
controlled
DVT (4.8%), dislocation (1.1%), loosening 
(2.1%), infection (4.5%), mortality (2.4%), 
pain in joint (46,3%), revision (2.1%), 
stiffness (8.2%), mechanical complication 
(3.4%), wound (1.1%)
1.6% (not further specified) NA* 2 years 9
Table 2. Expert opinion and literature based patient selection criteria for OJA.
Inclusion criteria Expert opinion 
General Able and willing to participate, understanding the OJA protocol and care 
must be provided during the first postoperative days.
Exclusion criteria
General None
Cardiology Coumarin-derivative usage based on atrial fibrillation or prosthetic valve, 
bridging anticoagulation, NYHA classification[14] III or IV.
Pulmonology Lung fibrosis, emphysema, carcinoma, pulmonary hypertension or embolism.
Internal medicine Extensive edema, chronic usage of prednisolone, severe renal function 
disorders, DM type I.
Geriatrics History of (frequent) falling in the past three months, cognitive function 
disorders (e.g. history of delirium, dementia, memory difficulties), need for 
additional inpatient rehabilitation, polypharmacy and/or substance abuse.
Urology Pre-existing voiding difficulties, preoperative use of urologic medication.
Neurology Severe mobility disorders (e.g. loss function due to cerebrovascular accident, 
Parkinson, peripheral neurologic function disorders).
Psychiatry No criteria were given.
Patient selection criteria
According to recent literature, patients, who are able and willing to participate, with a 
low ASA classification (<III), undergoing primary arthroplasty, age <75 and with support 
at home during the first postoperative days are eligible candidates for OJA. Patients 
with a high ASA classification (>II), bleeding disorders, poorly controlled and/or severe 
cardiac (e.g. heart failure, arrhythmia) or pulmonary (e.g. embolism, respiratory failure) 
comorbidities, uncontrolled DM (type I or II), a high BMI (>30 m2/kg), chronic opioid 
consumption, functional neurological impairments, dependent functional status, 
chronic/end-stage renal disease and/or reduced preoperative cognitive capacity should 
be excluded from OJA.
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Internal medicine Extensive edema, chronic usage of prednisolone, severe renal function 
disorders, DM type I.
Geriatrics History of (frequent) falling in the past three months, cognitive function 
disorders (e.g. history of delirium, dementia, memory difficulties), need for 
additional inpatient rehabilitation, polypharmacy and/or substance abuse.
Urology Pre-existing voiding difficulties, preoperative use of urologic medication.
Neurology Severe mobility disorders (e.g. loss function due to cerebrovascular accident, 
Parkinson, peripheral neurologic function disorders).
Psychiatry No criteria were given.
Patient selection criteria
According to recent literature, patients, who are able and willing to participate, with a 
low ASA classification (<III), undergoing primary arthroplasty, age <75 and with support 
at home during the first postoperative days are eligible candidates for OJA. Patients 
with a high ASA classification (>II), bleeding disorders, poorly controlled and/or severe 
cardiac (e.g. heart failure, arrhythmia) or pulmonary (e.g. embolism, respiratory failure) 
comorbidities, uncontrolled DM (type I or II), a high BMI (>30 m2/kg), chronic opioid 
consumption, functional neurological impairments, dependent functional status, 
chronic/end-stage renal disease and/or reduced preoperative cognitive capacity should 
be excluded from OJA.
Expert opinion
All medical specialists agreed and participated. Table 2 presents an overview of expert 
opinion-based patient selection criteria per given discipline.
Discussion
The most important finding of the present study was that an extensive and well-
conducted patient selection procedure is needed to perform safe and effective OJA 
with acceptable clinical outcome. Despite OJA being increasingly applied in daily 
orthopaedic practice, general consensus on patient selection criteria is lacking. It is 
known that comorbidities can predispose patients to increased AEs, readmission rates 
and increased length of hospital stay [7, 28, 30]. Patient selection seems to be crucial 
in the prevention of AEs and readmissions [4, 15]. This selection for OJA patients was 
previously studied by Lovald et al. [28, 30]. In the latest series [28], outpatient and short-
stay TKA patients were analysed as one cohort. These results are of major interest in 
patient selection; however, the selection criteria for outpatient TKA were not described. 
In addition, the question remains whether outpatient TKA resulted in comparable 
outcome as the short-stay group, since enhanced recovery pathways are increasingly 
applied as the standard care for arthroplasty [22]. In previous series [30], standardized 
3–4 night’s hospitalization were compared with outpatient, shortened or extended stay. 
Unfortunately, the inclusion and exclusion criteria for outpatient TKA were not reported. 
On the other hand, the results showed that outpatient TKA improved more in terms of 
functioning, quality of life and short-term outcomes including lower incidence of knee 
pain and stiffness. Despite there were no significant differences found between groups, 
awareness for potential increase of postoperative complications in outpatient and short-
stay TKA was suggested. When implementing an outpatient surgery pathway for hip 
and/or knee arthroplasty, surgeons need to consider proper patient selection criteria 
to prevent AEs and readmissions while ensuring the quality of care, to maintain patient 
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satisfaction and function with a reduction in length of stay. A limitation of the present 
study is the methodological quality of the included studies. There are no multicentre 
randomized controlled trials comparing the conventional with the outpatient pathway. 
In order to create general applicable patient selection criteria with a multidisciplinary 
approach, the expert opinions were reviewed. Besides the presented differences between 
THA and TKA risk factors for OJA, literature is inconclusive to establish specific patient 
selection criteria for either hip- or knee arthroplasty. The presented results provide a 
basis for patient selection criteria in daily practice, but on the other hand highlighting 
the need for further development of these criteria.
Further research needs to identify the patients who will do well with the outpatient 
procedure and those who will do better with the more traditional care. Today, this 
twopronged type of clinical “pathway” research is essential for patients and healthcare 
systems worldwide.
Conclusion 
In this review, an evidence and expert opinion-based summary of patient selection 
criteria are presented to prevent prolonged hospital stay, AEs and readmissions 
following OJA. These criteria can be useful when selecting patients for OJA. With a 
change in mindset, literature-based protocols and patient selection criteria, outpatient 
hip and knee arthroplasty can be applied in daily orthopaedic practice while ensuring 
patients’ safety.
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Purpose and hypothesis The purpose of this study was to ‘objectively’ measure 
improvement of physical activity with the use of an activity monitor between patients 
who followed an enhanced recovery- or outpatient surgery pathway after total knee 
arthroplasty (TKA). It was hypothesized that both pathways will have comparable 
physical activity after TKA at 6-week follow-up.
Methods This prospective observational comparative case study was designed to 
investigate activity parameters (e.g. physical activity, number of steps, sit–stand 
transfers) of two different pathways after 6 weeks with the use of a non-invasive triaxial 
accelerometer activity monitor. This study included 20 patients with a mean age of 65.5 
years (SD 6.1) undergoing TKA who were allocated to follow one of the two pathways: 
enhanced recovery (n = 10) or outpatient surgery (n = 10). Patients were monitored for 
4 days pre-, 4 days during and 4 days after 5 weeks postoperatively. Patient-reported 
outcome measures (PROMs) and range of knee motion were obtained pre- and 6 weeks 
postoperatively.
Results The activity parameters recovered steeply during the first 4 postoperative days 
and continued to improve within both pathways (n.s.). Preoperative and during the first 
4 days and 5 weeks postoperative, activity parameters were comparable (n.s.) between 
both pathways but did not reach preoperative levels of physical activity and range of 
motion (n.s.). PROMs improved within each pathway, and no difference between both 
pathways was observed (n.s.).
Conclusions This study demonstrates that the early physical activity parameters of 
patients after TKA, following the outpatient surgery pathway, were similar to patients 
who followed the standard enhanced recovery pathway. The activity monitor is an added 
value for a more detailed and objective analysis of the physical performance in patients 
after TKA.
Keywords Outpatient surgery; Day care surgery; Enhanced recovery; Fast track; Pathway; 
Total knee arthroplasty; Physical activity; Activity monitor; Accelerometer




Enhanced recovery pathways and the further development to outpatient surgery (OS) 
pathways should focus on reduction of surgical stress, postoperative nausea, vomiting 
(PONV) and pain [12, 14, 15, 32]. With this optimisation, a reduction in the length of 
hospital stay (LoS) can be possible [16]. Recent literature supports early discharge 
on the day of surgery [1, 5, 6, 9, 17, 18]. Together with patient-based selection criteria, 
a change in mindset and a multidisciplinary approach, OS pathways are as safe and 
efficient as conventional pathways, in terms of readmissions and complications [18, 
19]. Nevertheless, the physical activity of patients in the early postoperative phase is 
still unclear. A more accurate and objective measure of actual physical activity would 
therefore be useful for predicting performance in patients with specific activity levels. 
This includes creating reference data, verifying compliance to rehabilitation protocols, 
objectify outcome and to better manage patient expectations. Furthermore, it creates 
the possibility to provide activity-based biofeedback to motivate patients. In addition 
to patient-reported outcome measures (PROMs), acceleration-based gait analysis has 
been accepted as an objective measurement of functional and clinical outcome in 
arthroplasty patients [2]. Results have shown that physical function after total knee 
arthroplasty (TKA), significantly improved within one year postoperative in terms of 
gait, sit-to-stand and block step-up transfers. These results were found after TKA in an 
enhanced recovery pathway (ERP), but data on activity after OS TKA are lacking. This 
single surgeon, comparative case study was designed to investigate clinical outcomes 
after TKA following an OS pathway compared to the standard ERP, which brings us to 
the following research questions; first, is there a difference in physical activity of daily 
life between ERP and OS as assessed with a non-invasive triaxial accelerometer-based 
Activity Monitor (AM) and secondly, is there a difference in clinical outcome between 
ERP and OS patients as assessed with PROMs and knee range of motion (RoM). This is 
the first study to evaluate the physical activity during the early postoperative phase in 
patients undergoing TKA following an OS pathway. It was hypothesized that there would 
be no difference in physical activity PROMs and RoM between both pathways.
Materials and methods
Between April 2014 and December 2015, twenty patients gave consent to participate in 
this prospective observational comparative case study. This study was performed in 
compliance with the Helsinki Declaration of 1975, as revised in 2000, and was approved 
by the Institutional Review Board (IRB: Zuyderland-Zuyd, Heerlen, The Netherlands, 
IRB Nr. 16N33). Patients with disabling unilateral moderate-severe osteoarthritis, who 
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were able and willing to follow instructions and return to the outpatient clinic for follow-
up evaluations, were eligible for inclusion in the study. Patients with previous knee 
surgery (except for arthroscopic meniscectomy), active or recently treated infections 
and patients who were wheelchair-bound were excluded from the study. Included 
patients were not randomly selected for one of the two pathways, 10 patients followed 
ERP and 10 other patients followed the OS pathway [18]. There were no bilateral cases. 
Allocation of patients for the OS pathway was performed by the operating surgeon (NK) 
and based on the following criteria: no severe cardiologic, pulmonary and/or internal 
diseases, no additional treatment pre-, periand postoperative needed (e.g. medication 
adjustment in diabetes mellitus, bridging anticoagulation), patients can be discharged 
to home environment, able to understand and willing to participate in the OS pathway 
[18]. Pre-, peri- and postoperative protocols were previously described in detail [18]. 
A further optimisation of the RR pathway, as the standard pathway for arthroplasty, 
resulted in similar protocols regarding the use of dexamethasone and tranexamic acid 
within the conventional (ERP) and OS pathways in this study. Knee flexion as a discharge 
criterion is no longer applied. The differences between pathways are summarized in 
Table 1. The clinical reports and patient information were identical in both groups as 
well as the pain protocol [7]. No adrenaline was used during local infiltration analgesia 
(LIA) in the OS pathway, since it was shown that adrenaline could be omitted from the 
LIA mixture [32]. All TKA procedures were performed by one experienced knee surgeon 
(NK), performing a minimum of 150 TKA procedures annually. Patients were operated 
with the use of Patient Specific Guides (Signature, Zimmer Biomet, Warsaw, IN, USA) 
for the implantation of the cemented Vanguard CR TKA  IN, USA). Baseline conditions 
and operative data are summarised in Table 2.
Table 1. Differences between pathways pre-, peri- and postoperative care. 
ERP OS
Preoperative
Admission Night before/day of surgery Day of surgery
Planned discharge <3 days postoperative Day of admission
Perioperative
Prophylactic antibiotics I.v. I.v. and oral 
Adrenaline in LIA mixture Yes No
Postoperative
First mobilization <6hrs <4hrs
Compression bandages 24hrs postoperative 8hrs postoperative, first 4 days 
postoperative elastic bandage
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Age (years) at index surgery 66.9 (7.9) 64.1 (3.5) n.s.
Male/ female 5/5 8/2 n.s.
BMI kg/m2 29.2 (6.0) 27.7 (4.7) n.s.
ASA, I/II/III 2/8/0 3/7/0 n.s.
Operative data
Blood loss, mL 237.5 (106.1) 233.3 (136.9) n.s.
OR time, min 65.8 (13.8) 58.8 (18.9) n.s.
Outcome
Physical activity in the daily life of patients was measured in a non-invasive way using 
triaxial accelerometer (GC Dataconcepts LLC, Waveland, USA). The AM was attached onto 
the lateral side of the non-affected upper leg. Based on previously published principles 
[27, 28], raw accelerometer data were post-processed and analysed using self-developed 
algorithms for feature detection and activity classification written in Matlab (MATLAB 
R2010a, The Mathworks Inc., Natick, Massachusetts, USA) [25]. More detailed information of 
the AM and its clinical application are described in a previous study [34]. Activity parameters 
calculated were the daily number of events (counts) and total time (duration) spent sitting or 
lying (inactive), standing, walking or cycling (active) and the number of steps and sit–stand 
transfers. In addition to these quantitative parameters, qualitative aspects of activities could 
also be calculated, such as walking cadence (steps/min), time-wise distribution of walking 
bouts (e.g. number walking bouts consisting of less or more than an amount of steps), sitting 
and standing. Physical activity was measured for four consecutive days [13, 26]. The AM 
was worn only during waking hours with a minimum of 8 h a day and removed at night 
and during showering. The daily physical activity was measured at three time points. First, 
patients wore the monitor during four days before surgery until the day of surgery. During 
the surgery hours, the AM data were extracted. Second, once the surgery was completed, 
the AM was returned to the patients and they wore the sensor until the fourth postoperative 
day. Within the first 4–6 h after surgery, the patient started with early mobilization (Table 
2). Patients following the OS pathway were discharged later the same day, while the ERP 
patients were evaluated twice a day to check whether they met discharge criteria (e.g. safe 
mobilization, able to climb stairs and able to perform sit–stand transfers, adequate pain/
PONV control). The third activity assessment was during the 6th postoperative week 
and again measured for four consecutive days. The time between hospital admission and 
discharge and the time between the start of anaesthesia until the first mobilization were 
recorded in hours in the patient’s clinical report. PROMs were obtained pre- and 6 weeks 
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postoperative including the Dutch validated Oxford Knee Score (OKS; 12–60, 12 being the 
best outcome) [10], Western Ontario and McMaster Universities Arthritis Index (WOMAC; 
0–100, 100 being the best outcome) [29] and the Euro-Qol-5D (EQ-5D; 0–1, 1 indicates the best 
health state) [3]. Experienced pain was measured by a Numerical Rating Scale (NRS, 0–10, 10 
being ‘worst pain’). All PROMs were conducted prior to the outpatient visit. Active measures 
of flexion and extension were determined using a digital inclinometer (MicroFET 5, Hoggan 
Health Industries, Salt Lake City, USA) with a high level of accuracy. The RoM of the operated 
leg was measured twice, and the average value was used [36, 37]. RoM was obtained pre-, 1 
and 6 weeks postoperative. 
Statistical analysis
All statistical analysis was done with use of SPSS version 17.0 for windows (Inc., 
Chicago, IL). Statistically significant differences between both groups were analysed 
with nonparametric Mann–Whitney U test, since the group sizes were small. Chi-square 
test was used for categorical variables. P values were considered to be statistically 
significant at p ≤ 0.05 for all analysis. This study was carried out in an attempt to predict 
an appropriate sample size to design a full-scale research project. A minimum pilot trial 
sample size per arm of 10 patients is appropriate [35].
Results
No patients were lost to follow-up. At 6-week follow-up, all physical activity parameters 
were comparable between both groups (Fig. 1; Table 3). Looking at the preoperative 
activity levels and longitudinally also at the direct postoperative days (Fig. 1), groups 
were statistically comparable showing equal amounts of preoperative activity and 
matching recovery profiles in all activity parameters with no group difference (n.s.). 
Activity recovers steeply during the first 4 postoperative days and continues to improve 
towards the 6-week assessment when it remains below preoperative levels. As expected, 
the overall mean LoS was statistically significant different (p ≤ 0.000) in favour of the OS 
pathway. The ERP patients were discharged after a mean of 52:30 h (range, 25:12–97:12) 
compared to a mean discharge of 9:30 h (range, 8:20–12:06) in the OS pathway. Early 
mobilization was not different between both groups (n.s.). Patients mobilized within 
a mean of 4:06 h (range, 1:15–6:37) and 3:11 h (range, 2:10–4:22) for, respectively, the 
ERP and OS pathway. One patient in the ERP pathway was not able to mobilize <4 h 
postoperative due to loss of sensibility, and the first mobilization was postponed. At 6 
weeks postoperatively, mean (±SD) PROMs improved within each pathway compared 
to preoperative values. No statistically significant or clinically relevant differences for 
the PROMs and RoM were found between both pathways (Table 4).
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Figure 1. Mean daily Physical Activity (A), sit-stand transfers (B), amount of steps (C) and cadans (D) 
(vertical axis) before and after TKA. Preoperative (Pre OR), day of surgery (DoS) up to postoperative 
day (PoD) 3 and 6th week postoperative (horizontal axis) for the ERP (white-bars) and OS pathway 
(black-bars). Standard deviations are displayed with whiskers. 
 
Table 3. Mean amount of average daily activity (e.g. walking, standing, cycling) in minutes (min) with 
percentage (%) of the total physical activity during the 6th postoperative week for both pathways.
ERP OS P-value
Physical Activity, min (%) 253.9 (33.5) 221.4 (31.5) n.s.
Walking, min (%) 81.8 (10.6) 80.5 (11.5) n.s.
Standing, min (%) 170.3 (22.6) 131.7 (18.9) n.s.
Cycling, min (%) 1.8 (0.3) 9.2 (1.1) n.s.
Sitting, min (%) 509.3 (66.5) 404.4 (68.5) n.s.
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Table 4. Mean (±SD) pre- and 6-wks postoperative PROMs and RoM for both pathways.
ERP OS p-value
OKS Pre 34.8 (7.6) 32.0 (10.3) n.s.
6-wks 25.4 (1.8) 29.0 (8.2) n.s.
WOMAC Pre 49.0 (14.8) 49.2 (25.7) n.s.
6-wks 70.8 (11.9) 76.7 (18.1) n.s.
EQ-5D Pre 0.79 (0.04) 0.63 (0.24) n.s.
6-wks 0.87 (0.10) 0.75 (0.26) n.s.
NRS-pain Pre 4.7 (1.6) 5.2 (2.5) n.s.
6-wks 2.6 (2.1) 2.6 (2.2) n.s.
RoM Pre 120.6 (11.3) 115.9 (24.0) n.s.
6-wks 104.3 (17.2) 106.2 (20.0) n.s.
Discussion
The most important finding of the present study was that OS was not inferior but equal 
compared to ERP regarding physical activity of daily life, PROMs and RoM as it was 
hypothesized. Both groups did not reach preoperative levels of physical activity during 
the 6th postoperative week. Physical activity after TKA has a positive impact on the 
early recovery and length of stay after arthroplasty [4, 7, 20, 21, 30]. At this moment, there 
are no data to suggest the effect of OS on early postoperative physical activity after TKA. 
In this study, OS was not clearly superior to ERP with respect to physical activity directly 
after TKA during the first week and 6th postoperative week. Both groups in this study 
improved with comparable physical activity at a minimum 6 weeks follow-up. It has 
been stated that PROMs represent the best subjective measurement of clinical outcome 
[31]. Studies have shown that patients who followed enhanced recovery pathways after 
arthroplasty were as satisfied or even more satisfied compared to patients who followed 
conventional pathways, with regard to the PROMs at 3, 4 and 12 months postoperative [11, 
22–24]. However, there is no single best outcome measurement tool after TKA. Beside 
the positive results of PROMs on enhanced recovery pathways, various scores are not 
capturing the changes due to a lack of power of the scores as averse to a lack of change 
(e.g. floor and ceiling effects) [8]. For example, pain during the early recovery phase can 
conceal the functional changes [33]. The PROMs in this study failed to detect subjective 
changes after an early rehabilitation period of 6 weeks. In order to characterize the 
objective changes in physical activity after TKA in detail, the AM was used to capture 
changes over time and to detect potential objective differences (e.g. activity, steps, sit–
stand transfers, cadence) between both pathways during the early recovery phase [2, 
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8]. Minimal information exists regarding the physical activity after TKA in an OS setting. 
Early experience with OS in patients operated for unicompartmental knee arthroplasty 
(UKA) showed promising results in terms of safety and efficiency [18]. Recently, Krenk 
et al. [20] reported on 20 patients operated for TKA and total hip arthroplasty (THA) 
following an enhanced recovery pathway. They found similar results in the postoperative 
physical activity in patients who were discharged after a mean of 2.6 days. However, with 
a substantial difference, this study captured changes within the early recovery phase 
up to 6 weeks postoperative compared to 6 days postoperative. Furthermore, patients 
in the OS pathway were compared with patients who followed the ERP as a control 
group. When comparing these pathways, both groups experienced a drop in physical 
activity during the first postoperative days after TKA, with a comparable improvement 
at 6 weeks postoperative. A particular strength of this study is the assessment of physical 
activity over three time points, which allows a more detailed analysis of the activity 
of the different parameters into the early recovery phase. After hospital discharge, 
patients need to be encouraged to do their daily exercises in their home environment. 
With the use of the AM, we were able to objectively monitor if patients were physically 
active in their home environment during the first week and 6th postoperative week. 
On the other hand, this study and the results of Krenk et al. [20] demonstrate the need 
for follow-up beyond 6 weeks postoperative. This is of interest and needs attention in 
further research. Finally, this study does have some limitations. The most important 
limitation was the limited number of patients and power of this study. Nevertheless, 
this study was carried out in order to evaluate the daily physical activity in patients 
following OS after TKA, in an attempt to predict an appropriate sample size to design a 
performance of a full-scale research project [35]. A possible mismatch in the study could 
be the potential selection bias. Patients were not individually randomly selected for one 
of the two pathways due to practical and financial consideration (e.g. limited number of 
AMs). Even though medical comorbidities in both pathways were comparable, it resulted 
in equal physical activity up to six weeks postoperative. After surgery, patients did not 
change from one pathway to another. 
Conclusions
This study demonstrates that the early physical activity parameters of patients 
undergoing TKA in the OS pathway were similar to patients who followed the standard 
ERP. Measurement with the AM is an added value for a more detailed and objective 
analysis of the physical activity during the early recovery phase in patients after TKA 
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Purpose Enhanced recovery pathways after knee arthroplasty have been introduced 
worldwide with positive results. The present study investigated the improvements 
of health-related quality of life and functional outcome in patients operated for knee 
arthroplasty who followed an Outpatient Surgery (OS) or Enhanced Recovery (ER) 
pathway.
Methods We reviewed our institutional database of 361 consecutive patients undergoing 
knee arthroplasty (total and partial) who followed either the OS-pathway (n=94; 26.1%) 
or ER-pathway (n=267; 73.9%). Recorded outcomes included 4 different patient reported 
outcome measures (PROMs; EuroQol-5D (both index and VAS), Oxford Knee Score, 
Western Ontario and McMaster Universities Arthritis Index and the Pain-Numerical 
Rating Scale) obtained pre-and during the 3-and 12-months postoperative follow-up. 
Results 93 patients (99%) in the OS-group were discharged on the day of surgery as 
scheduled, whereas in the ER-group 70% of the patients were discharged<3 days 
postoperatively. At 12-month follow-up, the EQ-5D (both index and VAS) and other 
PROMs improved significantly (p<0.000) within each pathway. There were no significant 
differences between both pathways.
Conclusion One year after knee arthroplasty, patients who were included in an Outpatient 
Surgery pathway had comparable quality of life and PROMs as patients operated in an 
Enhanced Recovery pathway.
Keywords Quality of life; Clinical pathways; Outpatient surgery; Knee arthroplasty; 
Clinical outcome




Modification of a selected number of literature-based protocols, used together, can be 
implemented in a care pathway. Such optimisation is also known as ‘outpatient joint 
arthroplasty’, a multimodal clinical pathway based on well-defined patient selection 
criteria [1-3] with the focus on discharge on the day of surgery while ensuring patients’ 
safety [1,4-8] and cost reduction [9,10,11]. Results have shown that quality of life after 
TKA, significantly improved within one year postoperative [11]. Although, these results 
were found after TKA in an enhanced recovery pathway, results during the early 
postoperative phase have shown that patients following the outpatient joint arthroplasty 
pathway were satisfied with sufficient physical activity [8,12,13]. Data on the quality 
of life after outpatient surgery on the long term are lacking. This is the first study to 
evaluate the quality of life during the long postoperative phase in patients undergoing 
knee arthroplasty following an outpatient surgery (OS) pathway compared to the 
standard enhanced recovery pathway (ERP) as measured with the EQ-5D and other 
patient reported outcome measures (PROMs). It was hypothesized that there would 
be no difference in quality of life between both pathways 1-yr after knee arthroplasty.
Materials and Methods
This comparative case study reviewed a consecutive series of patients (n=361) operated 
for knee arthroplasty (total and partial), with the use of patient specific instruments 
(Signature, Zimmer-Biomet, Warsaw INC) by one experienced knee surgeon (NK). 
Patients were operated between January 2014 and June 2015. Allocation of patients for 
the OS pathway or ERP was performed based on previous described selection criteria 
[14]. Pre-, peri- and postoperative protocols were described in detail in previous study for 
OS [8]. A further optimisation of the ERP resulted in similar protocols, regarding the use 
of Dexamethasone, Tranexamic acid (both perioperative). Knee flexion as a discharge 
criterion is no longer applied. The differences between both pathways are summarized 
in Table 1.The clinical reports and patient information were identical in both groups as 
well as the pain protocol [8]. No adrenaline was used during local infiltration analgesia 




Table 1. Differences between both pathways extracted for pre-, peri- and postoperative care and 
discharge criteria.
Enhanced Recovery Pathway Outpatient Surgery Pathway
Preoperative
Admission Night before/day of operation Day of operation
Planned discharge <3 days postoperative Day of admission
Perioperative
Antibiotics prophylactic I.v. I.v. and oral 
Postoperative
First mobilization <6hrs <4hrs
Compression bandages 24hrs postoperative 8hrs postoperative, first 4 days 
postoperative elastic bandage
Prior to each outpatient visit (preoperative, 3- and 12-months postoperative) patients 
filled out 4 different Patient reported outcome measures (PROMs) as standard control in 
our department for knee arthroplasty patients. PROMs included the EuroQol-5D (EQ-5D; 
0 to 1, 1 indicates the best health state) [15], Oxford Knee Score (OKS; 12 to 60, 12 being the 
best outcome) [16] and the Western Ontario and McMaster Universities Arthritis Index 
(WOMAC; 0 to 100, 100 being the best outcome) [17]. Experienced pain was measured by 
a Numerical Rating Scale (NRS, 0 to 10, 10 being ‘worst pain’). This study was validated 
and approved by the Independent Review Board (METC Z, Heerlen, the Netherlands; 
IRB-nr.16N194) and registered online at the Dutch Trial Register (www.trialregister.nl). 
Statistical analysis
SPSS Version 17.0 for windows (Inc., Chicago, IL) was used. Standard descriptive statistics 
were used to describe the patient demographic data and baseline characteristics. Fisher’s 
exact test was used to test differences of proportions. Students T-tests were performed 
on the baseline conditions for significant interactions. A mixed model (GLMM) approach 
was used to take into account the repeated-measures design of the study, to cope with 
any missing data being collected during the pre-, 3- and 12-months postoperative follow-
up and to cope with the wide range of a possible variation in relation to the time-frame 
the data was collected [18]. The GLMM contained fixed variables, to estimate the effect 
of the different pathways and age on the trend of the PROMs (dependent variables). For 
all analyses, a p-value was considered to be statistically significant at P ≤ 0.05.




94 cases (26.1%) followed the outpatient surgery pathway (OS), while 267 patients 
(73.9%) followed the protocols of an enhanced recovery pathway (ERP). Baseline and 
operative data are presented in Table 2. 93 patients (99%) in the OS pathway were 
discharged on the day of surgery as scheduled, whereas in the ERP pathway 70% of the 
patients were discharged<3 days postoperatively. One patient in the OS pathway had 
prolonged hospital stay because not fulfilling the discharge criteria walking stairs. The 
first day postoperative the patient was discharged. At 12-month follow-up, the EQ-5D 
(both index and VAS), the OKS, WOMAC and NRS-pain score improved significantly 
(p<0.000) within each pathway. There were no significant differences between both 
pathways. Outcome measures data are summarized in Table 3.
Table 2. Baseline and operative data presented as mean (±SD) or absolute numbers for both groups.
ERP (n=267) OS (n=94) p-value
Age (years) at index surgery 68.4 (9.0) 63.4 (8.0) 0.033
Gender, Male/ female 94/173 49/45 0.005
BMI, kg/m2 29.49 (5.05) 28.25 (3.68) n.s.
ASA, ≤II / >II 253/14 94/0 0.025
Implant, TKA/UKA 230/37 51/43 0.022
Table 3. Mean (SD) and p-values are presented for the PROMs for both groups for each different follow-







EQ-5D Pre 0.77 0.06 0.80 0.07
(Index) 3-months 0.85 0.10 0.86 0.10
12-months 0.88 0.10 0.85 0.08 n.s.
EQ-5D Pre 62.5 18.5 66.4 19.4
(VAS) 3-months 73.5 16.8 79.8 11.7
12-months 73.6 17.2 82.5 13.1 n.s.
OKS Pre 36.9 7.7 34.8 8.0
3-months 25.9 8.1 23.6 7.5
12-months 21.3 7.2 19.2 5.8 n.s.
WOMAC Pre 58.8 23.6 64.3 21.8
3-months 78.1 18.5 81.7 16.7




The most important findings of the present study were that preselected patients who 
followed the outpatient knee arthroplasty pathway have comparable quality of life and 
PROMs as patients who followed the conventional pathway. Other studies showed that 
enhanced recovery pathways were as satisfying or even more satisfied compared to 
conventional pathways regarding the PROMS [19]. Increased PROMS were reported 
by Larsen et al. [11,20,21] at 3, 4 and 12 months postoperative. They reported that early 
mobilization, a nurse-led organization and optimisation of the preoperative education 
were a possible reason for these improved PROMs [11,20,21]. Our preoperative education 
and postoperative organization was unchanged. Therefore, a possible explanation for 
our results could be the strict patient selection criteria to select patients into one of 
the two clinical pathways. Besides, the results of Larson et al. were found after TKA 
in an enhanced recovery pathway [11,20,21], data after outpatient surgery are lacking. 
Hoorntje et al. [12] recently published their case-controlled study regarding the 
presence of symptoms of anxiety and depression, by means of the Hospital Anxiety 
and Depression Scale (HADS) in patients operated after UKA. They found that at 
the first postoperative day, the median HADS score was significantly (p=0.02) lower 
in the OS group compared to the ERP group and that patients in the OS group were 
significantly more satisfied (NRS satisfaction score, p=0.03) without any differences 
between both groups at 3-month follow-up [12] Pain relief and improved function 
are one of the principal aims of arthroplasty, thus it was expected that PROMs would 
improve significantly after knee arthroplasty. Due to aging and associated health issues, 
decreased selfrated health scores could be a logic consequence. However, the EQ-5D 
was still significantly better than the preoperative value but not different between both 
pathways. This shows that the possible problems associated with the knee arthritis 
alone, determine partially the overall health score. In the present study a wide range of 
PROMs were used to measure pre- and postoperative outcome after knee arthroplasty 
in preselected patients following ERP or OS. PROMs are a subjective measurement of 
clinical outcome after arthroplasty [22]. The used PROMs in this study did not capturing 
changes over time due to a lack of sensitivity to change of these scores [23]. Nonetheless, 
PROMs remain inherently subjective, prone to an individual’s interpretation and 
perception of function [22,24]. A more accurate and objective measure to validate 
patient clinical outcome after knee arthroplasty is highly sought. In addition to PROMs, 
acceleration-based gait analysis has been accepted as an objective measurement of 
functional and clinical outcome in arthroplasty patients [25]. Recent results have shown 
that the physical activity parameters of patients after TKA, following the outpatient 
surgery pathway, were similar to patients who followed the standard enhanced recovery 
pathway [13]. Acceleration-based gait analysis provides more insight information rather 
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than PROMs alone. A potential criticism in the study was the significant differences 
in baseline condition. To ensure a proper comparison, both groups should be equal 
(e.g. age, gender and ASA classification). On the other hand, our primary goal was to 
compare two pathways in which different patient selection criteria were used. Practical 
applicability of simplified protocols and new techniques are progressive. Although, these 
optimisations are associated with initial costs, they will reduce costs for the long term 
[26]. Firstly there must be an investment in training, knowledge and adjustments to daily 
practice for the surgeon, nurse and physiotherapist [27]. Good cooperation between 
these professionals and patients are necessary. All disciplines should be informed about, 
and involved in the whole process. Together with well-defined patient-based selection 
criteria, a change in mind set and a multidisciplinary approach, OS pathways are as safe 
and efficient as conventional pathways, in terms of readmissions, complications [8,14] 
and clinical outcome [12,13].
Conclusion
With the present study, we are able to conclude that patients, who are selected 
according to strict criteria for inclusion in an outpatient knee arthroplasty pathway, have 
comparable quality of life and PROMs as patients operated in a conventional enhanced 
recovery pathway.
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Arthroplasty surgeries are globally increasingly performed due to ageing of the 
population and higher demands of functional capabilities in (working) life [1,2]. Cost-
effectiveness and maximum functional recovery after surgery is therefore of increasing 
importance. To satisfy this higher volume and high-demanding expectations, the 
outcomes after surgery should ideally be evaluated and adjusted according to most 
recent literature. The improvement of healthcare is an ongoing process, rather than 
an one-way optimisation process, which should be initiated by the complete multi-
disciplinary team (e.g. orthopaedic surgeon, physiotherapists, anaesthesiologists, 
hospital pharmacist, nurses, hospital managers, scrub nurses, operation room 
planners, physician assistants) involved in the orthopaedic care regarding hip and knee 
arthroplasty. It holds an indispensable role to optimise outcomes after surgery, with a 
possible reduction of costs of the complete pre-, peri- and postoperative procedure [3]. 
A combination of an optimised arthroplasty pathway to reduce side-effects and/or (S)
AEs, and shortened LOS, will eventually contribute to a sustainable social-economic 
solution for this increasing demand [4]. 
The conduction of a perioperative arthroplasty pathway is done by further elaboration of 
the steps included in this pathway. As presented in part 1, several protocol optimisations 
led to improvement of patient preoperative information, more adequate perioperative 
blood management to prevent for blood transfusions, low postoperative amount of 
urinary retentions with omission of urinary catheters and acceptable pain scores to 
mobilize patients early after surgery. This step-wise work process is needed to cope 
with potential setbacks. It is not only the protocol itself which makes an optimisation 
effective and successful. The ongoing process towards the ‘perfect’ protocol is of even 
more importance. To incorporate the protocol in the current work processes, the 
involvement of all stakeholders is crucial. As, for example, orthopaedic surgeons and 
anaesthesiologists, need to step over traditions within the care of arthroplasty patients to 
reduce morbidity, mortality and costs [5]. In this matter, cost reduction is not only based 
on LOS, but it is also found by the introduction and optimisation of clinical protocols. 
For example, by implementing TXA, a tremendous decrease in postoperative blood 
transfusions was found. These transfusions are not only expensive but can potentially 
increase (S)AEs (e.g. thromboembolic events, infections), which also contribute to higher 
costs [6,7]. The same results are found after implementation of LIA in knee arthroplasty 
surgery. It decreased postoperative pain scores and makes it possible for patients to 
mobilize early after surgery, which improves outcomes and decreases LOS [8-11]. 
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When the fast-track pathway is enrolled as daily clinical practice, a further development 
of the pathway could lead to outpatient joint arthroplasty (OJA). The ultimate goal of 
OJA is not the discharge itself on the day of surgery, but rather the ambition towards 
perfection of the pre-, peri- and postoperative process which leads to the ability to safely 
discharge patients on the day of surgery, while maintaining or even improving patient 
satisfaction. During the past decades, OJA pathways are increasingly implemented, with 
success [12-14]. As most of the papers included the rather healthier and younger patients, 
the selection process of patients is of crucial importance [15,16]. Valuable information 
is stated in this thesis regarding the role of patient selection for these OJA pathways. 
The selection criteria are paramount to prevent for these (S)AEs and thus readmissions. 
Future research should focus on more precise criteria to extended OJA to daily practice 
and provide a choice for our patients (fast-track or OJA). These selection criteria are not 
solely based on medical conditions (or arguments), but also patient’s wishes are of (even 
more) importance. Several studies highlighted the preoperative education towards, for 
example, discharge on the day of surgery. One of the main reasons for discharge on the 
day of surgery is fear [17,18,19]. To prevent these delayed discharges, this fear has to be 
allayed. In first place by providing adequate information before surgery, for the patient 
as well as their relatives/caregivers. Adequate information on forehand can adjust 
postoperative expectations [20,21] and create the basics for preoperative preparation 
of their home-situation. 
After surgery, patients should be monitored closely to prevent for (S)AEs and/or 
readmissions. Future research holds an important role to optimise this monitoring. 
These days, several steps are already made towards better understanding and optimising 
the patients’ recovery after discharge, laid out in digital solutions (e.g. applications, 
smart-watches, health-care information systems, tele-rehabilitation) but need further 
evidence-based support for implementation in daily practice [22,23]. 
To connect the patients’ needs, medical interventions and the in-hospital logistical process, 
a case manager or project leader should ideally be appointed. It is of paramount importance 
to appoint a project leader which has substantive knowledge of the arthroplasty operation 
itself in first place, but more importantly, has insight in the complete patient ‘journey’ 
regarding the arthroplasty surgery. A physician assistant (PA), a specially trained healthcare 
professional (e.g. former physiotherapist, nurse, scrub nurse) who is certified to provide 
low complex medical services without direct supervision, can fulfil this position [24]. The 
PA has knowledge and experience with this process and is able to oversee the different 
stages during the patients’ journey. Potentially, it will reduce the surgeon’s workload by 
taking over the work regarding the evidence-based drafting and implementation of the 
perioperative protocols. As a clinically trained healthcare professional, the PA is able to 
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consult and debate the content of these protocols and processes with other healthcare 
professionals (e.g. physicians, nurses, planners, anaesthesiologists, hospital pharmacist, 
and other medical specialists). Furthermore, a point of contact is necessary as most 
of the process optimisations are accompanied by contrariety. In case of a setback, or 
adverse result of an optimisation, a project leader should be contacted to solve the arose 
problem. The ‘plan-do-check-act’ (PDCA) circle provides a tool for the basic principles 
of the optimisation. This optimisation process starts by outlining and analysing the 
current situation regarding clinical results (e.g. LOS, patient satisfaction, complication 
and readmission rate). Main reasons for the current (prolonged) LOS should be outlined. 
For example, statistics on pain scores, number of patients with PONV, early mobilisation 
success percentages, orthostatic intolerance, wound complications, urinary status etc. 
must be mapped. An analysis on the logistical process, the pathway from first contact 
preoperatively to last outpatient visit postoperatively, should be made, in order to 
streamline patients’ journey in-hospital. 
A profound analysis on patients’ needs and wishes regarding the perioperative process 
should be done in order to create ‘mind-set’ towards patient involvement in the 
perioperative treatment rather than a professional imposed process. In order to draw 
the ‘plan’ of optimisation, with its goal to improve the in-hospital process for patients and 
compromising the risk of peri- and direct postoperative complications. With an adequate 
‘plan’, the elaboration of the current evidence-based protocols should be made and 
implemented to the pathway itself. Comparing the current protocols with the state-of-the-
art in the latest literature. This process is time consuming, in which a PA plays an important 
role as the connector in a guiding role between the patient and the multidisciplinary 
health-care professional team, reporting to the orthopaedic surgeon. Contrary evidence 
statements exist, for example as outlined in chapter 3 several types of administrations, 
time regimens and dosages can be used for TXA implementation [25-28]. The drafted 
protocols should be discussed, chosen and approved by all professionals within the team 
in order to create a supportive base. Without compliance, these optimised protocols are 
destined to fail, as the effectiveness depends on the practical usage. 
When the newly designed protocols are finished and ready to be implemented, the step 
‘do’ takes effect. To create awareness of these novel protocols, communication towards 
all involved health-care professionals is paramount. Possible options to accomplish this 
are; (oral) presentations on the workplace with Q and A opportunities, (digital) update 
of the protocol database, issue a newsletter and/or subject-oriented training courses for 
several stakeholders (e.g. physiotherapists, nurses, planners), distribute new evidence-
base insights and most important, provide evidence on the data extracted from their 
own patients population (ideally as published results). 
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An indispensable role is held for the surgeon and PA; they are the representatives of the 
newly addressed workflow and should be on the ward, operation room, post anaesthetic 
care unit (PACU) and the outpatient clinic to answers questions and guide colleagues 
through the implementation process. After the implementation of the newly designed 
protocols, the evaluation should take place as outlined in this thesis on several topics 
within the clinical pathway. In first place, results regarding patient’s clinical data should 
be gathered and monitored on those subjects whom delay or negatively influence the 
patients’ journey (e.g. pain experience, PONV, urinary retention, wound complications, 
early mobilization). Secondly, adequate and repeatedly review of the literature should 
be done. To adjust the implemented protocols, the multi-disciplinary team should 
collaborate and provide regular consultation to adjust when deemed appropriate, which 
includes the final ‘act’ step of the PDCA circle. 
Final remark
By optimising the pre-, peri- and postoperative protocols, clinical pathways for hip and 
knee arthroplasty successfully resulted in well-established concepts such as fast-track 
surgery and OJA. With the aims of improving postoperative recovery in terms of lower 
morbidity and mortality with comparable or even improved PROMs and thus patient 
satisfaction. These improvements consist of evidence-based treatment modalities 
which are based on the reduction of surgical stress response and with an additional 
optimised logistical process. But most important, tailored information to the patient 
is crucial. Especially when implementing an OJA pathway, patients preoperative 
planning is of paramount importance. Patients need to know and understand the 
process to create the correct mind-set for discharge on the day of surgery to their home-
environment. Future research strategies should focus on a further evaluation of safety 
(e.g. (S)AEs, readmission rate) and efficacy (e.g. pain management, blood management, 
early mobilization, discharge criteria) aspects of OJA, substantiated with evidence-
based patient selection criteria with as major goal improving patients healthcare and 
satisfaction while reducing healthcare costs.
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Scientific innovations in healthcare only apply when the innovation itself is 
implemented into daily practice. The shift from scientific research towards newly 
designed clinical protocols used in future practice, holds an indispensable role during 
the innovation process. Sharing the current knowledge will ultimately increase 
the supportive base for these innovations. Valorisation is the supply of knowledge 
for different stakeholders within the clinical pathways, not only consisting of the 
healthcare staff, but also companies, governments and human society. This chapter 
attempts to discuss the medical, social and financial value of this thesis. 
Globally, rising healthcare costs are one of the most important challenges we face 
in the upcoming years. In orthopaedic care, especially the rise of hip and knee 
arthroplasty procedures to be performed on a global scale, demands critical analysis 
and distribution of healthcare resources. Innovations within the orthopaedic care 
should therefore not only focus on patient related outcomes (e.g. safety and efficacy) 
but also on reducing costs to maintain a sustainable and ‘financial healthy’ healthcare 
system. Care pathways are essential and play a major role in this challenge. Over 
the past decades, research has shown that LOS after hip and/or knee arthroplasty 
can be decreased by implementing an evidence-based clinical pathway. With the 
introduction of so-called OJA pathways, an even larger reduction is possible, and 
patients can be discharged on the day of surgery to their home-environment. The 
main challenge is to maintain the patient’s safety during the process of reduction of 
LOS. For example, when the fast-discharging protocol results in a higher readmission 
rate, it will lead to an opposite effect and thereby the number of (S)AEs and costs 
will only be higher. 
Besides the potential financial positive side-effects, the needs and wishes for 
patients to recover in their own environment could be encountered. In future, the 
organisation of postoperative care after arthroplasty surgery following an OJA 
pathway needs to be further developed. Adaptation of the patients’ needs and 
wishes are of primary importance to ensure that patients experience outpatient 
joint arthroplasty as an added value. The implementation of OJA should meet the 
need and expectations of patients. The role of the patient, in close contact with their 
relatives and/or caregivers, should be put first in the implementation process. For 
some patients, rapid discharge is desirable. The transition of hospital care to home 
could increase patient satisfaction. Whereas other patients feel safer in the hospital 
after surgery and require several days in the hospital. The differences between 
patients must be weighed in the decision for short (outpatient) or regular (several 
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days) hospital stay. Ideally, patients who are operated, decide after the operation, 
in close consultation with the ward doctor (personified by a physician assistant 
for example) and/or operating surgeon, when to leave the hospital according to 
preoperatively instructed discharge criteria. 
Future research should focus on a thorough clinical pathway for fast-track and outpatient 
hip and knee arthroplasty. By examining the different entities within these clinical 
pathways, a further improvement in the outcomes after surgery can be achieved. In 
particular precise patient selection criteria will provide an evidence-based foundation 
for implementation of these clinical pathways to daily practice. More insights in the 
postoperative experiences and needs for care should be gathered. These new insights, 
directly after discharge, will lead to a more patients’ tailored care. To streamline this 
ongoing process and evidence-based discussion, peer collaboration between all the 
involved health-care professionals, led by a project manager (e.g. physician assistant), 












On a global scale, hip and knee arthroplasty surgeries as treatment for end-stage 
osteoarthritis are increasingly performed, making these operations one of the most 
performed and successful orthopaedic surgeries. Improvement of outcomes after 
these surgeries is not solely based on the surgical procedure itself. In the past decades, 
the introduction of so-called clinical pathways improved postoperative outcomes in 
terms of safety and efficacy. Making it nowadays possible to discharge patients faster 
(within 2 days), and in selected populations even on the day of surgery. A clinical 
pathway consists of a combination of pre-, peri- and postoperative protocols, which 
form the patients’ process (or journey) throughout their surgical procedure. Ideally, 
these protocols are the result of a multi-disciplinary approach (e.g. orthopaedic surgeon, 
physiotherapists, anaesthesiologists, hospital pharmacist, nurses, hospital managers, 
scrub nurses, operation room planners, physician assistants) and is completely based 
on the latest scientific evidence. This thesis examined several crucial components of 
these enhanced recovery pathways in the first place and adds new insights in outpatient 
joint arthroplasty pathways. 
Part one start with addressing and examination of several keystones in the formation of 
an enhanced recovery pathway for hip and knee arthroplasty.
As preoperative information influences postoperative outcomes (in terms of satisfaction, 
by addressing expectations), type and form of provided information is paramount. In 
chapter 2 the patients’ experiences on the usage of an information brochure handed 
out to knee arthroplasty patients were investigated. Within this brief qualitative study, 
patients reported to be satisfied with the provided information brochure, making this an 
adequate method to prepare patients for surgery. Although patients reported no need 
for digital forms of information (e.g. websites, applications), the debate on these types 
of information sources will continue in future due to the digitization within society. 
After hip and knee arthroplasty, the need for postoperative blood transfusions rise 
up to 20%. The potential side effects of blood transfusions and the increased risks 
of complications after these transfusions (e.g. postoperative joint infection) make 
it undesirable. The introduction of tranexamic acid (TXA) reduced these numbers 
significantly. In chapter 3 the current TXA protocol (combining oral and intravenous 
administration) was retrospectively examined by investigating the transfusion rates 
in a large cohort of 5205 hip and knee arthroplasty patients. Only 0.9% of the patients 
received perioperative allogenic blood transfusions. Several clinical factors (e.g. age, 
body-mass index, American Society of Anaesthesiologists score, duration of surgery, 
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type of arthroplasty, estimated blood loss, perioperative Hb levels and length of stay) 
were statistically significant different between transfused and non-transfused patients. 
The incidence of thromboembolic adverse events (e.g. deep vein thrombosis/lung 
embolism) was acceptable low. 
One of the major issues for prolonged hospital stay and/or delayed mobilization is severe 
postoperative pain. Multi-modal pain modalities are conducted to control postoperative 
pain which makes the patient able to mobilize hours after surgery, reduce (opioid) 
pain medication and thereby effectuate early discharge. The introduction of local 
infiltration analgesia (LIA) in knee arthroplasty is the most considerable contributor 
to adequate pain control after surgery. Several methods are described, with variety of 
analgesics used in the mixture of LIA. Chapter 4 examined, via a randomized controlled 
trial, the effect of adrenaline in the LIA mixture. The postoperative pain scores and 
opioid consumption did not differ between patients who received LIA with or without 
adrenaline. To prevent for possible adrenaline-related side effects and maintaining the 
analgesic effect, omission of adrenaline from the LIA mixture is eligible.
Postoperative urinary retention (POUR) is a challenging condition after hip and knee 
arthroplasty surgery. It requires preventive measures, adequate monitoring and precise 
treatment if it does occur. Chapter 5 presents the results of a retrospective investigation 
of 803 patients, which showed 12.9% incidence of POUR after implementation of a nurse-
led bladder scan protocol. Patients characteristics and bladder volumes at different time-
point throughout the surgical process (pre-, peri- and postoperative) were analysed, 
showing >200ml of bladder volume directly after surgery as a risk factor for POUR. 
Part two continues with safety and efficacy evaluations of outpatient joint arthroplasty 
(OJA). 
When introducing newly designed methods and treatment protocols, a pilot or case-
controlled study can be conducted. Chapter 6 presents results of the first consecutive 
patients undergoing unicompartmental knee arthroplasty in an outpatient pathway. 
The outcomes, regarding safety (e.g. (serious) adverse events, readmissions) and 
efficacy (e.g. postoperative pain scores, postoperative nausea and vomiting (PONV), 
successful discharge on day of surgery) were compared with patients following the 
standard inpatient pathway. Postoperative pain was the most common reason for 
prolonged hospital stay for patients in the outpatient pathway group. Nevertheless, 
85% of the patients went home on the day of surgery. Regarding efficacy, no significant 
differences were found for postoperative pain scores, numbers of patients with PONV 




between outpatient and inpatients patients in terms of (serious) adverse events and/or 
readmission. Patient reported outcome measures (PROMs) improved equally between 
both groups. 
With the increased application of OJA pathways globally, evidence is growing. Chapter 7 
shows the results of a systematic review with meta-analysis on studies comparing 
OJA with standard inpatient pathways in terms of safety and efficacy (e.g. (S)AEs, 
readmissions, successful same day discharge rates, PROMs and costs). A total of 41 
studies met the inclusion criteria and were methodologically assessed. In general, 
patients who followed the outpatients pathway were younger, had a lower BMI and ASA 
class when compared with patients who followed the inpatient pathway. No statistically 
significant differences between outpatients and inpatients were found regarding the 
overall complication and readmission rates, and improvement in PROMs. OJA resulted 
in an average cost reduction of $6.797,02. Therefore, OJA pathways are as safe and 
effective as inpatient pathways in selected populations, with a potential reduction of 
costs. Considerable risk of bias in the majority of studies was found and should be taken 
into account. 
As outlined in the above-mentioned chapter, current literature mostly exists of papers 
including a selected group of patients for OJA pathways. In general, the younger and 
healthier patients are selected, since it is considered to be safer when starting with 
these OJA pathways. Adequate selection of patients for OJA is important to prevent 
for (serious) adverse events and readmissions. Chapter 8 reviewed the literature on 
these patient selection criteria and additional expert opinion-based selection criteria 
were established by interviewing different medical specialists. The described evidence-
based patient selection criteria, supplemented with expert opinions, provide a basis for 
outpatient joint arthroplasty and can be useful when selecting patients. 
After discharge, patients need to be physical active to prevent for complications (e.g. 
thrombo-embolic events) and to start the rehabilitation process. Chapter 9 examined 
patients’ physical activity during the first 6 weeks postoperative, comparing OJA with 
inpatient TKA surgery. Data was obtained with usage of an activity monitor. The activity 
parameters recovered steeply during the first 4 postoperative days and continued to 
improve within both pathways. No differences were found between both pathways 
regarding physical activity, both cohorts of patients did not reach preoperative levels 
at 5 weeks postoperative. This study demonstrates that the early physical activity 
parameters of patients after TKA recover independently of the clinical pathway 
(inpatient vs. outpatient) they were treated in.
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The further development and usage of OJA pathways can only be justified if it doesn’t 
lead to increased complications and readmissions, which has been outlined in the 
previous chapters, but also maintains PROMs after surgery. Chapter 10 examined 
the PROMs after knee arthroplasty surgery between in- and outpatients by assessing 
health-related quality of life (EuroQol-5D) and functional outcome (Oxford Knee Score, 
Western Ontario and McMaster Universities Arthritis Index and the Pain-Numerical 
Rating Scale). A total of 361 consecutive patients undergoing knee arthroplasty (total 
and partial) who followed either the OJA pathway (n=94; 26.1%) or standard inpatient 
pathway (n=267; 73.9%) were analysed preoperative, and at 3 and 12-months follow up. 
At one year postoperative, patients in both pathways improved equally, which confirms 
that type of pathway does not influence PROMs, regarding quality of life or functional 
outcome, after knee arthroplasty surgery. 
In conclusion, this thesis provides several pre-, peri-, and postoperative protocols, which 
optimise current treatment strategies in hip and knee arthroplasty patients, elaborated 
in two parts describing fast-track and OJA protocols.
Recommendation for future research
● High-quality trials (including randomized-controlled trials) comparing fast-track 
surgery with OJA. 
● In-depth analysis and drafting of precise patient selection criteria for roll out OJA 
pathways to general orthopaedic practice in hip and knee arthroplasty surgery.
● Exploring the patients experience, perspective and recommendations for OJA 
pathways. 





Als behandeling van eindstadium artrose, zal de vraag naar heup- en kniegewricht 
vervangende chirurgie de komende jaren wereldwijd stijgen. De uitkomst van deze 
behandeling is niet alleen gebaseerd op de operatie zelf, maar vooral ook op het gehele 
zorgproces rondom deze operatie. Dit zorgproces wordt beschreven in klinische 
zorgpaden en hebben de laatste jaren toenemende aandacht gekregen. Een klinisch 
zorgpad bestaat uit een aaneenschakeling van, op aangetoonde en wetenschappelijk 
bewezen, pre-, peri- en postoperatieve protocollen. Idealiter zijn deze protocollen 
het resultaat van een multidisciplinaire samenwerking, waarvan de invulling wordt 
vormgegeven door o.a. de orthopedisch chirurg, fysiotherapeut, anesthesioloog, 
verpleegkundige, managers, operatieassistenten, planners en physician assistant. 
Door het optimaliseren van deze zorgpaden, verbeteren de klinische uitkomstmaten 
in termen van ziekenhuis opnameduur, postoperatieve pijnbeleving, vroegtijdige 
mobilisatie, reductie van complicaties en heropnames (fast-track surgery). Als gevolg 
van deze optimalisaties, is het voor vooraf geselcteerde patiënten zelfs mogelijk om in 
dagbehandeling geopereerd te worden (outpatient joint arthroplasty). In dit proefschrift 
worden verschillende specifieke onderdelen van deze klinische zorgpaden voor heup- 
en knieprotheses onderzocht, met een verdere verdieping naar dagbehandeling. 
In Deel 1 van dit proefschrift worden de verschillende optimalisatiestappen van een 
fast-track surgery zorgpad uiteengezet. 
Het preoperatief correct informeren van patiënten zorgt voor een hogere patiënt 
tevredenheid. Dit maakt dat de manier waarop dit gebeurt essentieel. In hoofdstuk 2 
worden de resultaten weergegeven van een kwalitatieve studie naar de patiëntervaringen 
met het gebruik van een brochure over de knieprothese operatie. Patiënten geven aan 
dat het gebruik van deze brochure aan te raden is en dat zij naar tevredenheid zijn 
voorgelicht. Er werden enkele punten van optimalisatie genoemd (o.a. vorm, weergave). 
Ondanks dat patiënten in deze studie geen behoefte rapporteerde aan digitale vormen 
van informatie (o.a. apps, websites), blijft dit naar de toekomst toe een punt van discussie 
gezien de digitalisering van onze samenleving en steeds jongere populatie knieprothese 
patiënten. 
Eén van de grootste uitdagingen tijdens een heup- of knieprothese operatie, is het 
beperken van bloedverlies en daarmee postoperatieve bloedtransfusies. De potentiele 
bijwerkingen van bloedtransfusies kunnen ingrijpend zijn (o.a. transfusiereactie, 
verhoogde kans op een postoperatieve wondinfectie). Door de introductie van 
tranexaminezuur zien wij een forse reductie in het aantal bloedtransfusies na de 
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operatie. In hoofdstuk 3 worden de resultaten weergegeven van een perioperatief 
tranexaminezuur protocol voor heup- en knieprothese operaties. In een cohort van 5205 
patiënten, welke preoperatief (oraal) en perioperatief (intraveneus) tranexaminezuur 
kregen toegediend, werd een bloedtransfusie percentage van 0.9% gevonden, afgezet 
tegen een transfusie percentage die in de huidige literatuur zelfs oploopt tot 20%. 
Verschillende klinische factoren waren statistisch significant verschillend tussen 
getransfundeerde en niet-getransfundeerde patiënten (o.a. leeftijd, body-mass index, 
American Society of Anaesthesiologists score, duur van de operatie, type prothese, 
geschat bloedverlies, perioperatieve hemoglobinegehalte en ligduur). Er werd een lage 
incidentie van trombo-embolische events (o.a. diep veneuze trombose/longembolie) 
gezien. 
Een van de meest gerapporteerde redenen voor een verlengde ziekenhuis opname, 
is postoperatieve pijn. Protocollen waarin het gebruik van opiaten beperkt wordt, zijn 
opgesteld om postoperatieve pijn te verminderen zonder de nadelige bijwerkingen 
van opioïden (o.a. PONV). Dit maakt mede een vroegtijdige mobilisatie na de operatie 
mogelijk en bespoedigt het ontslag. Lokale infiltratie anesthesie (LIA) in knieprothese 
chirurgie is een van de meest effectieve methoden om direct postoperatieve pijn te 
verminderen. Verschillende methodieken zijn beschreven met een verscheidenheid 
aan analgetica in de injectievloeistof. Hoofdstuk 4 presenteert de resultaten van een 
gerandomiseerde klinische trial over het effect van adrenaline in deze injectievloeistof. 
Er werden twee groepen vergeleken (ropivacaïne met en zonder toevoeging van 
adrenaline). De postoperatieve pijn scores waren niet verschillend tussen beide 
groepen, evenals het postoperatieve gebruik van opiaten. Concluderend kunnen we 
zeggen dat adrenaline niet bijdraagd aan de effectiviteit van LIA met ropivacaïne bij 
knieprotheses, en dus niet toegevoegd hoeft te worden aan de LIA injectievloeistof. 
Postoperatieve urineretentie is een veelvoorkomende complicatie na een heup- of 
knieprothese operatie. Een bladder scan protocol zorgt voor een adequate monitoring 
van urine volume en, in geval van urineretentie, vroegtijdige behandeling. Hoofdstuk 5 
beschrijft een retrospectieve studie waarbij de resultaten van de implementatie van een 
bladder scan protocol, in een cohort van 803 heup- of knieprothese patiënten. Een lage 
incidentie (12.9%) van urineretenties werd gevonden in deze populatie. Verschillende 
patiënt karakteristieken werden geanalyseerd. Patiënten met een blaasvolume van meer 
dan 200ml direct na de operatie zijn ‘at risk’ voor de ontwikkeling van postoperatieve 
urineretentie. 
Deel 2 van dit proefschrift richt zich op de verdere uitwerking van dagbehandeling voor 




Hoofdstuk 6 presenteert de resultaten van de eerste patiënten die een hemiknieprothese 
operatie hebben ondergaan in een dagbehandeling zorgpad. Uitkomsten betreffende 
veiligheid (o.a. complicaties, heropnames) en effectiviteit (o.a. pijnscores, aantal patiënten 
ontslagen op dag van operatie) werden vergeleken met patiënten behandeld met het 
standaard zorgpad (enkele dagen opname). 85% van de in opzet dagbehandeling patiënten 
ging daadwerkelijk op de dag van de operatie naar huis. Postoperatieve pijn was de meest 
gerapporteerde reden voor falen van dagbehandeling. Er werden geen statistisch significante 
verschillen gevonden tussen beide groepen patiënten in veiligheid en effectiviteit. 
Wereldwijd is er een groei van het aantal patiënten dat een heup- of knieprothese operatie 
ondergaat in dagbehandeling. Hoofdstuk 7 toont de resultaten van een systematische 
review en meta-analysis over dagbehandeling voor heup- en knieprothese welke vergeleken 
worden met de standaard fast-track zorgpaden. Als uitkomstmaten werd gekeken naar 
veiligheid en effectiviteit (o.a. complicatie risico, heropnames, succes percentage ontslag op 
dag van operatie, PROMs en kosten). In totaal werden 41 studies methodologisch beoordeeld 
en meegenomen in de analyse. Er werd een laag tot gemiddeld bias risico gevonden, waarbij 
het grootste deel van de studies retrospectief van aard zijn. Over het algemeen wordt 
gezien dat de patiëntenpopulatie die in dagbehandeling een heup- of knieprothese operatie 
ondergaat jonger is met een lagere ASA score en BMI. Over het algemeen werden er geen 
statistisch significante verschillen gevonden voor het aantal complicaties, heropnames en 
PROMs. Voor patienten die een heupprothese in dagbheandeling kregen, werden minder 
complicaties gerapporteerd. Dagbehandeling resulteerde in een gemiddelde kostenreductie 
van $6.797,02. Het lijkt erop dat dagbehandeling, voor een selecte groep patiënten, veilig 
en effectief is met behoud van patiënt tevredenheid met een mogelijke kostenbesparing. 
Zoals in het vorige hoofdstuk beschreven, is het toepassen van dagbehandeling 
voornamelijk onderzocht in selectieve patiëntengroepen van vooral jongere en 
gezondere patiënten als onderzoekpopulatie. Ter preventie van complicaties en 
heropnames is het van cruciaal belang om criteria te hanteren waarop patiënten 
geselecteerd worden. Hoofdstuk 8 presenteert de resultaten van een literatuurstudie 
en expert opinie naar selectie criteria voor dagbehandeling heup- en knieprothese 
operaties. Verschillende selectie criteria werden beschreven, aangevuld met meningen 
van verschillende medisch specialisten. Deze criteria vormen de basis voor verder 
onderzoek en de implementatie van dagbehandeling voor heup- en knieprothesiologie. 
Om complicaties te voorkomen is het van belang dat patiënten na de operatie fysiek 
actief zijn. Hoofdstuk 9 geeft de resultaten weer van een vergelijkende studie naar 
fysieke activiteit tussen patiënten die in dagbehandeling een knieprothese kregen, 
vergeleken met patiënten in het standaard fast-track zorgpad. Data werden verzameld 
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middels een activity monitor. Er werden geen statistisch significante verschillen gezien 
in fysieke activiteit tussen dagbehandeling en fast-track patiënten. Beide cohorten 
haalde na 6 weken niet het fysieke activiteitniveau van voor de operatie. Deze studie laat 
daarmee zien dat fysieke activiteit in de direct postoperatieve fase na een knieprothese 
vergelijkbaar is tussen dagbehandeling en fast-track patiënten.
De verdere ontwikkeling en inzet van dagbehandeling voor heup- en knieprothesiologie 
kan alleen worden gerechtvaardigd wanneer dit niet leidt tot een toename van 
complicaties, heropnames of een invloed heeft op patiënt tevredenheid. In hoofdstuk 10 
wordt de invloed van dagbehandeling op patiënt gerapporteerde uitkomsten (PROMs) 
vergeleken met een standaard fast-track zorgpad bij knieprothese patiënten. Kwaliteit 
van leven en functionele uitkomsten werden vergeleken door middel van vragenlijsten 
(EuroQol-5D, Oxford Knee Score, Western Ontario and McMaster Universities Arthritis 
Index and the Pain-Numerical Rating Scale). In totaal werd de data van 361 patiënten 
(n=94 dagbehandeling, 26.1%) geanalyseerd voor en op twee momenten na de operatie 
(3 en 12 maanden postoperatief). De verbetering van kwaliteit van leven en functionele 
uitkomstmaten waren gelijk tussen dagbehandeling en fast-track patiënten en laat 
daarmee zien dat het type zorgpad de PROMs na de operatie niet beïnvloedt. 
Concluderend wordt in dit proefschrift een overzicht gegeven van de pre-, peri- en 
postoperatieve protocollen die de basis kunnen vormen voor fast-track zorgpaden. 
Daarnaast worden er diverse studies gepresenteerd over de doorontwikkeling naar 
dagbehandeling voor heup- en knieprotheses en de veiligheid en effectiviteit hiervan. 
Aanbevelingen voor toekomstig 
wetenschappelijk onderzoek
● Kwalitatief hoge klinische trials die fast-track zorgpaden vergelijken met 
dagbehandeling, met als doel meer inzicht te krijgen in de veiligheid en effectiviteit 
van dagbehandeling. 
● Verdere ontwikkelingen en diepgaand onderzoek naar de selectiecriteria voor 
dagbehandeling, met als doel het reduceren van complicaties en heropnames, en 
daarbij waarborgen van de patiënt tevredenheid. 
● Analyseren van patiënt ervaringen, perspectieven en aanbevelingen voor 
dagbehandeling, met als doel het verder door ontwikkelen van het zorgpad vanuit 
patiënt perspectief. 
















Het doen van wetenschappelijk onderzoek is teamwork en een proefschrift ontstaat 
niet zonder hulp van anderen. Daarom wil ik iedereen bedanken die geholpen heeft in 
de totstandkoming van dit proefschrift en een aantal in het bijzonder; 
Co-promotor: dr. M.G.M. Schotanus, beste Martijn, eerlijk is eerlijk, zonder jou was dit 
proefschrift er niet geweest. Vanaf dag één bij de orthopedie heb je me betrokken bij 
wetenschappelijk onderzoek en op sleeptouw genomen. Je hebt me geleerd hoe je 
onderzoek doet en bent altijd bereidt mij te ondersteunen. Ik ben je eeuwig dankbaar 
voor al je hulp. 
Co-promotor: dr. E.H. van Haaren, beste Emil, daar waar ik moeite had om het geheel 
te overzien, zorgde jij voor de rode draad en het overzicht. Je vertrouwen in mijn 
onderzoek maar ook in mijn werk als PA, waardeer ik enorm. Door dit vertrouwen heb 
je mij naar een hoger niveau gebracht als zorgprofessional maar nu ook als onderzoeker.
Promotor: Prof. dr. L. van Rhijn, beste Lodewijk, dank voor je bijdrage aan dit proefschrift. 
Vanaf begin af aan stelde je dat het ‘mijn boekje’ moest worden. Je open houding met 
daarbij het persoonlijke resultaat voor mij, waardeer ik enorm. Mijn dank is groot voor 
je vertrouwen en ondersteuning. 
Leden van de beoordelingscommissie: Prof. dr. R.A. de Bie, Prof. dr. N.L.U. van Meeteren, 
Prof. dr. J.H.M. van Zundert, Prof. dr. P.C.P.H. Willems, dr. R.C.I. van Geenen, allen dank 
voor jullie inzet en tijd om dit proefschrift grondig te bestuderen en te beoordelen. 
Maatschap orthopedie Zuyderland, dank voor jullie vertrouwen en de ruimte die ik heb 
gekregen om mijzelf te ontwikkelen. In het bijzonder dank aan oud-collega dr. J.J. van Os 
voor de begeleiding tijdens mijn opleiding en wijze lessen in het vak orthopedie. 
Paranimfen Bianca Vanwersch en Niels Bemelmans, het is een eer om dit proefschrift 
te verdedigen met jullie aan mijn zijde! 
De coauteurs van alle artikelen bedankt voor de prettige samenwerking en de mooie 
artikelen. In het bijzonder dank aan mijn opleider dr. N.P. Kort. Hoewel onze wegen zijn 
gescheiden halverwege dit proefschrift, hebben we samen veel onderzoek gedaan, wat 
uiteindelijk de basis vormde. Dank voor je vertrouwen en de productieve samenwerking. 
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Collega’s van de afdeling orthopedie, polikliniek orthopedie, zorgplanners, DBC-
consulenten, gipsmeesters, (poliklinische) operatieassistenten, fysiotherapeuten, 
management RVE mobiliteit & bewegen; dank voor alle ondersteuning. 
Mede PA studenten Marly, Esther & Mayk, dank voor jullie steun en vooral de gezellige 
autoritten van en naar Nijmegen. 
Alle patiënten die hebben deelgenomen aan de studies in dit proefschrift wil ik danken 
voor hun deelname. 
Collegae physician assistants, arts-assistenten, semi-artsen, co-assistenten, bedankt 
voor jullie hulp in de afgelopen tijd en de rooster ruimte om te werken aan onderzoek. 
Vrienden en familie, dank voor al jullie steun en hulp. Mijn broers Lars en Niels, hoewel 
ik betwijfel of het jullie interesseerde, stoom afblazen over de frustraties die gepaard 
kunnen gaan met onderzoek doen, kon ik bij jullie prima. Onze gezamenlijke interesses 
vormen de perfecte basis voor ontspanning in drukke tijden. Mijn ouders, Pap en Mam, 
jullie gaven mij de vrijheid en ruimte die ik nodig had om te komen waar ik nu ben. Niets 
is onmogelijk, zolang je maar je best doet. Dank voor alles. 
Tot slot, lieve Vanity, Sophie & Oliver, zonder jullie liefde, steun en hulp was het nooit 
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